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Schizophrenia is a challenging and complex disorder with 30–50% of patients not
responding to rst line antipsychotic treatment. Clozapine is the only antipsychotic
approved by the FDA for treatment-resistant schizophrenia and is the most eective
antipsychotic medication currently available. Yet, clozapine remains underutilized
because of the requirements for frequent invasive and burdensome monitoring to 1) titrate
doses to achieve eective blood levels, as well as 2) monitor white blood cells on a weekly
basis for the rst six months due to risk of agranulocytosis, a rare but potentially fatal
side eect of clozapine. These blood draws, and the time lag in receiving reports from
central labs, can add several more visits to the caregivers’ treatment plan, which may
not be feasible for the patient nor the treatment team. This contributes to a very low
prescription rate for clozapine, making it one of the most underutilized evidence-based
treatments in the eld of mental health.
The objective of this work is to progress toward a point-of-care approach to monitor
both white blood cells and clozapine within a clinical setting. This would signicantly
lower the burden associated with clozapine treatment by allowing both tests to be
performed rapidly during a single doctor’s oce visit or at the pharmacy. Specically, I
have developed and studied novel clozapine detection schemes based on electrochemical
signal amplication in chitosan-based lms. Moreover, I have investigated impedance
cytometry coupled with hydrodynamic focusing and osmotic lysis to provide label- and
reagent-free dierential white blood cell counting capabilities. Finally, I have integrated
the components in a microsystem capable of concurrent sensing of both biomarkers
in whole blood samples. This proof-of-concept device lays the foundation for a fully
integrated and automated lab-on-a-chip for point-of-care or even at-home testing to
ensure treatment adherence, ecacy, and safety. This will allow for broader use of
clozapine by increasing convenience to patients as well as medical professionals, thus
improving the lives of people aected by schizophrenia through personalized medicine.
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1.1 Motivation & Background
Lab-on-a-chip devices have rapidly proliferated in the past decade, resulting not
only in the creation of the eponymous journal but also in a signicant number of
commercialized applications [1]. These research eorts, however, have by comparison
only marginally extended into the eld of mental health. Examples include the detection
of neurotransmitters, analysis of stress levels from saliva, and monitoring of lithium
treatment for bipolar disorder [2–4]. To the best of my knowledge, there exist no specic
applications towards schizophrenia as yet.
Schizophrenia is one of the most challenging and complex neuropsychiatric
disorders aicting humanity. The lifelong devastating illness is characterized by an
abnormal interpretation of reality. The burden of the disorder is high, accounting for
0.5% of the global disability-adjusted life years lost – more than all STDs (except HIV)
combined [5]. Its direct and indirect costs are estimated to exceed $150 billion annually in
the US alone [6]. The recommended treatment, for lack of a cure, is lifelong antipsychotic
medication [7]. However, 30–50% of patients do not respond to rst line psychiatric drug
treatment [8]. Clozapine is the most eective drug available, providing symptom relief
even to patients unresponsive to other second-line medication [9]. It is also the only
FDA-approved antipsychotic for treatment-resistant schizophrenia.
In spite of the overwhelming evidence of the superior ecacy of clozapine compared
to other drugs, it is prescribed infrequently in the United States – to less than 10% of all
patients with schizophrenia, a disproportionately lower rate than the estimated prevalence
of treatment-resistant schizophrenia [10]. A major factor in this underutilization is the
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required invasive monitoring at regular intervals for agranulocytosis (a severe loss of
granulocytes, a type of white blood cell) [11]. To avoid this rare but potentially fatal
side eect, the FDA stipulates weekly blood draws for at least the rst six months of
treatment, with decreasing intervals thereafter [12]. The current FDA classication of an
abnormal event – requiring interruption of clozapine treatment – involves a granulocyte
count of less than 1,000/µl, or 500/µl for people with naturally low granulocyte counts.
These tests imply a signicant burden for both the patient and treatment team in terms of
unpleasant venous blood sampling, wait times for results from centralized labs, logistics
of organization and transportation for these oce visits, etc.
Supplementary tests for accurate clozapine dosage control have been shown to
improve outcomes and decrease the risk of toxicity [7,13]. Clozapine is one of the few
antipsychotics with a well-established eective range of blood plasma levels, namely
1–3 µM [14]. Below this range the drug is unlikely to provide relief, while above toxicity
side eects such as seizures become much more likely. However, the blood draws for
clozapine monitoring are rarely implemented, especially beyond the initial titration
phase, i.e. where the dose is gradually increased. These supplementary blood draws,
again requiring testing at centralized labs, further compound the aforementioned burden
to patients and clinicians in terms of cost and time. Thus, real-time monitoring of both
clozapine and granulocytes at the point of care would have signicant positive impact by
allowing physicians to rapidly adjust dosages to reach safe and eective levels as well as
check for onset of agranulocytosis [8].
Furthermore, nonadherence to medication regimens is a widespread challenge in
medical treatment [14]. This applies even more so to people with neuropsychiatric disor-
ders such as schizophrenia, where patients may be more prone to actively stop medicating
(in addition to the generally prevalent passive forgetfulness). Indeed, nonadherence is
found to be one of the more frequent reasons for relapse, rehospitalization, and higher
treatment costs [15]. Currently there is no good way to measure adherence; testing for
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Figure 1.1: Schematic showing the current burdensome monitoring associated with
clozapine treatment, and the envisioned point-of-care monitoring solution.
presence of antipsychotics in the blood solely for this purpose is burdensome and not cost
eective. However, monitoring blood levels to optimize clozapine ecacy and reduce
the risk of side eects will also allow physicians to know if patients are adherent to their
treatment or need interventions to support adherence. Thus, non-cumbersome blood
level monitoring is critical to maximizing success and safety for each patient.
It is essential that physicians who prescribe clozapine or would consider prescribing
clozapine nd this type of device equally important. Pilot data from my collaborator Dr.
Deanna Kelly demonstrates that point-of-care monitoring of clozapine, as illustrated in
Figure 1.1, would indeed represent a major advance in the treatment of schizophrenia.
In an IRB-approved anonymous survey of physicians, this is the number one ranked
solution to improving barriers of prescribing [11]. The survey consisted of a series of
questions ranking barriers to the use of clozapine and possible ways to improve clozapine
utilization from 1 (strongly disagree) to 5 (strongly agree). It further included a series
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of questions asking specically whether point-of-care devices would improve current
care and increase their willingness to prescribe clozapine. Among 28 listed barriers
(clinical, nonclinical, and side eects) to more frequent use of clozapine, the two highest
ranked choices were 1) patients will likely be nonadherent to blood work (score 3.7/5)
and 2) the burden of blood work on the patient (3.6/5). Also, among nine potential
solutions for increased clozapine use, clozapine levels and white blood cell measurement
in the physician’s oce or pharmacy was top-ranked (4.0/5). Overall, physicians agreed
that such a point-of-care device would improve care and increase their prescription of
clozapine.
1.2 Summary of Accomplishments
No studies, to date, have developed microsystems designed for mental health therapeutic
drug monitoring. With no superior treatment on the horizon for schizophrenia, research
that allows using clozapine more frequently could improve the lives of potentially millions
of patients aected by this devastating illness. My research in this dissertation aims
at developing a proof-of-concept device for concurrent monitoring of clozapine and
granulocytes, schematically illustrated in Figure 1.2, that is suitable for translation to
the point of care such as the physician’s oce or pharmacy. This will enable physicians
to easily obtain clozapine levels for early detection of nonadherence and optimization
of plasma levels for clinical response while avoiding side eects and toxicity. A major
aspect of this thesis is the integration of the critical components on a single lab-on-a-
chip. As discussed herein, work has been done on dierential blood cell counting and
clozapine sensing, but my research demonstrates the rst integrated device approach to
monitor both cellular and acellular components of blood. By incorporating a unique and
extensive plan for sub-system evaluation and integration, a crucial aspect that has often
been overlooked, I overcome previous barriers of detection. These concepts also extend
beyond the original application, and can be adapted for many other areas of mental and
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Figure 1.2: Schematic rendering of the integrated microsystem developed in this thesis.
general health care and treatment that require simultaneous monitoring of both blood
cells and plasma biomarkers.
1.2.1 Miniaturizable Electrochemical Clozapine Detection Mechanisms
In this thesis, I present three related but distinct approaches to detecting clozapine in
complex biological samples based on its electrochemical activity. Previously published
techniques have shown good sensitivity but fallen short on selectivity, often resorting
to extensive pre-treatment procedures. Here, I rely on a matrix of the biomaterial
chitosan, further modied with the small redox-active molecule catechol, or combined
with carbon nanotubes and/or graphene. First, I characterize sensing gures of merit
for the chitosan-catechol redox cycling system, determining a detection limit of less
than 1 µM, and demonstrating selectivity over other redox species such as clozapine’s
highly analogous metabolite norclozapine. I further assess lm stability and the impact
of the electrode material on clozapine sensing. My work not only demonstrates a novel
sensing approach, but also yields a deeper understanding of the interplay between
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biomolecules, biomaterials, and electrochemistry in this realm. Finally, the chitosan-
carbon nanotube/graphene redox catalysis system is shown to oer distinct sensing
capabilities, with high sensitivity to clozapine and selectivity over endogenous species in
serum.
1.2.2 Reagent- and Label-free White Blood Cell Counting
In this thesis, I develop an easy-to-fabricate, microuidic, impedance-based white blood
cell counter. Existing approaches suer from limited sensitivity or employ reagents
or labels to enable dierential cell counts. Here, I investigate two specic sub-system
integration approaches for impedance cytometry – capable of label-free cell counts
– intended to overcome these limitations. First, I conduct an in-depth study of its
systems interplay with hydrodynamic focusing, whereby the sample is conned using
non-conducting laminar sheath ows to increase performance. I demonstrate an up to
5-fold increase in sensitivity, and more importantly, shed light on the typically neglected
importance of diusion eects in such a system. Second, I consider the systems interplay
between impedance cytometry and osmotic lysis. Therein, pure water instead of chemical
agents is utilized to lyse the 1,000-fold more prevalent erythrocytes to enable leukocyte
counts. I nd that osmotic lysis is over 99.9% eective and does not interfere with
cytometry performance.
1.2.3 Microsystem Integration for Dual Plasma/Cellular Sensing
In this thesis, I ultimately integrate the aforementioned subsystems into a holistic
microsystem for concurrent cellular and acellular (small-molecule) whole blood analysis.
To the best of my knowledge, no such device exists as yet. I evaluate plasma skimming, a
passive hydrodynamic approach for separating blood plasma and cells, for its suitability
in such a device. I utilize a proof-of-concept, label-free, impedimetric immunoassay
approach for this purpose. With this, I demonstrate the detection of antibodies in whole
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blood without the need for pumps or bulky readout equipment, but discover limited
continuous-ow capabilities. For the integrated clozapine treatment monitoring device,
I therefore integrate the redox catalysis system in-line and upstream from the white
blood cell counting sub-systems. I showcase whole-blood clozapine detection and blood
cell dierentiation capabilities with my nal microsystem, highlighting the feasibility of
concurrent clozapine and granulocyte monitoring.
1.3 Literature Review
1.3.1 Clozapine Pharmacology
Typically, clozapine is administered orally in divided doses totaling 300 to 800 mg per
day [7,12]. This dosage is gradually reached over an initial titration period of ∼ 2 weeks
under close monitoring by the treatment team. To enter systemic circulation, clozapine
has to pass through the liver where it undergoes extensive rst-pass metabolism. It
acts as a substrate for cytochrome P450 enzymes, particularly the 1A2 variety, with the
two major stable products being N -desmethylclozapine (norclozapine; shown alongside
clozapine itself in Figure 1.3) and clozapine N -oxide [16]. This limits bioavailability of the
drug, necessitates the typically divided dosing mentioned earlier, and links bioavailability
closely to factors interacting with these hepatic pathways such as other drugs, smoking,
or inammation [17]. Once in circulation, therapeutic availability of clozapine is limited
by its strong anity to serum proteins. Up to 97% of clozapine is present in a bound state,
mostly with serum albumin and alpha-1 acid glycoprotein (AAG) [18,19].
While the therapeutic mechanism of action of clozapine is poorly understood,
it shows a wealth of interactions with nervous system receptors [20]. Antagonism to
dopamine type 2 and serotonin type 2A receptors is likely central [21]. The metabolite
norclozapine is thought to have weak therapeutic activity as well, though possibly only
in combination with clozapine itself. The lowest eective plasma level of clozapine is
7
clozapine | norclozapine
Figure 1.3: Chemical structures of the antipsychotic clozapine (left) and its metabolite
norclozapine (right).
commonly reported as & 1 µM (350 ng/ml) [14]. Like many antipsychotic drugs, clozapine
can also cause a range of adverse side eects [12]. Central and autonomous nervous
system eects like drowsiness and hypersalivation are among the most common; many of
these side eects can be eectively managed, for instance with co-prescribed medications.
Some serious neural and cardiac adverse reactions such as seizures and cardiac arrest are
linked to clozapine toxicity, i.e. excessively high levels of the drug & 3 µM (1000 ng/ml)
[13]. The gradual and controlled upward titration at the start of treatment has proven to
both help ecacy and decrease toxicity.
Other adverse eects appear to be independent of dosage [13]. The most severe
and least uncommon in this category is agranulocytosis, aicting up to 1% of patients.
The condition can be fatal if granulocyte levels drop to less than 500/µl, severely
compromising the immune system and leaving the patient vulnerable to infection. The
mechanism behind clozapine-induced agranulocytosis is still unclear [22]. It has been
established that both myeloid precurser cells as well as adult neutrophils are aected,
decreasing the existing white blood cell population and compromising regeneration.
However, neither clozapine nor its stable metabolites have shown toxicity to these
cells. Metabolism of clozapine into a reactive intermediate inside the aected cells
themselves could be responsible. The low patient incidence appears to be the result of
a complex, multi-factorial set of parameters determining predisposition for clozapine-
induced agranulocytosis.
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1.3.2 Clozapine Detection Approaches
In current procedure, the preferred method for measuring clozapine plasma levels is a
combination of high-performance liquid chromatography and tandem mass spectrometry
(HPLC/MS/MS), the method of choice for therapeutic drug monitoring in general
[14]. First, patient samples undergo sample preparation that may include dilution,
centrifugation, and the addition of reagents. Then, a small (microliter-scale) volume
is injected into the mobile phase passing through the chromatography column, where
the sample is fractionated based on physical interactions with the stationary phase. At
the outlet, an ionized gas is created from the liquid and two-stage mass spectrometry is
applied to the various sample fractions to identify constituents based on their mass-to-
charge ratios. This approach allows for sensitive simultaneous detection of many dierent
analytes with a limit of detection (LOD) as low as 5 nM for clozapine [23]. However, the
sample preparation is clearly time-consuming and requires a trained technician or costly
automation, which also applies to the the bulky and expensive requisite equipment itself.
Moreover, due to the reagents employed in the process, protein-bound clozapine is freed
prior to measurement. Thus, laboratories report the total (protein-bound and -unbound)
clozapine and norclozapine concentrations. To determine bound and -unbound fractions,
equilibrium dialysis has to be applied prior to HPLC/MS/MS [24].
It is immediately apparent that the HPLC/MS/MS approach is not very amenable to
translation to the point of care. Research has been done on miniaturizing such systems,
especially in terms of the HPLC column and sample ionization [25,26]. However, the
nature of mass spectrometry – based on ionized compounds being subjected to high
external elds in a near vacuum – renders it impractical for lab-on-a-chip systems for the
foreseeable future. Toward clozapine detection, other researchers have thus investigated
replacing the signal transduction mechanism. Two of the earliest reports in this regard
show detection based on ultraviolet absorbance (LOD 15 nM) [27] and amperometric
detection (LOD 60 nM) [28], with a later report also demonstrating uorimetric detection
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(LOD < 150 nM) [29]. It becomes apparent that the detection limit – in all cases for
clinical samples, though calculated using slightly dierent methodologies – is compatible
with the clinical range independent of the transduction, demonstrating the advantages
of HPLC. Both optical approaches rely on the highly aromatic nature of clozapine seen
in Figure 1.3, yielding the necessary delocalization of pi electrons. The amperometric
detection relies on clozapine’s inherent redox activity.
Initially reported by Kaumann et al., clozapine has a standard reduction potential
of Eo ∼ +0.95 V (vs. standard hydrogen electrode), undergoing a partially reversible two-
electron, one-proton reaction as shown in Figure 1.4 [30]. The overall reaction scheme is
quite complex, with a number of products of varying stability and redox activity formed,
as demonstrated by Leeuwen et al. utilizing electrochemistry followed by on-line LC/MS
for analysis [31]. However, for most electroanalytical purposes, the aforementioned
primary reaction dominates. Due to the involvement of a proton in the reaction, the
reaction potential of course depends on the pH of the solution – at physiological pH and
with respect to a common Ag/AgCl reference (henceforth the default in this thesis unless
noted otherwise), it is observed around Eo′ = +0.37 V.
Utilizing chromatography in the analysis methods retains the advantage of at
least partially decoupling selectivity (from chromatography) and sensitivity (from
transduction). However, this also retains HPLC’s aforementioned limitations in terms of
sample preparation and reagent requirements. Capillary zone electrophoresis oers a way
to reduce those limitations with lower requirements in equipment bulk, reagent volume,
and sample preparation, while preserving sample fractionation capabilities. Instead of
physical interactions within the HPLC column, the electrophoretic mobility (broadly, size-
to-charge ratio) of molecules determines their transition time through a glass capillary
under a strong applied potential (kV range). For non-clinical samples, a simple phosphate
buer (PB) can serve as a running buer. However, even in this case, molarity and pH
(typically < 4) are critical to ensure selectivity, as both these parameters strongly aect the
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Figure 1.4: (left) Dominant electrochemical reaction scheme of clozapine. Adapted with
permission from [31]. (right) Cyclic voltammogram of clozapine in buer measured using
a carbon paste working electrode and saturated calomel reference electrode. Note that
oxidative current is shown negative in this plot, opposite the convention used otherwise
throughout this work. The dominant reaction appears at 0.5 V here (due to the pH 4
buer and the reference electrode utilized), with a secondary reaction appearing at a
lower potential over time. Reproduced with permission from [30].
electrophoretic mobility of the analytical species [32,33]. With UV absorbance detection,
Hillaert et al. achieve a detection limit below 75 nM. For handling biological samples,
more sample preparation becomes necessary, particularly to avoid contamination of the
capillary with proteins. Jin et al., for instance, employ a two-step process utilizing ether
to extract clozapine from whole blood samples into their electrophoresis buer [34]. They
couple this to the rst demonstration of an electrochemical detection approach, utilizing
a custom-made carbon ber disk electrode and amperometric readout for a detection
limit of 420 nM. Raggi et al. also demonstrate detection from clinical serum samples,
employing a dierent yet similarly involved sample preparation involving solid phase
extraction [35]. Relying on UV absorbance detection, they show a clinical detection
limit of 60 nM, comparable to that in buer solutions by Hillaert et al. Finally, while
not utilizing clinical samples, Sekula et al. demonstrate the importance of the employed
working electrode for electrochemical readout [36]. With an ionically conductive rubber
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phase coating applied to a metal substrate, they achieve a limit of detection of 146 nM.
Researchers have also studied approaches independent of chromatography or
electrophoresis, potentially simplifying measurements further. A major hurdle in this
regard is the lack of a selective biorecognition element – enzyme, antibody, aptamer –
such as employed by glucose sensors, or indeed most biosensors. Although, as mentioned
before, clozapine binds to dopamine type 2 and serotonin type 2A receptors, and is
metabolized by cytochrome P450 1A2, none of these interactions are exclusive. The liver
enzyme, for instance, also metabolizes a host of other antipsychotics and small molecules
such as caeine [37]. Thus, a biosensor concept designed around such recognition
elements, like that by Paternolli et al., oers only very poor selectivity in spite of a limit
of detection below 150 nM in buer solution [38]. Most researchers therefore attempt to
leverage clozapine’s redox activity – providing selectivity from the fact that only a small
subset of species in serum are redox-active, and even fewer will be oxidized near the same
+0.37 V – coupled with additional semi-specic physicochemical interactions provided
by some form of electrode modication. This presents numerous advantages also down
the line for miniaturization, as electrochemical sensors are relatively simple to implement
(requiring only electrodes) and extremely sensitive instruments are available for readout
[39]. Since the 1979 study by Kaumann et al. [30], many examples using various
electrochemical measurement techniques to quantify clozapine have been presented. For
brevity, I will focus on works explicitly considering selectivity. Hernández et al. utilize a
carbon paste electrode modied with sepiolite to initially absorb and pre-concentrate
clozapine from a potassium nitrate-based buer solution at pH 4.2 [40]. The electrode is
then washed and transferred into fresh solution for measurement by dierential pulse
voltammetry. They are able to show detection of 200 nM clozapine in a serum sample by
diluting it 12-fold into their pre-concentration solution. Hammam et al. utilize a hanging
drop mercury electrode in neutral, de-oxygenated Britton–Robinson buer to quantify
clozapine by square-wave adsorptive cathodic stripping voltammetry [41]. By applying
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a negative −0.7 V potential over 30 s, clozapine is adsorbed and pre-concentrated onto
the mercury drop, and subsequently scanning the potential toward even more negative
values reveals a clozapine reduction peak around −1.5 V. The utilized potential range
explains the need for an oxygen-free solution, which would otherwise dominate the
reduction signal. It should also be noted that the monitored reduction peak here is
distinctly dierent from that of the typically monitored redox reaction at +0.37 V. For
measurements in serum, they rst precipitate proteins out of serum (using methanol and
centrifugation) before spiking clozapine into the samples, diluting the serum 100-fold in
the process, ultimately showing a detection limit of 100 nM. Farhadi et al. employ a glassy
carbon electrode that they subject to anodic oxidation prior to use [42]. They argue that
this enhances clozapine absorption onto the electrode in a pre-concentration step at open
circuit potential for subsequent cyclic voltammetry measurements, all performed in a pH 6
phosphate buer. For serum, they achieve a 25 µM detection limit by spiking clozapine
into the samples before precipitating proteins out of solution, and diluting them 300-fold
before measurements. Finally, Shahrokhian et al. coat glassy carbon electrodes with thin
lms of multi-walled carbon nanotubes and conductive polymer, polypyrrole doped with
new coccine [43]. Experiments are carried out in de-oxygenated pH 5.4 Britton–Robinson
buer using linear scan voltammetry after an accumulation step. Serum samples spiked
with 10 µM clozapine or less are successfully analyzed after precipitating proteins and
diluting the samples 10-fold.
It becomes clear that, though about half of these studies have shown detection in
the clinically relevant range, they all fall short on one count or another. None of them
demonstrate detection directly in complex biological samples (blood, plasma or serum),
which present challenges in terms of interference from other compounds, potential cross-
reactivity between those and the analyte, or non-specic adsorption leading to fouling.
Instead, all studies to date require relatively extensive sample pre-treatment in terms of
dilution and protein precipitation, which is dicult to translate into a point-of-care device
13
from both technical and regulatory points of view. Some, moreover, require specialized
and/or de-oxygenated buer solutions for the measurements, where especially the latter
is prohibitive for microsystems integration. Finally, none of these studies have attempted
or investigated translation of their approaches into lab-on-a-chip-type systems.
1.3.3 White Blood Cell Enumeration
Blood cell counts are not only critical in clozapine treatment monitoring, but are in
general the most commonly prescribed medical test, accounting for around 15% of all
medical tests performed by volume [44]. The test plays a central role in diagnosing
disorders ranging from anemia or leukemia to infection, based on the abundance of red
and white blood cell, and platelets, illustrated in Figure 1.5 [45]. Traditionally conducted
by manually counting cells in a stained blood smear on a glass slide under a microscope,
automated techniques are now more common. These approaches have in turn driven the
wide adoption of full dierential counts, wherein leukocytes are quantied in terms of
sub-populations – 30% lymphocytes, 5% monocytes, and granulocytes (themselves further
split up into 62% neutrophils, 2% eosinophils, and 1% basophils). The gold standard is
ow cytometry, where thousands of cells can be analyzed within less than a minute. As
shown in Figure 1.6a, the sample is hydrodynamically focused to force single-le passage
of cells past an array of detectors. These detectors typically consist of forward and side
laser scattering, supplemented with uorescent labels for population-specic surface
antigens such as CD4, and impedance measurements. Information is thus collected on
multiple dimensions on a cell-by-cell basis, and can subsequently be analyzed in terms of
populations as well as in terms of rare events (e.g. for very rare and highly specic cell
types such as circulating tumor cells).
Due to their ubiquity in medical diagnostics – combined with the fact that although
ow cytometry equipment tends to be bulky, it already relies on microuidics – blood
cell counters have a long history of miniaturization [45,47–49]. Especially impedance
14
Figure 1.5: Schematic drawings of erythrocytes (top left), platelets (bottom left), and the
major leukocyte subtypes (right). Reproduced with permission from [46].
cytometry is well suited towards integration in microsystems, as it does not rely on
labels or complex optics [39,50]. The approach in its most basic form applies the Coulter
principle illustrated in Figure 1.6b. In an electrolyte-lled channel with two chambers
separated by an aperture of diameter DA, an impedance Zempty can be measured between
two electrodes on either side of the aperture. As a particle (or cell) of diameter /o passes
through the aperture, it displaces electrolyte, and thus – relative to the empty-channel
impedance – causes an increase in absolute impedance [51]:
|∆Z | =
|Z | − ZemptyZempty ∝ /o3/DA2 (1.1)
Consequently, the impedance signal |∆Z | can be used to dierentiate particles based on
their size. This is useful for blood cell dierentials, as there are signicant dierences in
geometry: Discoid red blood cells with 6–8 µm diameters, compared to spherical white
blood cells with diameters ranging from 6–20 µm for the various sub-populations.
The rst lab-on-a-chip Coulter counter was presented by Larsen et al. in 1997 and
is depicted in Figure 1.7 [53]. They utilize silicon micromachining to dene 50 µm deep
microuidics, bonded to a glass wafer patterned with gold electrodes. Due to the lack
of a follow-up journal manuscript, details on this device and its characterization are











Figure 1.6: Schematics showing the working principles of (a) an optical ow cytometer;
reproduced with permission from [52]; and (b) a Coulter counter with the particle in red
passing through the aperture in the lower image.
authors are unable to obtain reproducible results even with only polystyrene beads.
Critically, however, this work identies the advantages of hydrodynamic focusing.
Specically, it employs two layers of sheath ows around the sample (an electrolyte,
as well as a non-conducting sheath ow) and includes the option for an additional out-
of-plane sheath ow to assist in vertical particle positioning. The authors note that
hydrodynamic focusing greatly reduces the risk of device clogging in general, and that a
non-conductive sheath ow allows for dynamic adjustment of the sensitivity.
The rst work to actually present cell counting results from a lab-on-a-chip was
that by Gawad et al. in 2001 [54]. Their device consists of platinum electrodes (20 µm
length, width, and spacing) on glass and microuidics (20 µm width and depth) dened
in photosensitive polyimide, covered with planar polydimethylsiloxane (PDMS). Two
pairs of electrodes and two external resistors each serve as one leg in a Wheatstone
bridge circuit, allowing for sensitive dierential readout of the signal (assuming only
one electrode pair is occupied by a cell at any given time). Specically, they show
16
Figure 1.7: Micrograph showing the rst microfabricated Coulter counter. As particles
in the central sample stream À pass the electrodes, the measured impedance changes.
The sample ow is sheathed by electrolyte Á and deionized water Â. Reproduced with
permission from [53].
being able to dierentiate polystyrene particles, erythrocytes, and ghosts (red blood
cells emptied of their contents). While the rst two populations can be separated
simply based on geometry as explained above, the latter two are virtually identical
in that regard. The breakthrough in population separation capabilities here relies on the
realization that the impedance at dierent signal frequencies reveals dierent information
about the particle in question. While direct current (DC) or low-frequency alternating
current (AC) impedance is sensitive to cell size, higher-frequency AC probes the internal
structure of the cell as illustrated in Figure 1.8. The authors develop the relevant
theoretical background for this conclusion based on an equivalent circuit model of
the cell as a spherical shelled particle (which I explore in more depth and build upon in
Subsection 3.1.2). Furthermore, they analytically and numerically consider advantages of
a parallel facing electrode layout compared to the co-planar electrode layout used both
in their own experiments and in Larsen et al.’s device.
The nal study of note was presented by Holmes et al. in 2009 [55]. Utilizing
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Figure 1.8: (a) Simple equivalent circuit model of a cell as a spherical shelled
particle between an electrode pair. (b) Signal response as a function of AC signal
frequency showing that dierent frequencies are sensitive to dierent cellular properties.
Reproduced with permission from [54].
fabrication process and dimensions practically identical with those by Gawad et al.,
they realize the parallel facing electrode layout by aligning and pressure-bonding two
identical chips, pictured in Figure 1.9a–b. Their readout circuitry employs transimpedance
ampliers for each of two electrode pairs feeding into a lock-in amplier (more specically
one for each measurement frequency) for dierential readout. By pre-treating whole
blood samples with saponin and formic acid (which also serve as a lysis agent) o-
chip, the authors are able to dierentiate leukocytes, monocytes, and granulocytes
from their dual-frequency impedance measurements as shown in Figure 1.9c. They
corroborate these results with analysis of puried sub-populations and on-line microscopy.
A follow-up paper by the same research group further expands on this by integrating the
aforementioned pre-treatment on-chip in a device with a somewhat larger (40 µm width
and depth) cross-section, and by validating results against clinical laboratory analysis
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Figure 1.9: (a) Schematic of the parallel-electrode impedance cytometer combined with an
external optical system for validation purposes. (b) Picture of the microuidic impedance
cytometry chip. (c) Impedance scatter plot of low- and high-frequency signals from a
whole blood sample, pre-treated o-chip with saponin/formic acid, with the three major
white blood cell populations highlighted. Reproduced with permission from [55,57].
[56].
The three seminal studies described above were followed by numerous advances
in theory and renements in experiments (e.g. in terms of cell positioning, or in post-
detection sorting), discussed in depth in the excellent review papers on the subject
[49,52,58–64]. These also lay out alternative transduction approaches, in part enabled by
progress in miniaturization of optical components and broader trends in novel microuidic
concepts. This includes exploratory research such as lens-free optical cytometry [65],
magnetic levitation of blood cells with smartphone-based readout [66], paper-based
devices [67], and in-vivo optical ow cytometry [68]. Some of these developments,
however, have also contributed in bringing commercial devices to market, with two in
particular standing out: The Chempaq XBC, and the HemoCue WBC Di. Both rely
on a piece of equipment integrating necessary and reusable electronic and mechanical
components for automated analysis and readout (∼$5,000 in the case of the HemoCue;
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no gures available for the Chempaq), as well as disposable and comparatively cheap
cartridges (∼$5 in the case of the HemoCue) for sample handling. The Chempaq XBC,
shown in Figure 1.10, distinguishes itself as being possibly the earliest example of such a
device and weighing less than 2 kg [69]. It combines an optical readout of hemoglobin
with impedance analysis for white blood cells. The cartridge accepts a whole blood
sample as small as 10 µl via capillary action, of which a metered 3 µl is mixed with pre-
packaged liquid reagents upon insertion into the device. These reagents lyse erythrocytes,
enable optical hemoglobin measurements, and aect leukocytes such that they can be
distinguished based on size alone. Liquid ow inside the cartridge is then actively pressure-
actuated, with ow sensors providing feedback. The cells pass through an aperture –
laser-machined separately from the rest of the cartridge in a polymer membrane – that
divides two compartments housing a bulk electrode each interfaced to external contacts.
With the reagent-exposed blood samples, this allows for a three-part dierential white
blood cell count. The HemoCue WBC Di, shown in Figure 1.11, smaller and lighter
by about 30%, distinguishes itself as the only commercial product capable of a ve-part
white blood cell dierential [70,71]. Although the use concept is similar to that of the
Chempaq, the technology is quite dierent: It relies on optical image analysis of stained
blood cells. The cartridge again utilizes capillary action for sampling of blood, whereafter
the (in this case, dry) reagents for red blood cell lysis and white blood cell staining mix
with the sample. Unlike with the Chempaq, however, the cartridge does not include any
other components or functions, leading to a much simpler (and thus likely cheaper and
more robust) design. The cartridge is then inserted into the reader, where an image is
taken and the full ve-part dierential result displayed on algorithmic analysis of an
optical image corresponding to ∼ 0.2 µl of sample.
Interestingly, studies have been carried out with both systems geared specically
toward point-of-care monitoring of granulocytes in clozapine patient populations [72,73].
Nielsen et al. utilize the Chempaq XBC and focus mostly on the patient burden. With a
20
Figure 1.10: The Chempaq XBC device and corresponding cartridge [69,71].
Figure 1.11: The HemoCue WBC device and corresponding cartridge. The components
shown are practically identical for the WBC Di [71].
77 patient sample size, they nd that the point-of-care device signicantly reduces pain
and increases convenience, highlighting the conceptual advantages. Bui et al. utilize the
HemoCue WBC Di and focus mostly on clinical accuracy versus gold standard laboratory
tests. With a sample size of 60, they determine that point-of-care measurements can serve
to screen for agranulocytosis. For diagnosis, however, they suggest that follow-up testing
utilizing venous sampling is called for. This is due to the general dierences between
venous and capillary blood samples (with regulatory limits only having been established
for the former), as well as the generally higher variability, even within-patient, for the
latter [74]. It should also be noted that all available data for these devices comes from
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Europe; neither are available in the US.
Overall, while impressive progress has been made in point-of-care dierential
blood counts, both research and commercial devices suer from drawbacks. A notable
limitation is the reliance on chemicals to achieve sucient cell type dierentiation. For
eventual clinical application, limiting the amount of required chemicals is an important
consideration, as additional reagents complicate lab-on-a-chip packaging (cf. Chempaq
cartridge). Moreover, the fabrication complexities of the multi-layer devices by Holmes
et al., or the assembly of Chempaq cartridges from multiple separately manufactured
components, represent practical drawbacks. Finally, these single-purpose devices cannot
easily be integrated with other sensing modalities, a critical point that I will explore
further in the following Subsection.
1.3.4 Systems Integration
A signicant challenge toward a combined clozapine and granulocyte monitoring device
is the underlying systems integration of cellular and acellular sensors. The research-type
blood cell sensors reviewed above are sometimes integrated with downstream sorting of
the cell populations, analogous to benchtop uorescence-activated cell sorting (FACS)
– cell populations of interest are separated out, to then be subjected to further intra-
cellular analysis, e.g. for DNA or protein biomarkers [49,61,75,76]. In continuous-ow
type devices dealing with large cell numbers, i.e. microuidic ow cytometers, such
analysis is however typically carried out o-chip. For blood cell counters, to the best
of my knowledge, hemoglobin analysis is the only existing example of simultaneously
sensing a molecular species. This is implemented in both the Chempaq XBC, and by van
Berkel et al. in a device based o that by Holmes et al. [69,77]. The analysis relies on
absorption measurements of the red blood cell lysate to quantify the released hemoglobin
in the sample stream.
Considering molecular species in serum, the literature is even more sparse. In
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typical biomarker analysis, researchers generally employ some form of blood/plasma
separation, as blood cells would add signicant interference to most transduction methods
– blocking optical pathways, adding mass, or changing the eective refractive index.
O-chip, such separation is typically accomplished through centrifugation and addition
of chemical reagents. For lab-on-a-chip applications, researchers have attempted adapting
similar concepts based on external force application, ranging from actual centrifugation
to electrophoretic and acoustophoretic [76,78]. Such approaches, however, signicantly
increase the complexity both in terms of fabrication and integration of the overall lab-on-
a-chip system. Passive approaches as illustrated in Figure 1.12 are based solely on blood
ow behavior in the device through informed design of materials and geometry (cell
sedimentation, cell ltration, inertial force separation, etc.). They also add complexity for
fabrication, but do not require additional external components for operation. Most still
suer from additional drawbacks such as requiring dilution of the samples (e.g. micro-
pillar arrays), which precludes tests for all but the most abundant plasma biomarkers, or
conversely discarding the cellular fraction during or after plasma separation (e.g. micro-
lters). Only a few are theoretically capable of recovering both cellular and acellular
components intact, and to the best of my knowledge Fan et al. published the only paper
utilizing one such an approach in a biosensor [79]. Specically, they detect an array of
protein biomarkers in plasma skimmed o 10-fold diluted blood (I discuss the approach
in more detail in Section 4.1) but discard the cellular fraction.
From both perspectives, the progress toward concurrent cellular/acellular sensing
approaches remains unsatisfactory. The hemoglobin measurement represents a special
case that is not easily generalized, as the protein features highly specic optical properties
and is one of the most abundant biological targets available at a concentration of 10 mM
(exceeding even that of glucose). Conversely, Peter Sorger notes the possibility for
downstream recovery of the cellular fraction in the work by Fan et al. in an opinion
piece in the relevant journal issue and acknowledges the promise of such an integrated
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Figure 1.12: Illustration of dierent blood/plasma separation formats (a) and solutions
specically for microuidic chips (b). Reproduced with permission from [78].
sensor. Yet this approach remains unexplored to date. The only works attempting to
develop and study true cellular/acellular sensors are the recent ones by Huang et al.
They employ a microuidic device for capturing cellular and protein analytes from blood
samples using antibody-coated magnetic beads as shown in Figure 1.13. Specically, they
target cancer-associated proteins and circulating cells – folate receptor protein and folate
receptor-expressing cells, or prostate-specic membrane antigen and -expressing cells
[80,81]. Both free proteins and the protein-expressing cells are captured by the magnetic
beads, and the concentration assessed by uorescence microscopy. The protein and
cell signals are deconvoluted based on the large discrepancy in sizes, employing image
analysis (cells are identied and then excluded from subsequent protein quantication)
or a built-in membrane for cross-ow ltration. These microuidic chips still suer from
a number of limitations, however. First, the use of magnetic beads limits the applicability
to molecular analytes with matching traditional biorecognition elements (antibodies,
aptamers, etc.) and to rare cell types – targeted at white blood cells, this approach
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Figure 1.13: Schematic showing the operation principles of the microuidic chamber
designed for immunomagnetic detection of folate receptor-positive cells and free folate
receptor. Reproduced with permission from [80].
would lead to signal saturation and/or device clogging. Second, in combination with the
uorescent labels, the approach necessitates readout optics as well as multiple changes
in solution (sample, wash, label, wash), both factors that are not ideal for point-of-care
applications as discussed earlier. Therefore, a broadly applicable cellular/acellular whole
blood analysis microsystem will present a signicant advancement in lab-on-a-chip
technology.
1.4 Structure of Dissertation
In the preceding Chapter 1, I have discussed the underlying motivation for my
research and reviewed related research in existing literature. In Chapter 2, I present
the electrochemical detection of clozapine with the chitosan-catechol and chitosan-
carbon nanotube/graphene signal amplication systems. In Chapter 3, I investigate
the integration of hydrodynamic focusing and osmotic lysis with impedance cytometry,
approaches that are critical for label- and reagent-free white blood cell counting. I proceed
to discuss overall microsystem integration for concurrent clozapine and white blood cell
monitoring in Chapter 4. Finally, I summarize the contributions of my dissertation and
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cover future relevant directions of study in Chapter 5.
Chapter 2
Chitosan-based Clozapine Sensors with Electrochemical Signal
Amplication
Chitosan is a versatile bio-derived hydrogel-forming polysaccharide. Its applications
range from wound healing to drug delivery [82,83]. It can also easily be integrated into
lab-on-a-chip systems, pioneered through eorts led by our group and collaborators [84].
In this regard, chitosan’s selective electrodeposition capabilities are especially useful.
With its pKa of 6.5, it is soluble in weakly acidic medium. Applying a cathodic current
to induce electrolysis at an electrode locally generates an excess of protons, equating a
localized increase in pH. This deprotonates chitosan’s amine groups, insolubilizing the
polysaccharide chains as shown in Figure 2.1. The resulting deposited hydrogel lms
are stable at neutral pH, and the amine groups allow for facile biochemical modication.
Thus, the chitosan can serve as a matrix for anything from small molecules to proteins.
For the purposes of detecting clozapine, I consider two options in particular: First,
chitosan can be modied biochemically with the small quinone catechol. Most of my own
work focuses on the in-depth characterization of the resulting redox cycling system as
laid out in Section 2.1. Second, nano-carbon compounds such as nanotubes or graphene
can be dispersed in the chitosan. This redox catalysis system is discussed in Section 2.3.
In this Chapter, I demonstrate that both of these compound lm types exhibit high
sensitivity and selectivity to clozapine, based on entirely distinct mechanisms, each with
distinct strengths and weaknesses.
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Figure 2.1: Schematic drawing of chitosan electrodeposition due to the highly localized
pH gradient formed at the electrode, turning dissolved chitosan polymer into an insoluble
chitosan hydrogel at the electrode. Reproduced with permission from [85].
2.1 Redox Cycling System
The chitosan-catechol redox cycling system was rst presented by my collaborator Dr.
Eunkyoung Kim in 2010 [86]. After chitosan electrodeposition, redox-active catechol
(Eo′ = +0.14 V [87]) can be electrochemically grafted onto the lm, oxidizing it so
the resulting 1,2-benzoquinone can react with the chitosan amine group as shown in
Figure 2.2a. The resulting redox capacitor was initially demonstrated with model redox
mediators 1-1’-ferrocenedimethanol (Fc; Eo′ = +0.23 V) and hexaammineruthenium (Ru;
Eo′ = −0.14 V [88]) and was later utilized to detect the bacterial metabolite pyocyanin (a
reducing mediator akin to Ru) [89].
I demonstrate that clozapine can act as an oxidizing mediator akin to Fc in this
system, as schematically illustrated in Figure 2.2b–c. The drug can diuse through
the chitosan lm and undergo an electron transfer reaction at the electrode (at E ≥
Eo′
CLZ
= 0.37 V). Without catechol in the lm, oxidized clozapine would diuse away
and not participate further. In the catechol-modied chitosan lm, however, catechol is
immobilized in close proximity to the electrode and can reduce back oxidized clozapine.
The same clozapine molecule can then be re-oxidized at the electrode, further contributing
to the measured current. This action of clozapine as an oxidizing mediator results in a
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Figure 2.2: (a) Putative chemistry of catechol grafting to chitosan [86]. (b) Standard
reduction potentials and overall electron transfer scheme for the major redox species
discussed. (c) Schematic of the catechol-modied chitosan redox cycling system. The
diusing clozapine acts as an oxidizing mediator; the redox capacitor allows for a
repeating cycle of clozapine reduction in the presence of reduced catechol, followed
by clozapine re-oxidation at the anode (left; E ≥ 0.37 V). Conversely, under negative
potentials, Ru in solution acts as a reducing mediator, regenerating the oxidized catechol
(right). Adapted with permission from [90].
continuous cycle of oxidation at the electrode, followed by reduction in the presence of
catechol. Consequently, the total charge transfer generated by the available clozapine
is increased, amplifying the measured electrochemical current and thus the signal. To
recover the catechol to the reduced state, negative potential can be applied in the presence
of a reducing mediator such as Ru.
Redox cycling is rather obviously expected to enhance sensitivity due to redox
signal amplication. However, in complex biological uids with many redox-active
species, the redox cycling amplication approach could be expected to indiscriminately
amplify everything, enhancing not only the clozapine signal but also the background
noise. However, selectivity for clozapine in this system is intuitively three-fold. First,
because the amplication relies on redox cycling, redox species that show irreversible
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reduction or oxidation will contribute signicantly less to the electrochemical signal. Only
the signal from reversible or quasi-reversible species, such as clozapine, will be amplied.
Second, based on the standard reduction potential of catechol, signal amplication is
limited to species with Eo′ & +0.15 V. Those with lower Eo′ cannot participate in the redox
cycling. Third, the chosen electrochemical technique allows for further discrimination.
Voltammetry, where voltage is scanned continuously (or, depending on the specic
technique, in a step-wise fashion) at a certain rate while recording current, allows for
direct dierentiation based on Eo′ – the signal will show a peak in current at that potential.
In the following Subsections, I will be addressing both sensitivity and selectivity, as well as
other aspects of this compound lm to establish its suitability for point-of-care clozapine
sensing.
2.1.1 Experimental Methods
For my research, I employ three-electrode electrochemical cells controlled by a CH
Instruments 660D or Bio-logic VSP-300 potentiostat. The cells consist of a 1.5 ml volume
sample reservoir with a platinum counter electrode and an Ag/AgCl (1 M KCl electrolyte)
reference electrode immersed, as shown in Figure 2.3. As a working electrode, I generally
utilize custom planar microfabricated gold electrodes, which are intended to provide
a similar surface to later microsystem implementations. I fabricate the 7.5 × 7.5 mm2
surface area electrodes utilizing standard photolithography processes on a silicon wafer.
Specically, I coat the wafer with 500 nm silicon oxide using plasma-enhanced chemical
vapor deposition (PECVD) for electrical insulation. The subsequent metal coating,
lithography, and wet etching are described in full in Subsection 3.1.3 (here, I use mask
6.1 in Appendix A: Photomasks). Before use, I dice the wafer and clean electrodes using
Piranha (3:1 sulfuric acid : hydrogen peroxide).
For some fundamental studies on the molecular processes in the redox cycling










Figure 2.3: Schematic and photograph of typical three-electrode electrochemical cell
setup.
utilizing the microfabricated electrodes, or large (> 50) numbers of independent
experiments, which become prohibitively expensive and time-consuming using the
single-use microfabricated electrodes – I instead employ commercial 2 mm gold disk
electrodes. These electrodes are polished before each use with alumina powder according
to manufacturer specications.
I prepare a 1% w/w solution of chitosan by adding akes to deionized (DI) water
under constant stirring overnight, with the pH gradually adjusted to 5.5 by titrating
1 M hydrochloric acid. The solution is then ltered successively through a mesh lter
and a porous glass lter to remove any undissolved chitosan. The nal concentration
is determined by weighing ∼ 2 ml of solution before and after dehydration in an oven
at 65 °C overnight, and adjusted to 1% by adding water if needed (the concentration is
typically slightly above 1%). Catechol is prepared as a 5 mM solution in deionized water.
Chitosan electrodeposition is achieved by applying a constant cathodic current of 6 A/m2
for 45 s, followed by immersing the electrode in 0.1 M, pH 7 PB. Catechol is electrografted
onto the lms at a constant anodic potential of +0.6 V over 180 s, followed by rinsing in
DI water.
Test solutions are generally based on 0.1 M phosphate buer spiked with 25 µM
Ru (reducing mediator), though some experiments were carried out with 1× phosphate
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buered saline (PBS) or commercial human serum. Commercial human serum is more
readily and inexpensively available compared to clinical samples and is thus employed in
the initial studies of this Section. I utilize every redox capacitor lm at least twice – rst a
baseline measurement, followed by one in solution also containing the oxidizing mediator
of interest, i.e. typically clozapine. At the very start of experiments, I nd that a lm
initialization procedure (cyclic voltammetry in a test solution with 25 µM Fc) is helpful.
The purpose of this is three-fold: First, it serves as an electrochemical cleaning step to
oxidize any remaining entrapped ungrafted catechol. Second, it ensures a consistent
charge state of the lm prior to subsequent measurements. Third, it provides quality
control – a working lm will amplify the Fc signal.
The measurement method utilized, unless noted otherwise, is cyclic voltammetry.
Operated here between −0.4 and +0.7 V at a scan rate of ν = 0.02 V/s, this has the added
advantage of allowing for repeated cycles of clozapine oxidation (at positive potentials)
as well as catechol recharging by Ru (in the negative range). I run at least three cycles,
with the third cycle – where the system typically reaches an equilibrium and signal
amplication saturates – used for analysis, particularly in terms of peak current Ip and
corresponding potential Ep. It is worth here to consider the governing equations for
these two parameters in traditional electrochemical systems, i.e. with bare, unmodied






Therein, A is the electrode surface area,C the concentration of the analyte, D its diusion
constant, n the number of electrons per reaction, T the solution temperature, F the
Faraday constant, and R the universal gas constant. The corresponding potential for this







Both equations assume an ideal, diusion-limited, fully reversible redox couple, which
is an assumption that does not apply to clozapine (as explored in more detail in
Subsection 2.1.5). However, the equations can still serve as rst-order approximations,
and deviations can give insight into underlying processes.
2.1.2 Signal Amplication
















That is, the background-subtracted peak current with a modied electrode (e.g. the redox
cycling system) expressed relative to that observed with a bare electrode. The background-
subtracted current in general is useful to better visualize the signal caused specically
by the analyte, and is employed in many of the following gures. The amplication
ratio provides a simple though imperfect way to assess the gain in sensitivity for a
given set of conditions. Only two or four measurements are required for assessing
electrode modication or a set of electrochemical measurement parameters, respectively.
However, this approach does not take into account variations over the clinically relevant
concentration range needed to determine the true sensitivity as shown in Subsection 2.1.3.
My exemplary results in Figure 2.4 show that chitosan-catechol yields 3.64-fold
signal amplication [91]. Compared to 0.91 for only catechol and 0.24 for only chitosan,
this demonstrates signicant bio-amplication through the redox cycling system. Without
chitosan, the catechol cannot be eciently immobilized in the vicinity of the electrode.
This leads to the lack of amplication and increased signal interference from residual
free catechol. Without catechol, I hypothesize that the lower mobility of clozapine in the
chitosan compared to in solution, combined with the lm’s non-conductive nature, lead
to the decreased faradaic currents. This is further explored in 2.1.5.
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potential vs. Ag/AgCl (V)
Figure 2.4: Signal amplication in the redox cycling system. Oxidative current
(background-subtracted) measured in clozapine solutions using electrodes bare (black
dash-dotted), chitosan-modied (dashed green), catechol-modied (dashed blue), or
modied with the chitosan-catechol redox cycling system (solid red). Adapted with
permission from [91].
Besides the lm components, another factor in the amplication system is the
reducing mediator. In Figure 2.5a I show results from an optimization study utilizing
various concentrations of Ru [90]. Its utility is immediately apparent – the peak current
Ip reduces by up to 1.75 times in the absence of Ru, compared to its presence. The
specic dependence of the signal amplication on the Ru concentration is intriguing
in that it is non-monotonous. At 6.25 µM, Ru is signicantly less abundant than the
25 µM clozapine. In this case, the oxidizing mediator is more ecient at discharging
the catechol than the reducing mediator is at recovering it, resulting in sub-optimal
amplication of the clozapine signal. At 25 µM, I record maximum amplication, the
clozapine oxidation now no longer limited by insucient recharging of the catechol.
While intuitively an even higher concentration of Ru should not adversely aect redox
cycling performance, I note a drop in amplication performance at 100 µM. I hypothesize
this is due to the large concentration of Ru causing a very high background signal
in the control measurements (Figure 2.5b), yielding smaller relative changes when
introducing clozapine. Thus, while the reducing mediator is essential for sustained
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(b)
Figure 2.5: Impact of Ru on redox cycling performance. (a) Cyclic voltammograms
(oxidative region shown; baseline subtracted) measured with the redox cycling system
for solutions containing 25 µM clozapine and Ru at 0 µM (red dash dot dot), 6.25 µM
(green dash dot), 25 µM (black solid) or 100 µM (blue dash). (b) Corresponding baseline
measurements (i.e., without clozapine). Both adapted with permission from [90].
clozapine signal amplication, its concentration needs to be chosen with the dynamic
range of the application in mind. In addition to the changes in electrochemical current, I
also observe a positive shift in peak potential Ep by 391±15 µV per µM of Ru (R
2 = 0.998),
with an additional positive oset of 46 ± 1 mV likely from non-linear eects at lower
concentrations than the ones investigated. Typically, shifts in peak potential speak to
underlying changes in electron transfer kinetics, as explored further in Subsection 2.1.5.
These are, however, unlikely to be aected for clozapine by the presence of Ru. Instead,
the reducing mediator enables longer sustenance of the redox cycle – with time and
potential inherently conated by the very nature of voltammetry with its potential scan
rate ν , this results in a mainly temporal delay of the peak potential.
2.1.3 Sensitivity
While the signal amplication veries the underlying principle of the approach, a sensor
requires a dose-dependent response. To obtain a calibration curve, I measured test
solutions of clozapine concentrations between 100 nM and 30 µM. This is chosen based
on the clinically relevant range of 1–3 µM [13], plus or minus one order of magnitude.
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Figure 2.6: Clozapine sensing performance with the redox cycling system. (a) Clozapine
detection in buer solutions plotted in terms of background-subtracted peak current
as a function of concentration for both unmodied (open blue squares) and redox
cycling system-modied (solid red circles) electrodes. (b) The corresponding eect of the
clozapine concentration on the oxidative peak potential. Both adapted with permission
from [91].
Figure 2.6a presents such curves for clozapine detection in phosphate buer with the
redox cycling system as well as with a bare electrode for comparison [91]. In terms of
gures of merit, I dene sensitivity as the slope of the dose-response plot in the linear
regime (as per the plot, on a log-log scale), with the detection limit as the intersection
of that line with the constant background signal level, plus three standard deviations,
loosely following [92]. Thus, for the chitosan-catechol electrodes, I obtain a sensitivity
of 0.55 log A / log M and a detection limit of 0.95 µM. Critically, this detection limit is
compatible with the clinically relevant range of 1–3 µM clozapine. While the very best
existing electrochemical detection approaches reviewed in Subsection 1.3.2 can exceed
this by up to an order of magnitude, their limitations need to be considered as well. For
one, my study here is carried out in physiological buer solutions where most of the
reviewed techniques perform poorly. More importantly, however, all of these approaches
focus exclusively on detection limit, ignoring many of the other important factors for a
point-of-care sensing approach that I will explore throughout this Chapter.
For the bare electrodes, the high noise level at low concentrations makes
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determination of both gures challenging. They can be estimated to be at least 2-fold
lower in sensitivity and 30-fold higher in detection limit. This bears comparison with the
approximately 3.6-fold amplication provided by the redox cycling system, implying that
a large component of the system is not only amplication of the clozapine signal, but more
importantly suppression of background noise. This is in line with the observations from
chitosan-only electrodes, which showed a signicant reduction in electrochemical signals
earlier. Overall, these results highlight the signicant promise of the chitosan-catechol
system for clozapine detection.
Alongside the observed changes in Ip, I also nd interesting behavior in the
corresponding peak potentials Ep in Figure 2.6b [91]. While the lowest-concentration
values can be regarded simply as background noise according to the observations in Ip,
there is a clear inversely proportional trend in peak potentials for clozapine concentrations
≥ 1 µM. This may be attributed to the slow electron transfer kinetics of clozapine, further
discussed in 2.1.5. At higher clozapine concentration, this can yield a relative excess of
reduced clozapine near the electrode, lowering the observed potential as described by
the Nernst equation outside equilibrium conditions [88].
2.1.4 Film Stability with Reuse and Storage
While sensitivity is critical, an eventual point-of-care sensor also needs to be robust.
Testing reusability gives useful insights into lm fouling mechanisms, and also helps
evaluate the potential use of the biosensor as a continuous monitoring system. For this,
I reuse individual lms for 20 successive measurements, alternating between control
and sample solutions prepared fresh with each iteration. The cyclic voltammograms
in Figure 2.7a reveal a gradual decrease in peak current with reuse, combined with an
increase in peak potential [90]. Both are highly linear at −1.04 ± 0.03 µA (2.2% of the
absolute signal; R2 = 0.992) and 5.47 ± 0.22 mV (1.2%; R2 = 0.988) per reuse. As also
seen in the plot, the baseline signals from the control solutions decrease in a similar
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Figure 2.7: Reusability of the redox cycling system. (a) Selected cyclic voltammograms
(lines; oxidative region shown) and signal peaks (gray triangles) for 25 µM clozapine
samples measured with the same chitosan-catechol electrode. Corresponding baseline
measurements are included (black dots). The arrows indicate the progression of
measurement runs. (b) Normalization of the same data with respect to immediately
preceding baseline measurements. Both adapted with permission from [90].
fashion. The concurrent decrease of both clozapine peak current and baseline current
suggests gradual degradation of the lm from repeated use and/or the associated wash
steps. If clozapine fouling of the lm were responsible, both sample and baseline signals
would instead be expected to increase, with clozapine from previous solutions adding
to the measured signals. The observed increase in the required overpotential is also
consistent with lm degradation. Specically, it implies a slowing-down of the redox
cycling kinetics, which could be due to gradual loss of catechol with reuse, thereby
leading to longer mean diusion times of the clozapine between the electrode and the
catechol.
Interestingly, the lm degradation mechanism provides a means to adjust for the
observed signal loss independently of the actual sample measurements. Specically,
I calculate the total baseline charge transfer Q =
∫
I background dV from the respective
control solutions to quantify the degradation, and divide the measured clozapine current
I by this value to derive a normalized signal S = I/Q . This is plotted in Figure 2.7b,
showing that the peak signals remain constant with lm reuse at 24.8 ± 0.7 ks−1.
While biofabrication enables our unique sensor functionality, the biomaterials are
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inherently more fragile than solid-state components. Therefore, toward suitability for
point-of-care application, I seek to understand the material degradation of the redox
cycling system with reuse as well as with storage. Without a shelf life, the chitosan-
catechol modication in a real-world lab-on-a-chip would need to happen on-site, adding
complexity and variability to the device. Storage lifetime is evaluated by fabricating
redox cycling lms and immediately transferring them to either air or buer solution
for extended periods of time. At intervals up to 77 days, lms are removed from storage
and assessed in terms of signal amplication. Based on the results with reuse, I visualize
the storage data in a similarly normalized fashion in Figure 2.8, in comparison to data
from as-fabricated lms (solid black lines) [90]. This reveals a consistent 57.5 ± 3.0%
loss in peak signals from storage in air independent of storage duration (representative
time points shown with red dashed and blue dash-dotted lines). I attribute this to an
irreversible collapse of the hydrogel matrix upon prolonged exposure to air, wherein
re-hydration fails to recover the typical loose polymer network structure. A collapsed
hydrogel with a denser polymer network would lead to slower diusion of clozapine, in
line with the signicantly lower currents observed. While quantitative measurements of
the lm thickness were not possible in its hydrated state, this was qualitatively conrmed
by visual inspection of the lms.
For storage in solution, the mechanism is shown to be quite distinct, with the
measured clozapine signals gradually decreasing by 0.255 ± 0.072% per day (R2 = 0.64)
over the rst 1.5 months before saturating. This is accompanied by an increase in peak
potential reminiscent of what was observed with lm reuse. These symptoms imply a
similar lm degradation mechanism at work, yet more pronounced due to the inability
to adjust for it solely by considering the background signals. Other factors potentially
aecting degradation (oxygen, temperature, light) were similar for both in-air and in-
solution storage, thus are not thought to play a role in the observed dierences. The
results suggest that solution storage is advantageous over short times due to the low
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Figure 2.8: Storage of the redox cycling system. Normalized cyclic voltammograms
(oxidative region shown) for solutions containing 25 µM clozapine measured with
redox cycling system electrodes immediately after biofabrication (black solid) and for
representative timepoints after storage in air (a) or buer solution (b). Corresponding
baseline measurements are included (black dots). The arrows highlight the impact of
storage on the clozapine signal. Both adapted with permission from [90].
associated signal loss; at longer timescales, however, air storage appears benecial due
to the practically constant (albeit lower) performance over time.
2.1.5 Diusion and Redox Kinetics
Diusion and electron transfer kinetics have been alluded to in a number of places
within this Section to explain certain behavior observed in the redox cycling system.
They can also help in understanding and even enhancing selectivity of the system. My
goal is thus to systematically study and gain a deeper understanding of the interplay
between chitosan morphology, catechol grafting, and clozapine detection. This can be
investigated with the same techniques utilized for sensing, recalling the two equations
governing cyclic voltammetry from Subsection 2.1.1. In the Randles–Sevcik Equation 2.1,
the measured peak current Ip is related to the diusion coecient D. The latter can thus
be extracted from measurements, more accurately so when conducted at various scan
rates ν (another parameter in the equation). While the relation is derived for reversible
redox couples, it can also serve as a rst-order approximation for quasi-reversible ones.
39
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Figure 2.9: Cyclic voltammograms (background-subtracted) of Fc (red dotted), clozapine
(blue solid), and norclozapine (green dashed) in buer solution. Only the oxidative scan
direction is shown for the latter two for clarity. Adapted from [93].
In the Nernst Equation 2.2, the oxidative peak potential Ep is given for ideal redox species
as 29.6 mV (or 14.8 mV, for an n = 2 electron reaction) above the standard reduction
potential Eo′. Slow (or not fully reversible) redox species will show an increase in this
separation particularly at high scan rates, when the electron transfer rate (rather than
diusion) becomes a limiting factor. The redox kinetics of a given analyte can thus be
inferred by tracking Ep − E
o′
.
As a known control to validate the general approach, I utilize the well-described
fully reversible redox mediator Fc (Eo′ = +0.23 V), known to be suitable for redox cycling
[86]. I compare this with clozapine for three conditions: Bare electrodes to establish a
baseline, chitosan-catechol, and chitosan only to dierentiate chitosan matrix eects from
those of the full redox cycling system. Additionally, I compare clozapine to its metabolite
norclozapine – structurally similar and also known to be redox-active [31] – under the
same conditions to investigate selectivity. Representative cyclic voltammograms with
2 mm diameter bare gold electrodes are shown in Figure 2.9, highlighting the ideal nature
of Fc as well as the practically indistinguishable nature of clozapine and norclozapine
signals [93].
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In Table 2.1 I lay out diusion parameters for all three redox species [93]. While
a literature value is available for Fc, this is not the case for clozapine and norclozapine.










Therein, kB is the Boltzmann constant and µ the viscosity of the medium. The equation
is typically expressed as a function of the molecular radius. However, as becomes
obvious from the molecular structures in Figure 1.3, both clozapine and norclozapine
are distinctly non-spherical. Therefore I instead rely on the van der Waals volume V –
determined from molecular dynamics simulations [94] – to derive the respective expected
diusion coecients in the table. By conducting cyclic voltammetry for scan rates from
ν = 1 mV/s to 10 V/s, I determine the experimental diusion coecients also listed in the
table from a linear t of the measured peak currents Ip to the Randles–Sevcik Equation 2.1.
For the control mediator Fc, the experimental result agrees reasonably well with the
literature value, considering that my system is not necessarily optimized for the highest-
accuracy diusion coecient determination, and that the exact value can depend on the
ionic strength of the buer. For both clozapine and norclozapine, however, I observe
a much more signicant two-fold dierence between theory and experiments. As the
Stokes–Einstein diusion calculation is quite accurate for Fc with respect to the literature
value, this approximation is insucient to explain such a discrepancy. One aspect may
be electrophoretic eects, where negative charge on the electrode at low potentials may
attract the (at neutral pH) predominately positively charged clozapine and norclozapine.
Their respective net charge properties, as a function of pH, are illustrated in Figure 2.10.
This would also be in line with the larger discrepancy observed for norclozapine, which
is even more positively charged compared to clozapine at neutral pH. The electrophoretic
transport hypothesis is further explored in separate experiments described at the end




literature Stokes–Einstein Eq. 2.4 experimental
Fc 7.5 µSt [95] 7.6 µSt 8.2 ± 0.2 µSt
clozapine — 5.3 µSt 8.9 ± 0.3 µSt
norclozapine — 5.4 µSt 11 ± 1 µSt
Table 2.1: Expected and experimental diusion behavior of the three analytes. The
Stokes–Einstein calculations and experimental measurements are described in the text.
Adapted from [93].

















Figure 2.10: Net molecular charge of clozapine (blue solid) and norclozapine (green
dashed) as a function of pH, highlighting the dierent charge states at neutral pH [94].
Adapted from [93].
may be, to reiterate, the non-ideal redox nature of both molecules, which renders the
Randles–Sevcik equation only an approximation.
In the presence of chitosan, calculating the diusion coecient at each scan rate
from the measured peak current becomes insightful, shown in Figure 2.11a [93]. Two
regimes become apparent for all species. At low scan rates, diusion coecients approach
those observed with a bare electrode (gray area). At high scan rates, diusion coecients
drop – signicantly so for clozapine and norclozapine – before saturating. This is broadly
in line with expectations: At low scan rates, the depletion layer will extend signicantly
beyond the thin chitosan lm, therefore leading to dominance of bulk diusion in solution
as with a bare electrode. At high scan rates, the depletion layer will be fully contained
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Figure 2.11: Calculated diusion coecients D as a function of cyclic voltammetry scan
rate for clozapine (blue squares), norclozapine (green circles), and Fc (red crosses) with
chitosan-only electrodes (a; lines are for visual guidance only) or the redox cycling system
(b; blue line indicates clozapine chitosan-only data). The bare electrode regime for all
three species (cf. Table 2.1) is represented as a shaded gray area in both plots. Adapted
from [93].
within the chitosan lm, which restricts diusion compared to free solution. The smaller
Fc is signicantly less restricted compared to both other species. However, the orders-of-
magnitude dierence, especially in light of the reversed trend on bare electrodes, could
also point to clozapine-specic interactions with the chitosan. A likely candidate is
electrostatic interactions of the largely positively charged clozapine with the similarly
positively charged chitosan matrix. One aspect not necessarily expected ab initio is
the consistently 2-fold lower diusion of norclozapine compared to clozapine – both
molecules are practically the same size (cf. calculated diusion coecients in Table 2.1),
and were observed to have very similar diusion behavior on bare electrodes. The trend
is in line, however, with the charge repulsion hypothesis, since norclozapine is even
more positively charged compared to clozapine at neutral pH as seen in Figure 2.10, and
would thus be more strongly restricted within the chitosan matrix. This chitosan-based
selectivity is remarkable, considering the identical electrochemical characteristics of both
species with bare electrodes.
With the chitosan-catechol system, diusion determination is not as straightfor-
ward. Due to redox cycling, underlying assumptions of the Randles–Sevcik Equation 2.1
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break down as multiple diusion lengths and rates (in bulk solution, within the lm, and
between the electrode and the catechol) and redox reactions (at the electrode and with the
catechol) become relevant. Thus, apparent diusion coecients calculated based on the
equation will mostly reect signal amplication in the system. Indeed, Figure 2.11b shows
all species with higher apparent D compared to their chitosan-only values, indicating
the expected signal amplication [93]. While the signal for Fc is amplied above even its
bare electrode values for all scan rates, clozapine and norclozapine show this behavior
only at the lowest scan rates investigated. Critically, clozapine amplication is shown
to be higher than for norclozapine, further emphasizing emergent selectivity due to
electrode biomaterial modications. The reasons for this can in part be attributed to
the diering diusion behavior observed in chitosan, as well as to the diering electron
transfer kinetics considered below. At high scan rates, the observed D for clozapine again
saturates at the same value as when there is only chitosan on the electrode. In this regime,
the electron transfer kinetics are too slow to allow for more than a single reaction, thus
again reecting true diusion, which is apparently not altered by the presence of catechol
in the lm.
Looking next at electron transfer kinetics, the theoretical behavior for all species is
summarized in Table 2.2 [93]. Fc, with its ideal single-electron reaction should show a
peak potential in line with the at-equilibrium Nernst Equation 2.2. Both clozapine and
norclozapine feature two-electron redox reactions, but are expected to deviate strongly
from the tabulated Nernstian behavior due to slow and quasi-reversible kinetics. Fc indeed
closely follows theoretical expectations for an ideal single-electron redox mediator on
a bare electrode as seen in Figure 2.12. Its oxidative peak potential deviates from the
expected Ep = +0.26 V only at very high scan rates ν ≥ 1 V/s, highlighting the fast
electron transfer kinetics. Both clozapine and norclozapine, conversely, rapidly diverge
from the expected Ep = +0.39 V for scan rates above 10 mV/s, indicating signicantly











Fc 0.23 V 1 29.6 mV 0.26 V
clozapine 0.37 V 2 14.8 mV 0.39 V
norclozapine 0.37 V 2 14.8 mV 0.39 V
Table 2.2: Electron transfer parameters for the three analytes. The calculations are based
on the assumption of ideal Nernstian behavior as described in the text. Adapted from
[93].
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Figure 2.12: Observed oxidative peak potentials as a function of cyclic voltammetry
scan rate for clozapine (blue squares), norclozapine (green circles), and Fc (red crosses)
with bare electrodes. The theoretical ideal values for all three species (cf. Table 2.2) are
indicated by lines to the left of the data. Adapted from [93].
correlation of R2 = 0.99. Thus, while diusion diers slightly between these two species,
the remaining similarities practically prevent dierential determination of the two species
with a gold electrode.
In the presence of chitosan, as shown in Figure 2.13a, only minimal changes are
observed for Fc and clozapine versus their respective bare electrode results [93]. For the
latter, this can be quantied with a correlation of R2 = 0.99; since Fc yields a at line in
both cases, correlation cannot be applied. More interesting is the case of norclozapine,
which shows a drastic change toward a nearly constant oxidation peak potential 0.1 V
above its Eo′. Similar to its eect on diusion, chitosan appears to confer selectivity
between the two highly similar species to the system. A simple two-process view of
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Figure 2.13: Observed oxidative peak potentials as a function of cyclic voltammetry
scan rate for clozapine (blue squares), norclozapine (green circles), and Fc (red crosses)
with electrodes modied with chitosan-only electrodes (a) or the redox cycling system
(b; dotted red line indicates Fc bare electrode data). Clozapine and norclozapine bare
electrode data is represented as a gray line in both graphs. Adapted from [93].
the electrochemical reaction (diusion to the electrode, followed by electron transfer) is
insucient to explain such behavior, as the presence of chitosan on the surface should not
change the inherent reaction kinetics between norclozapine and gold. A three-process
picture more closely aligned with reality, however, can oer more insight: Between
diusing to the electrode and reacting with it, the redox species needs to adsorb to the
electrode surface, and subsequently desorb again. I hypothesize that the reaction constant
for this adsorption process changes for the case of norclozapine, and actually begins
dominating the overall kinetics. I posit that the underlying factor in play here is the
strong electrostatic repulsion between norclozapine and chitosan, which would hinder
adsorption more strongly than for clozapine (where the electron transfer reaction remains
the dominant factor).
For the chitosan-catechol redox cycling system, the complexity of the electron
transfer system increases to not only include the oxidation at the electrode, but also the
reduction facilitated by catechol (separated by a short diusion path from the electrode)
with its separate reaction rate. The electrochemical results in Figure 2.13b reect this in
a slowdown of electron transfer kinetics across the board, wherein the diusion between
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the electrode and the catechol likely becomes a limiting factor with Fc, which similarly
slows down clozapine [93]. Norclozapine still exhibits generally constant oxidative peak
potential (albeit with high variability), now at an even higher Ep = 0.61 V, likely also
reecting the aforementioned added reaction steps occurring in the system. Importantly,
however, this breaks the symmetry between clozapine and norclozapine even further
than chitosan alone. Indeed, at low scan rates ν < 100 mV/s, the high similarity between
both species in diusion and reaction kinetics is broken for both factors. Thus, the
chitosan-catechol lm can enable selective detection of both clozapine and norclozapine
via electrochemical methods, a feat not previously demonstrated using electrochemical
detection. This selectivity applies especially when investigating a range of scan rates,
where both species exhibit quite distinctive changes in behavior.
To further investigate the hypothesis of electrostatic eects for clozapine, I consider
variations on the typical redox cycle for the redox cycling system, bare electrodes, and
chitosan only. In the absence of Ru, omission of the negative potential would not be
expected to aect electrochemical signals in the positive potential range – the negative
potential only serves to reduce Ru to enable catechol regeneration in the lm. However,
comparing the current signals in Figure 2.14b corresponding to the voltage sweeps in
(a) highlights critical dierences [90]. In the absence of Ru, omission of the negative
scan potentials causes a signicant ∼ 2.5-fold decrease in the clozapine redox signal.
The signal can be recovered, however, by applying a short negative potential pulse.
This aligns with the previous hypothesis of electrostatic eects. Specically, I believe
that electrophoretic transport of the predominantly positively charged clozapine (cf.
Figure 2.10) to the electrode increases the locally available concentration. Although the
high ionic strength of the buer leads to charge screening and thus a decrease in mobility,
the latter can be calculated to retain half its magnitude [96,97]. Electrophoretic eects
are further supported by some capillary electrophoresis studies operating in a similar
range of ionic strength and pH [32,33].
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Figure 2.14: Impact of applied negative potential on amplication. (a) Schematic of
potential sweeps utilized in these experiments: Standard full voltammetry cycle (black
solid); omission of negative potential range (blue dash); application of negative potential
pulse (red dash dot). The current measurements corresponding to the bold sections are
plotted in (b) for the redox cycling system. Reproduced with permission from [90].
A compounding factor may be the presence of oxygen, which is reduced around
−0.2 V, a pronounced reaction that is omitted in the absence of negative potentials. To
consider this, I carry out further experiments in an oxygen-deprived environment. The
test solutions are bubbled with nitrogen gas prior to measurements, and nitrogen is own
across the solution surface during the measurements. These experiments necessitated
the use of commercial gold disc electrodes to better seal the measurement chamber,
thus current magnitudes are not comparable to the earlier results. However, with bare
electrodes, a less pronounced yet similar trend is apparent in Figure 2.15a: The clozapine
signal current decreases by 26% when omitting negative potentials from the scan, and
recovers with a negative potential pulse. The behavior is amplied in the presence of
a chitosan lm only, as seen in (b) [90]. Thus, I believe that diusion dominates over
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Figure 2.15: Impact of applied negative potential on amplication, continued from
Figure 2.14, showing electrostatically driven transport of clozapine for bare (a) and
chitosan-only-modied electrodes (b). Adapted with permission from [90].
electrophoretic transport with bare electrodes, but plays a signicant role in the presence
of the diusion-restricting chitosan lm, which can be further amplied when catechol is
also present. This electrophoretic transport may serve to explain pre-concentration eects
observed, but not further investigated, by other electrochemical studies of clozapine
[40–42,98]. Signal gains in those works were up to an order of magnitude higher compared
to this work, but that is likely due to the dierent nature of the electrode material –
the carbon-based electrodes utilized therein have stronger inherent interactions with
clozapine due to pi-pi interactions, likely enhancing the electrophoretic pre-concentration
much like the redox cycling lm does.
2.1.6 Serum Selectivity
The signicant gain in clozapine sensitivity with the redox cycling system in buer
solutions was illustrated in Subsection 2.1.3, and in the previous Subsection I demonstrate
that the biomaterial lms confer selectivity between clozapine and its metabolite
norclozapine. The situation is of course signicantly more complicated when
transitioning from buer samples to human serum, where thousands of other species
are present. Some of these species could interfere with the sensor through various
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Figure 2.16: Clozapine detection in spiked commercial human serum samples using
dierential pulse voltammetry using a bare gold electrode. Adapted with permission
from [99].
mechanisms, from redox activity of their own, or fouling of the electrode surface, to
direct reactions of the interferents with the clozapine in solution. Broadly, there are two
approaches to study this: Bottom-up, by analyzing the eects of individual potential
interfering species (such as previously norclozapine) in buer solution mixed with
clozapine, or top-down by looking at human serum mixed with clozapine directly; in my
work, I have employed both.
First, a simple electrochemical measurement of clozapine in commercial human
serum with a bare gold electrode is instructive. These are conducted utilizing 2 mm disk
electrodes and dierential pulse voltammetry – the potential is not swept continuously,
but instead in an oscillating step-wise fashion – which can be more sensitive than
cyclic voltammetry, as discussed further in Section 2.3 (but is less suitable for the redox
cycling system). As observed in Figure 2.17, serum exhibits a pronounced electrochemical
background peak around 0.4 V, which coincides with the typical clozapine oxidation
potential [99]. The additional signal of added clozapine does not become clearly apparent
even at the highest concentration of 20 µM shown here.
Continuing the top-down approach with the chitosan-catechol system in Fig-
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Figure 2.17: Clozapine detection in commercial human serum with the redox cycling
system. (a) Cyclic voltammograms (oxidative region shown) for serum background (dotted
black) plus either 75 µM Ru (dashed yellow) or 75 µM clozapine (solid red; dierence vs.
background shaded). (b) Cyclic voltammograms (background-subtracted; oxidative scan
direction only) for 75 µM clozapine in serum at various concentrations of Ru.
ure 2.17a, I observe similarly pronounced serum background signals, shifted to higher
potentials compared to bare gold. The signicant increase in background signals in the
presence of Ru indicates redox cycling of serum interferents. Adding a high concentration
of clozapine to the solution causes a comparably minor increase in the observed current (in
the absence of Ru). Looking at background-subtracted currents for clearer visualization of
the clozapine signal in Figure 2.17b, the clozapine-specic current is revealed to increase
in the additional presence of Ru. The trend is however non-monotonous – the highest
concentration of Ru (matching that of clozapine) only serves to depress the clozapine
signal compared to the case of 25 µM Ru. This bears comparison to earlier observations
in Subsection 2.1.2, where matched concentrations provided the best signal-to-noise ratio.
I hypothesize that this is due the to signicant protein binding of clozapine as discussed
in Subsection 1.3.1. With only a small fraction of the 75 µM clozapine free in solution
(and electrochemically active as laid out later in this Section), it is actually the lower Ru
concentration that more closely corresponds to the “matched” concentration condition.
The general requirement for Ru in solution observed here defeats the ab initio hypothesis


































Figure 2.18: Clozapine sensing performance in spiked commercial human serum with
the redox cycling system in terms of background-subtracted charge transfer from
chronocoulometry for a range of clozapine concentrations. Adapted with permission
from [91].
As the clozapine-specic peak can be ill-dened at lower concentrations in
serum (somewhat akin to what is observed in the absence of Ru), I instead employ
chronocoulometry to produce the calibration plot in Figure 2.18. For this technique, I
apply a constant potential −0.4 V to (re-)charge the catechol, and then measure the total
oxidative charge transfer over 60 s at an applied potential of +0.6 V. From the previous
plot, this potential clearly aligns with the observed clozapine peak current. Due to the
integrative nature of this method, it oers higher sensitivity at the expense of some
selectivity in terms of the potential. The result is a sensitivity of 2.17 µC/log M and a
detection limit of 0.59 µM, comparable to that achieved in buer using cyclic voltammetry
(in serum, cyclic voltammetry yields a detection limit at least 20 times higher). This
represents the very rst example of a sensor capable of measuring clozapine at clinically
relevant levels directly in serum samples, in stark contrast to the previous examples in
literature involving extensive pre-treatment as reviewed in Subsection 1.3.2.
The bottom-up approach now becomes useful toward attributing electrochemically
inuential elements of the serum background to individual interfering species. For an
extensive study of the most common and abundant endogenous interferents in mixtures
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with clozapine in buer solutions, conducted with a glassy carbon electrode (shown to
be inherently more sensitive to clozapine, but unsuitable for chitosan lm deposition due
to its inability to hydrolyze water), I refer to my colleague Sheryl Chocron’s extensive
work and resulting Master’s thesis [100]. She determined uric acid (Eo′ = +0.28 V [101])
to be the primary electrochemical interferent, responsible for the background signal in
human serum at its native concentration of up to 410 µM. It is worth noting that uric acid
requires signicant overpotentials for oxidation on either gold or glassy carbon electrodes,
explaining its interference with the clozapine signal (with a theoretically 0.1 V higher Eo′)
as observed e.g. in Figure 2.16. Cysteine and serum albumin also exhibited interference,
but with distinct mechanisms – a complex alteration of the current response, and a simple
inhibition of clozapine’s redox current, respectively. The latter is not surprising, and
likely accounts for the decreased sensitivity observed in serum with the bare electrode
(in buer, 25 µM is easily detected on such). As mentioned in Subsection 1.3.1, clozapine
is highly protein-bound in circulation, mostly to AAG and albumin. A separate study by
my colleague George Banis further investigated the protein-binding in a bottom-up study,
and found that 1) protein-bound clozapine possesses negligible electrochemical activity,
and 2) while protein binding accounts for most of the signal loss, and fouling was shown
to not be a signicant issue (at least for a carbon electrode), the presence of serum-level
amounts of protein inherently decreases all redox signals, likely due to crowding-type
interactions [102]. While the latter presents a challenge for electrochemical sensors
regarding serum measurements in general, the former provides an advantage over most
of the other transduction methods reviewed in Subsection 1.3.2. Those generally measure
the total concentration of clozapine in circulation, including the protein-bound fraction.
Our approach, however, is sensitive only to the therapeutically active free clozapine,
potentially providing better treatment monitoring [103].
Returning to the chitosan-catechol system, I consider some specic relevant
interfering species in Figure 2.19. Previously discussed in depth in Subsection 2.1.5,
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clozapine’s metabolite norclozapine is one such candidate. While it is virtually
indistinguishable from clozapine when utilizing a bare electrode, the biomaterial
modications enable dierentiation. An interferent potentially more specic to
the chitosan-catechol system is dopamine – although only present at nanomolar
concentrations in blood, it serves as a representative catecholamine that may exhibit
structure-specic interactions with the catechol-based redox capacitor. Dopamine
produces a pronounced signal peak around +0.2 V, very near its standard reduction
potential and far removed from the clozapine peak. The higher peak current compared
to the other species is likely due to its faster diusion and electron transfer kinetics, and
thus higher redox cycling eciency. Importantly, the baseline measurement remains
unchanged after the dopamine measurement, indicating that no signicant dopamine
grafting onto the chitosan occurs. The catechol appears to occupy a near-equilibrium of
available sites, which – combined with the short residence time of oxidized dopamine –
limit such lm adulteration. Next, acetaminophen is one of the most likely exogenous
interferents present in patient samples, being present in a wide range of over-the-counter
and prescription medications to reduce fever and/or relieve pain. This molecule shows a
redox peak at or above the +0.75 V limit of the cyclic voltammetry scan shown here, with
similar signal amplication to clozapine or norclozapine, but well removed from both
their reaction potentials. These results illustrate the capability of the redox cycling system
to dierentiate certain endogenous and exogenous redox-active species. Finally, uric acid
– the dominant interferent in serum – shows electrochemical signals signicantly lower
than that of clozapine, implying less ecient redox cycling. However, its peak potential
still matches that of clozapine with the redox cycling system, aligning with the serum
background signal observed previously. As mentioned earlier, uric acid is also typically
present at a 100-fold higher concentration than clozapine. This presents a challenge for
the redox cycling system, since high variability in uric acid can thus translate into still
signicant variability in clozapine measurements.
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Figure 2.19: Cyclic voltammograms (oxidative region shown) measured with the redox
cycling system for solutions containing various oxidizing mediators. (a) Baseline-
subtracted measurements showing 25 µM clozapine (black solid); 25 µM (green dash dot)
or 50 µM (green dash) norclozapine; and 50 µM dopamine (purple dash). Adapted with
permission from [90]. (b) Measurements from 2 mm disk electrodes for 50 µM each of
clozapine (black solid), uric acid (red dash), and acetaminophen (yellow dash).
2.1.7 Synopsis
I demonstrated that the chitosan-catechol redox cycling system oers high amplication
of clozapine’s electrochemical signal, yielding a limit of detection compatible with the
clinical range. Moreover, I showed that the lms are suitable for reuse and storage
when proper corrections in data analysis are made. I explored the rich interplay of
biomaterials and electrochemistry oered by the redox cycling system, highlighting that
this enables dierentiation of clozapine and its metabolite norclozapine. Additionally, I
established selectivity with respect to a number of other relevant compounds and showed
a dose-dependent clozapine response directly in serum with a clinically compatible limit
of detection – a rst for clozapine sensing methodologies. However, I found that the
dominant serum interferent uric acid – though less amplied than clozapine – undergoes
redox cycling in the chitosan-catechol system with a signal overlapping that of clozapine,
calling for other strategies to supplement this sensing approach.
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2.2 Alternative Electrode Materials
Gold is often the default material of choice for microfabricated electrochemical sensors
due to its ease of fabrication and relative inertness, and indeed is utilized throughout
most of this work for these very reasons. Yet, it is not as inert as often assumed,
and may not be an optimal choice for a given sensor application [104]. The electrode
material plays a critical role in determining analyte interactions. This includes surface
morphology, direct physicochemical interactions with the analyte, as well as surface
fouling or oxidation. For instance, dierent surface chemistry could reduce the free
energy associated with clozapine oxidation, and surface morphology could provide more
surface area for reactions to occur. In the case of the chitosan-catechol redox cycling
system, the importance is two-fold as the electrode material will also aect the lm
deposition process.
Here, I consider materials covering a wide range of characteristics. Gold serves
as a reference material, as well as the base layer on which the others are fabricated.
Specically, I investigate titanium nitride, platinum, platinum black, and glassy carbon.
Platinum, like gold, is a noble metal like gold with low reactivity, but at the same time
has well-established catalytic properties. This can shift the observed reaction potential
of redox species, possibly enhancing sensor selectivity. Platinum black is atomically
identical, but exhibits an extremely high surface roughness, sucient to scatter most
incoming light and therefore appear black [105]. This could be expected to further
enhance electrochemical currents simply due to the increase in surface area. Titanium
nitride possess characteristics at the other end of the spectrum as it is a conductive
ceramic with high stability and inertness [106]. Glassy carbon is often utilized in macro-
scale electrochemical systems due to its favorable properties [107], and for clozapine
specically could provide advantages due to resulting pi-pi interactions. At the macro-
scale, this was indeed observed by my colleague Sheryl Chocron in her interference
studies [100]. However, as carbon electrodes cannot be utilized for hydrolysis, I do not
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expect to be able to form chitosan lms (which rely on the hydrolysis-induced increase
in local pH).
2.2.1 Experimental Methods
The underlying electrodes utilized are standard planar gold-on-silicon oxide as described
previously, except with a surface area of only 5×5 mm2. Fabrication methods for the three
material types vary as much as the materials themselves. Titanium nitride is deposited
using atomic layer deposition to yield a highly homogeneous layer to further emphasize
its inert properties. Platinum black is formed by electrodeposition at 300 A/m2 from a
solution of 1% chloroplatinic acid, 0.0025% hydrochloric acid, and 0.05% lead acetate as a
catalyst [108]. Platinum is similarly electrodeposited for consistency, at a third of the
current density and without the lead acetate. Glassy carbon is formed by patterning
negative SU-8 photoresist on top of the gold, and subsequently pyrolyzing it under an
inert nitrogen atmosphere in a furnace (200 °C for 0.5 h, 900 °C for 1 h, 600 °C/h ramping)
[109]. Chitosan-catechol modication, as well as testing procedures otherwise, are carried
out as described in Subsection 2.1.1.
2.2.2 Surface Characterization
The titanium nitride yields an almost invisible lm, adding only a slight tint to the
inherent colors of the gold and the substrate. Platinum deposits as a shiny silver lm, with
platinum black exhibiting the expected black color. At the nanoscopic level, visualized
in electron micrographs in Figure 2.20, observations dier slightly. Titanium nitride
and gold both show similar low-contrast surfaces with only nanoscopic defects, in
line with the conformal nature of ALD lms. Platinum black, as expected, shows a
highly structured surface, with fractal features from micro- down to nanometer length
scales. Electroplated platinum – somewhat surprisingly – also reveals distinct roughness,
albeit only at sub-micron length scales, explaining its optically reective qualities.
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Figure 2.20: Scanning electron micrographs of gold, titanium nitride, platinum, and
platinum black electrode surfaces. Adapted from [110].
Energy-dispersive X-ray spectroscopy conrmed the atomic nature of the observed
structures. Glassy carbon represents a special case: Although the photoresist successfully
pyrolyzes, the high temperatures appear to compromise the gold layer itself, resulting
in gold and carbon peeling o the substrate. Although not exceeding the bulk melting
temperature of gold, signicant melting point suppression can occur at thicknesses in
the hundreds of nanometers or less, potentially explaining this peeling eect. Glassy
carbon microelectrodes were thus not pursued further.
For electrochemical characterization, I rst utilize cyclic voltammetry with the
standard ferri/ferrocyanide redox couple on bare electrodes as a control. This provides
a measure of the electrochemical surface area independent of any specic clozapine-
catalytic eects. I report the results in Table 2.3 as the peak current Ip-derived signal
amplication relative to a bare gold electrode (cf. Equation 2.3). Titanium nitride shows a
negligible 5% increase over gold, indicating that the surface area is still dened by the
underlying gold electrode, rather than by lateral conductivity in the thin ceramic. With
platinum, I see a 40% increase, conrming that electroplating yields non-negligible surface
roughness in spite of its mirror-like visual appearance. Platinum black, as expected, shows
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material ferri/ferrocyanide
gold 1.00 ± 0.02
titanium nitride 1.05 ± 0.01
platinum 1.40 ± 0.04
platinum black 2.70 ± 0.18
Table 2.3: Eective electrochemical surface area as characterized using the model redox
couple ferri/ferrocyanide. All values are normalized to that of gold (italics). Adapted
from [110].
the biggest increase at 2.7-fold. These ndings align well with the qualitative imaging
observations.
2.2.3 Electrochemical Sensing
After the initial electrochemical characterization above, both bare and chitosan-catechol-
modied electrodes are then tested with clozapine, where I quantify signal amplication
relative to bare gold as per Equation 2.3. The experiments, summarized in Table 2.4,
are conducted in both PB and PBS to investigate further the eects of chloride, which
will become especially relevant for platinum. For gold, the redox cycling system yields
∼ 3-fold amplication – in line with previous observations – with minimal dierence
between these condition. The generally high associated variability illustrates one of the
challenges of the chitosan-catechol lms on gold. During chitosan electrodeposition, cell
potentials typically exceed +1.5 V, sucient to cause oxidative surface fouling of the gold
lm, which I hypothesize is central to the high variability observed here [104]. Moreover,
nanoscopic defects in the gold may be translated into much larger inhomogeneities.
For bare titanium nitride electrodes, I verify a practically identical response
compared to gold in Figure 2.21a (PBS results shown; refer to the table for PB). This
matches what was observed with the standard ferri/ferrocyanide redox couple. The
intrinsic background reactions seen at potentials higher than that of clozapine – possibly
related to ozone formation or hydrogen peroxide decomposition [111] – are also
conserved, indicating they do not rely on surface chemistry. However, in the presence of
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material
clozapine in PB clozapine in PBS
bare RCS bare RCS
gold 1.00 ± 0.05 3.04 ± 0.59 1.00 ± 0.25 2.86 ± 1.25
titanium nitride 0.88 ± 0.07 6.14 ± 0.86 1.10 ± 0.15 7.54 ± 0.36
platinum 250 ± 56 125 ± 19 32 ± 11 —
platinum black 1490 ± 150 — 193 ± 20 —
Table 2.4: Electrochemical characterization results for the electrode materials studied
in this work. Toward therapeutic drug monitoring of clozapine, materials were tested
with (RCS) and without (bare) further redox-cycling system modication in either PB or
PBS. For each group, the relevant gold reference is in italics, and relative amplication by
more than a factor of ve is in bold. Adapted from [110].
the redox cycling system, signicant dierences between the two become apparent. The
signal amplication is 2.5-fold higher compared to the chitosan-catechol on gold, and the
signal variability 9-fold lower. This aligns well with our hypotheses on the underlying
reasons for the inherent variability with gold, in contrast to the highly homogeneous
ALD titanium nitride lm here [112].
With platinum in phosphate buer, I observe an intriguing signal amplication
of 250-fold as shown in Figure 2.21, and I conrm that this signal indeed depends
on the clozapine concentration. However, the high amplication is largely lost upon
switching to PBS, and the redox cycling system also decreases (rather than increases)
the electrochemical signal. Furthermore, the signal variability is larger than 10% for all
conditions. Apart from the higher currents, the corresponding peak potentials decrease
signicantly in PB, indicating that platinum functions as a redox catalyst as expected and
reduces the need for an overpotential. The observed behavior regarding amplication,
however, is counter-intuitive considering the much more limited signal enhancement
with the ferri/ferrocyanide. A key dierence between the standard redox couple and
clozapine is the much slower (limiting; cf. Subsection 2.1.5) electron transfer kinetics
of the latter compared to the traditional diusion limitation of the former (akin to Fc).
For a diusion-limited reaction, surface roughness below the micron scale will hardly
contribute, since the depletion layer thickness will extend far beyond (tens of microns)
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Figure 2.21: Cyclic voltammograms (oxidative section of third cycle) of clozapine solutions
(b) in PBS utilizing gold and titanium nitride (TiN) electrodes, without or with further
redox cycling system modication; (c) in PB or PBS utilizing gold and platinum electrodes,
without or with further redox cycling system modication. Peak potentials are marked
by symbols on the curves together with peak current standard deviations. Adapted from
[110].
[88]. By contrast, kinetics-limited species like clozapine exhibit a much more surface-
conformal depletion layer. These types of reactions are thus selectively amplied by
nano-scale morphology such as observed in our platinum lms. This eect has previously
been observed and exploited with enzyme-free sensors for glucose, another redox kinetics-
dominated analyte [113,114]. The performance decrease with the redox cycling system
also supports this interpretation, as the lm will slow down diusion and decrease the
dominance of electron transfer kinetics. The lower signals in the presence of chloride are
believed to be due to formation of a Pt-Cl complex at the electrode surface [115]. This
presents a major hurdle to the otherwise impressive performance of a bare platinum
clozapine sensor, since chloride will also be present in biological samples. The high
variability presents another limitation – this is notably not observed with the standard
redox couple, thus likely related to the sub-micron morphologies. The mechanism could
therefore be similar to that which resulted in the high variability with the redox cycling
system on gold – nanoscopic defects compounding to much larger eects upon deposition.
Platinum black further amplies the clozapine signal over that observed with
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platinum, again far more than the 2.7-fold increase seen with ferri/ferrocyanide. As with
platinum, the almost 1500-fold amplication decreases rapidly in the presence of chloride,
and suers from high variability. Here, however, variability is already signicant for the
standard redox couple, aligning well with the presence of both micro- and nanostructures.
No lm deposition was attempted based on the negative results with platinum alone.
Moreover, the platinum black electrodes degraded rapidly after fabrication within a
few days, likely due to surface oxygen interactions [116]. Even more so than platinum
itself, platinum black thus shows impressive clozapine detection performance that are
outweighed by a number of limitations for real-world use.
2.2.4 Synopsis
I discovered that platinum and platinum black can serve as highly sensitive clozapine
sensors based on redox catalysis and clozapine’s slow reaction kinetics. Associated
drawbacks are high variability as well as negative interactions with chloride, which
present challenges with application to biological samples. For the redox cycling system,
I found that titanium nitride oers a signicantly better underlying electrode surface
compared to gold, reducing noise, and increasing signal amplication.
2.3 Redox Catalysis System
Instead of modifying chitosan post-deposition, carbon nanotubes or graphene can be
physically mixed into the chitosan solution. Compound lms can then be directly
electrodeposited, as pioneered by my colleagues Dr. Eunkyoung Kim and Dr. Mijeong
Kang. These lms oer three advantages: First, the aforementioned favorable pi-pi
interactions between carbon compounds and clozapine; second, an increase in electrode
surface area from the high-surface-area conductive carbon network in the lm; third,
electrocatalytic properties akin to those provided by platinum [117–119]. These features
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are expected to signicantly amplify electrochemical signals in general, and clozapine’s in
particular, in addition to reducing required overpotentials and thereby shifting observed
signal peaks closer to their inherent Eo′. Here, I present data concerning these hypotheses,
focusing specically on the lm’s selectivity to critical interfering species as well as on
sensitivity in clinical serum samples.
2.3.1 Experimental Methods
Experimental methods largely follow those employed in Subsection 2.1.1, with commercial
2 mm diameter gold working electrodes. Carbon nanotubes up to 5% w/v or graphene up
to 2% w/v are dispersed in chitosan solution by ultrasonication for 45 minutes, preceded
and followed by brief vortex mixing. Immediately thereafter, lms are electrodeposited
onto the electrode surface at a constant cathodic current of 8 A/m2 for 60 s (CNT) or
90 s (graphene or mixtures). Excess material is allowed to dissociate with the electrode
immersed in DI water, followed by PB prior to experiments.
The measurement method utilized, unless noted otherwise, is dierential pulse
voltammetry. The chosen parameters are a potential sweep from 0 to +0.7 V at a scan
rate of ν = 2 mV/s in discrete 1 mV steps, overlaid with ∆E = 50 mV, τ = 200 ms pulses.
The current is measured just before the current pulse as well as at its end and expressed
as a dierential current. The main advantage oered here is that the dierential nature
of the measurement suppresses non-faradaic background currents, and yields sharper













In this Section, experiments are carried out with clozapine-spiked serum samples
from healthy subjects are employed instead of the commercial human serum employed
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in Section 2.1. These samples more closely resemble clinical patient samples, and were
collected at the Maryland Psychiatric Research Center under procedures approved by
the University of Maryland, Baltimore, Institutional Review Board (HCR-HP-00058348-2,
“Screening protocol for the evaluation of research participants”, and HCR-HP-00058348-2,
“Microsystem Development for Clozapine Monitoring in Schizophrenia”, both subject to
yearly review; and ). In the course of this study, blood is collected from healthy control
subjects as well as from schizophrenia patients, either treated with clozapine or on a
dierent treatment regimen. The serum is fractionated out in the collection tubes on
site, and aliquoted for research use as well as centralized clinical laboratory analysis for
clozapine. Samples are kept frozen until use.
2.3.2 Sensitivity and Selectivity
To verify the hypothesis of redox catalysis improving selectivity, a bottom-up-type
experiments with clozapine and select interferents in buer solutions is shown in
Figure 2.22a [120]. Specically, this illustrates the the electrochemical signals of clozapine,
uric acid, and norclozapine with 2% chitosan-graphene electrodes. Clozapine’s oxidative
peak is observed at its Eo′ = +0.37 V, similar to observations on bare gold electrodes in
earlier Sections, but amplied ∼ 50-fold. Uric acid, critically, shows a redox signal at
signicantly lower potentials around 0.2 V – in stark contrast to the overlap observed with
the chitosan-catechol system in Subsection 2.1.6. This veries the hypothesis that the low-
dimensional carbon compounds reduce the required overpotential for oxidation of this
dominant serum interferent. Norclozapine, on the other hand, shows indistinguishable
redox activity from clozapine. Unlike the chitosan-catechol system in Subsection 2.1.5,
the chitosan matrix here does not impart selectivity between these two compounds. In
the redox catalysis system, the redox reaction can occur at or near the surface of the
compound lm due to the conductive carbon network, eliminating the need for diusion
through the porous, charged chitosan network. While a drawback compared to the
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Figure 2.22: Selectivity and sensitivity of the redox catalysis system. (a) Dierential pulse
voltammograms from clozapine (solid black), uric acid (dashed red), and norclozapine
(dashed green) in buer solutions with chitosan-graphene electrodes, with the buer
background current subtracted. (b) Clozapine detection in spiked clinical serum from
healthy subjects plotted in terms of peak current as a function of concentration for both
chitosan-CNT (green) and chitosan-graphene (blue) electrodes. Adapted with permission
from [85] and [120].
chitosan-catechol system, the summed clozapine and norclozapine concentration (which
the redox catalysis system would thus measure) can still serve as a useful clinical marker
[121].
With the selectivity for clozapine over uric acid established, measurements in
human serum should prove relatively straightforward with the redox catalysis system.
Indeed, a calibration plot can be obtained directly from the DPV peak currents measured
in spiked clinical samples from healthy subjects as shown in Figure 2.22b. Following
previously utilized denitions, I calculate a sensitivity of 1.04 log A / log M (chitosan-
CNT) and 0.91 log A / log M (chitosan-graphene), with corresponding limits of detection
of 0.55 µM and 0.73 µM clozapine. Both systems are further validated with serum samples
from people with schizophrenia currently undergoing clozapine treatment (not shown;
cf. [85,120]). The higher sensitivity and lower detection limit of the CNT-based lms can
likely be attributed in part to the higher carbon mass loading at 5%, compared to 2% for
graphene. Both of these loadings are at the very upper limit for eective suspensions. On
balance, graphene appears to perform better in the redox catalysis system, as its signals
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lag behind those of the CNT by less than the 2.5-fold dierence in mass loading. Its 2%
suspensions are moreover subjectively less prone to aggregate formation and variability
in lm formation. Compared to the chitosan-catechol redox cycling system results
in Subsection 2.1.6, the limit of detection here falls in a very similar range. The redox
catalysis system oers greater selectivity, however, as those same gures of merit could be
obtained with voltammetry as opposed to chronocoulometry. The dierence in methods
also accounts for the dierence in linear behavior and thus the incomparability of the
sensitivity values; since sensitivity remains roughly conserved in the double-logarithmic
representation between serum and buer samples such as those in Subsection 2.1.3, the
redox catalysis system likely also scores better on that metric by a factor of two.
2.3.3 Synopsis
I demonstrated that the chitosan-CNT/graphene redox catalysis system oers high
amplication of clozapine’s electrochemical signal, with only minimal interference
of the dominant serum interferent uric acid. This enabled similarly sensitive, more
selective detection of clozapine directly in clinical serum samples as compared to the
redox cycling system. However, I showed that clozapine and its metabolite norclozapine
exhibit overlapping electrochemical signal peaks and cannot be dierentiated with the
redox catalysis system.
2.4 Chapter Summary
In this Chapter, I have explored various electrochemical sensing strategies for clozapine.
Both the chitosan-catechol redox cycling system and the chitosan-CNT/graphene redox
catalysis system have been shown capable of detecting clozapine directly in human
serum with limits of detection below 1 µM. This is in line with clinical requirements as
laid out in Subsection 1.3.1, and represents a breakthrough for electrochemical sensors,
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which to date have relied on extensive sample pre-treatment procedures as reviewed in
Subsection 1.3.2. I have also demonstrated the potential of high-surface-area platinum
surfaces for electrochemical clozapine detection, with even higher signal amplication
than chitosan-CNT/graphene. Particularly with the chitosan-catechol redox cycling
system, I have further explored the molecular mechanisms and interactions underlying
its functionality, from lm stability to diusion eects. All modalities oer unique
advantages – as well as limitations. Platinum is susceptible to performance degradation
by chloride, present in biological samples. The chitosan-catechol system allows for
dierentiation between clozapine and its metabolite norclozapine, but uric acid interferes
with clozapine’s signal. The chitosan-CNT/graphene system shows the reverse behavior,
and allows for more selective detection in serum. The latter moreover does not rely on a
separate reducing mediator. Therefore, the redox catalysis system is the best candidate
for a stand-alone electrochemical clozapine sensor, and is thus selected for the integrated
system in Chapter 4. However, future work (cf. Section 5.3) should focus on integrating
these modalities in an array of sensors to ultimately unlock their full synergistic potential.
Chapter 3
Hydrodynamic Focusing and Osmotic Lysis for Impedance Cytometry
Even if awless implementations of all the individual components needed in a clozapine
treatment monitoring lab-on-a-chip (blood fractionation, dierential cell counting,
clozapine sensing) were available today, the barrier of system integration remains. In a
microsystem combining these elements, a multitude of interactions, respective limitations
and requirements has to be considered. The ow rates are one main aspect of this in
an interconnected microuidic device, governed not only by the external inputs, but
also by the uidic resistances of all other parts of the design (for the relevant theoretical
treatment, see Subsection 4.1.4). Another example is that solutions to induce red blood
cell lysis could interfere with an impedance-based cell sizing method due to the altered
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solution resistivity. These points illustrate the challenges of microsystem integration;
overcoming these is a major contribution of this thesis.
To gain a better understanding of such microsystem integration, in this Chapter I
investigate integration of two critical sub-systems. First, in Section 3.1, that of impedance
cytometry with in-plane hydrodynamic focusing for enhanced sensitivity. Second, in
Section 3.2, that of impedance cytometry with osmotic lysis of erythrocytes to enable
entirely label- and reagent-free white blood cell counting. Although hydrodynamic
focusing and osmotic lysis themselves are not novel concepts, in this Chapter I present
the rst studies of systems interplay, highlighting the promise and feasibility of a fully
integrated device.
3.1 Hydrodynamic Focusing for Enhanced Sensitivity
One challenge for impedance cytometers becomes evident by considering the simplied
governing Equation Equation 1.1: |∆Z | ∝ /o3/DA2. Thus, the relative change in impedance
caused by a cell of diameter /o passing through the aperture DA is strongly dependent
on their relative size, with the aperture optimally as small as possible – that is, DA ≈ /o
considering the obvious constraint that the aperture cannot be smaller than the cell.
However, this optimization condition competes with biophysical limitations of blood –
granulocytes generally have diameters on the order of 10–15 µm, but clusters of cells or
other (albeit rarer) cell types in circulation can signicantly exceed that, with macrophages
at ∼ 20 µm [45]. An impedance cytometer perfectly matched to granulocyte sizes will
thus inevitably clog.
Hydrodynamic focusing has long been studied in microuidics, and has even
been applied to cytometry (including impedance cytometry), with Larsen et al.’s initial
microuidic implementation a prime example as discussed in Subsection 1.3.3. The
approach relies on laminar ow phenomena to tightly conne a sample stream within
one or more sheath ows. Its appeal is many-fold, providing 1) sample dilution to avoid
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coincident cell counting events and 2) well-dened cell positioning with respect to the
detector to reduce variability. For impedance cytometry, non-conductive sheath ows in
particular have the added advantage of also providing 3) detection volume connement
within the (conductive) sample stream between the non-conductive sheaths. This results
in a virtual aperture VA within a potentially much larger channel that oers the same
benets as a smaller physical aperture DA while minimizing the risk of clogging from
larger cells or aggregates.
As mentioned earlier, a few researchers have previously considered these
advantages with regard to impedance cytometry. Akin to the initial concept by Larsen et
al., a study by Rodriguez-Trujillo et al. employs in-plane DI water sheath ows for particle
counting [53,122]. Although both consider the hydrodynamics involved (the latter in
depth), both are lacking in experimental characterization of cytometry performance.
Works by Bernabini et al. and Evander et al. are aimed at impedance analysis of bacteria
and platelets, much smaller than typical blood cells, made possible by in-plane oil-based
sheath ows [123,124]. The systems interplay between focusing and cytometry, however,
is only considered briey in – respectively – theory and experiments. The two-phase
ow approach is moreover prone to suer from interfacial instabilities which can disrupt
the ows [125,126]. Many other researchers have further considered adding additional
connement in the out-of-plane direction, as again pioneered (though not characterized)
by Larsen et al. utilizing additional sheath ows [125,127,128]. Alternative approaches
employing inertial, acoustic, or other forces have also been investigated [52,58,59,126,129].
Still, the systems interplay of in-plane hydrodynamic focusing with impedance
cytometry – upon which many of the more elaborate techniques are based – remains
poorly understood. My study of the systems interplay consists of two parts: Modeling and
device experiments. Both are equally critical to develop a comprehensive understanding
of the phenomena at play. I construct models both analytically and numerically to
consider geometrical design parameters as well as experimental parameters such as
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ow rates, frequency dependence, etc. I conduct experiments with two populations of
polystyrene beads – equivalent to cells under certain conditions – to validate models and
reveal dependencies not captured by either modeling approach.
3.1.1 Design Overview
My design, shown in Figure 3.1, employs co-planar microelectrodes at a distance d =
170 µm downstream from a hydrodynamic focusing junction, where the sample stream
(ow rate Qs) is met perpendicularly by two streams of DI water (combined ow rate
Qf from a shared inlet port) [130]. The co-planar electrode design avoids the alignment
challenges in fabrication of facing ones with only a minor trade-o in sensitivity –
provided the channel height is dimensioned close to the cell diameter of interest, thereby
limiting the variability of how close (or far away) these cells pass over the electrodes
[54]. The water sheath ows provide lateral connement of the detection volume over
the electrodes. The perpendicular conuence angle design has previously been shown to
provide the tightest focusing over distances less than 1 mm [131,132].
Specically, my design to study the interplay of hydrodynamic focusing and
impedance cytometry utilizes microuidic channels with a height of h = 20 µm (close to
the ∼ 15 µm diameter of granulocytes) and a width ofw = 50 µm to still allow for passage
of larger cells and aggregates. Electrode width and spacing are chosen as l = д = 25 µm
based on design rules for interdigitated electrode sensors as well as biophysical cell
size considerations [133]. Furthermore, I study the hydrodynamic focus channel width
wfc, a parameter that has not previously been considered with respect to hydrodynamic
focusing geometries. I choose to operate in a creeping ow regime of constant Reynold’s
number Re < 1, i.e. constant total ow rate, specically Qs +Qf = 40 µl/h based o of
instrumentation capabilities.
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Figure 3.1: (a) Photograph of my impedance cytometry lab-on-a-chip. The microuidic
channels are lled with dye to enhance visualization. (b) Micrograph of the region of
interest highlighted by the blue dash-dotted box in (a). In-plane hydrodynamic focusing
is schematically illustrated by overlaid numerical simulation for a 1:1 ratio of sample
(particles in electrolyte; red) to focus (DI water; green) ows. The virtual aperture VA
sample connement is conserved downstream, where impedance is measured across
the rst gold microelectrode pair, separated from the junction by distance d . The other
pairs serve as backups and are not utilized here. (c) Numerical impedance cytometry
model corresponding to the red dashed box in (b). The cell (center) is suspended in a
microchannel between two electrodes (bottom; gold rectangles). The colors correspond to
the current density from blue (low) to red (high), clearly illustrating the diusely focused
electrolyte, with conductivity σmed ranging from high in the center to low on either side.
(d) Analytical equivalent circuit model corresponding to the red dashed box in (b). Shown
for VA > /o, this accounts for conduction pathways from the cell (top), the electrolyte
(middle), as well as the ionic double layer capacitance and the DI water aperture (bottom).
(e) Model of a cell as a spherical shelled particle consisting of cytoplasm and membrane,
surrounded by liquid medium. Reproduced with permission from [130].
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3.1.2 Analytical and Numerical Models
The analytical and numerical models both consist of three aspects: A hydrodynamic
model to predict the virtual aperture widthVA based on geometry and ow parameters, an
electrodynamic model to calculate impedance cytometry performance based on geometry
and environment, and an approach for coupling these two aspects for comprehensive
analysis. Although numerical models are exceedingly useful in modeling complex systems
and geometries, they are at a small but nonzero risk to produce nonsense results through
solutions in local, rather than global, minima. Thus, analytical models are critical to
validate numerical model results. They also require signicantly less computing power,
allowing for much faster exploration of the (albeit smaller) parameter space that is
accessible to them.
For hydrodynamics, an analytical description of in-plane ow focusing was
published by Lee et al. [134]. It denes the ratio of focus to total ow rate FR and
how that relates to the downstream width of the focused ow – i.e. the virtual aperture

































The velocity ratio γ arises out of integrating the velocity prole in the sample and focus
ow streams. The form of this equation obviates a closed-form solution for VA (FR),
but the problem is nonetheless easily solved by a numerical root-nding algorithm in
Wolfram Mathematica.
My nite element model, overlaid in Figure 3.1b, fullls the same overall purpose,
but can oer a few renements [130]. I implement it in COMSOL Multiphysics utilizing
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coupled Creeping Flow and Transport of Diluted Species modules. It allows for variations
in the focus channel geometry not considered in the analytical model, such as their
angle with respect to the sample channel or the width of the focus channels wfc. Most
importantly, this allows for including diusion of ions (Dion = 16.83 µSt; average of
dominant sodium and chloride ion diusion coecients [135]) that ultimately determine
medium conductivity σmed and thus the virtual aperture VA. I similarly include slow-
diusing cells (Dcell = 1 nSt; red blood cell diusion coecient [136]) in the sample
stream as a control. Diusion of the ions into the DI water sheath ows eliminates a
clearly-dened two-phase virtual aperture in the nite element model. Instead of a simple
VA value it provides a concentration proleC (x) (normalized to the input concentration)
across the width of the channel at a given distance d downstream from the focusing
junction. A limiting factor of the employed numerical model is its 2-dimensional nature,
which neglects out-of-plane variations in ion concentration.
Although the concentration prole allows for direct coupling into a numerical
electrodynamic model as described below, deriving a value for VA is still useful for
assessing the impact of diusion exclusively on the hydrodynamics and for comparison
to the analytical model. Analytically, diusion proles are described by the sigmoidal
error function, and can be closely approximated by hyperbolic trigonometric functions
that are more amenable to curve tting algorithms. For my case of symmetric ow
focusing, the diusion proles can thus be tted with the double-sigmoidal peak function
as shown in Figure 3.2:
















This describes the ionic concentration prole in terms of only four parameters: The oset
from zero Coset, the double sigmoidal peak amplitude Camp, the peak’s full width at half
maximum sp, and the width (= 1/steepness) of the peak’s slope ss, yielding t errors of less
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than 2% for all conditions studied. Based on these parameters, I design an approximation









This form converts the diusion prole into a roughly equivalent discrete-phase
concentration prole as overlaid in Figure 3.2 [130]. The rst term considers the central
focused concentration prole, somewhat analogous to integrating the double sigmoidal
peak (without its oset). The second term accounts for the oset – which reduces the
ecacy of any focusing in the center – by integrating over the area under the oset, scaled
to the prominence of the central peak. The equation is designed such that for limiting
cases, it reduces to expected values: For completely discrete phases (Camp = 1, Coset = 0,
ss = 0) it yields VA = sp, while for complete interdiusion (Camp = 0, C (x) = Coset) it
reduces toVA = w , reecting the equivalence to a simple decrease in input concentration
and the resulting lack of ow focusing eects.
For electrodynamic modeling, impedance cytometry itself has been extensively
analyzed in the works of Gawad, Morgan, Sun, and others [54,59,137]. They derive an
equivalent circuit model for the cell between the electrodes based on a model of the cell
as a spherical shelled particle (Figure 3.1e). Therein, the cell membrane (thickness t ) and
cytoplasm, with respective conductivities σ and relative permittivities ε , are treated as
the two relevant components of a spherical cell of diameter /o. The equivalent circuit
model likewise assigns each component a respective resistor and capacitor value in
parallel, arrayed in a series circuit. Maxwell’s Mixture Theory allows for derivation of
an overall eective conductivity and permittivity, including the surrounding medium
[138,139]. The double layer capacitance at the electrodes can be included as an additional
series circuit element [140]. For coplanar (rather than facing) electrodes, the highly
non-uniform electric eld presents an added challenge that can be addressed through
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fitted C(x) (Eq. 2)























Figure 3.2: Concentration (averaged along the height of the channel and normalized to
the input concentration) as a function of lateral position in the channel for an exemplary
FR = 0.75 (total ow 40 µl/h). The plot shows both numerical data (blue dots) as well as
the corresponding t with Equation 3.2 (orange line). The t parameters are illustrated
with black dashed lines, and the corresponding VA according to Equation 3.3 overlaid as
as an orange rectangle (illustrating a discrete-phase concentration prole resulting in
the same VA value). Reproduced with permission from [130].
Schwarz–Christoel mapping, constructing an equivalent facing electrode scenario [133].
While these aspects of the model have been published on, they have never been
presented in a fully integrated form. I address this in my thesis, and extend the approach
to be able to account for hydrodynamic focusing. The model is implemented in Wolfram
Mathematica and included in Appendix B: Analytical Model [130]. I choose a Helmholtz
approximation for the ionic double layer with a capacitance of F = lwεmed/λD (IS), where
λD is the Debye length as a function of the relevant ionic strength. For coupling the
hydrodynamic and electrodynamic models, assuming discrete phases of focusing and
sample ows downstream of the focusing junction as in analytical hydrodynamic model,
entirely parallel conduction pathways are introduced: One inside the focusing DI water,
another one through the sample solution containing the cell. For the case of VA > /o,
this is illustrated in Figure 3.1d. However, focusing can exceed this condition to yield








still inside the sample solution. I account for this by modifying
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the volume fraction Π = P/V of the particle within the electrical interaction volume by
substituting P → Pel. The remaining particle volume P−Pel is then conversely introduced
into the particle fraction within the focus ow (otherwise 0 for VA > /o).
I implement the nite element model in COMSOL Multiphysics, relying on the
Electric Currents and Electrical Circuits modules. With the aforementioned Maxwell’s
mixture theory, the cell can be modeled as a homogeneous sphere with an eective
conductivity and permittivity [141]. It is placed in a microchannel between electrodes as
shown in Figure 3.1c. Again, the numerical model allows for exploration of a much bigger
parameter space such as cell location (enabling also transient cell passage studies). For
the double layer capacitance, I rely on the same approximation as in the analytical model,
included as circuit elements at the electrodes. To couple in the hydrodynamic model,
the suspending electrolyte is described as a continuous phase with conductivity σmed =
σelCion (x), i.e. as the electrolyte conductivity scaled linearly by the ion concentration
calculated in the numerical hydrodynamic simulation. The double layer is similarly
adapted by substituting IS → ISDI + ISelCion (x). Although the linear assumption for
conductivity neglects certain non-linear contributions, these become exceedingly complex
for multi-ionic electrolytes such as PBS and only yield corrections on the order of 15%
even at high dilutions (where they would be most pronounced) [142,143]. A limiting
factor for the coupled model is that it neglects changes in ow and ion concentration
caused by the particle, such as boundary layer formation around it.
3.1.3 Device Fabrication
The design is implemented in two physical layers – the coplanar electrodes on glass, and
the microuidics in PDMS. The fabrication process ow is schematically illustrated in
Figure 3.3. The electrodes are fabricated by rst depositing 20 nm chrome (functioning as
an adhesion layer) and 200 nm gold on a borooat glass wafer utilizing e-beam deposition.














Figure 3.3: Abbreviated fabrication process ow for the rst-generation devices described
in the text.
peroxide : sulfuric acid), and dehydrate on a hotplate for at least 5 minutes. Then, I spin-
coat a layer of Shipley 1813 positive photoresist (4 s ramp, 4000 rpm, 30 s hold), followed
by a 60 s bake at 115 °C. The photomask 6.2 shown in Appendix A: Photomasks (printed
on transparency lm) is used to expose the resist to 140 mJ/cm2 UV light, followed by
another 60 s bake at 115 °C. I develop the resulting patterns for at least 45 s in Microposit
352 developer, followed by incremental 5 s immersions guided by pattern inspection
under a microscope (E1). Finally, I wet-etch the exposed metal utilizing Transene TFA
(gold) and 1020 (chrome) etchants (E2). The process is monitored utilizing microscopy
and conductance measurements. To protect the structures from scratches during the
subsequent wafer dicing, the entire wafer is again processed with photoresist as described
above, only utilizing ood exposure with a 3-fold higher dose and omitting development.
For the microuidics, I spin-coat negative SU-8 2015 photoresist to a thickness
of ∼ 20 µm (4 s ramp, 500 rpm, 10 s hold, followed by 3 s ramp, 1700 rpm, 30 s hold)
on a dehydrated Piranha-cleaned blank silicon wafer, followed by a 25 minute bake at
60 °C (ramped up from room temperature at 5 °C/minute). Utilizing the photomask 6.3
shown in Appendix A: Photomasks, again on transparency lm, I expose at a dose of
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157.5 mJ/cm2, followed by another 60 °C bake for 35 minutes (same ramp speed). I nd
that the long bake times and slow ramp speeds (compared to manufacturer specications)
used throughout processing are necessary to prevent the formation of small bubbles in
the photoresist layer. The patterns are developed by immersion in SU-8 developer for
∼ 5 minutes, stopped by a rinse in isoproyl alcohol, whereafter I inspect geometries under
a microscope and utilizing a contact prolometer (M1). I hard-bake the resist at 150 °C
for 10 minutes (ramp as before). To prepare the wafers for PDMS molding, I submerse
the wafer in a solution of ∼ 0.35% Alconox in water for ve minutes, then spin-dry. The
detergent is intended to form a non-stick coating on the silicon, enabling removal of the
molded PDMS. Spin drying was found to yield better coating retention than blow drying,
and a more homogeneous coating than evaporation drying. PDMS is prepared as a 10:1
mixture of Sylgard 184 base to curing agent to a total weight of 33 g, mixed well and
degassed under vacuum until no bubbles are observed. I pour the liquid PDMS over the
molds and cure it in a box furnace utilizing a 5 minute ramp up from room temperature
to 60 °C, followed by a 15 minute hold time (M2). I remove the PDMS when the oven
cools to ∼ 55 °C, where the PDMS has lost most of its inherent stickiness but is not yet
fully cured. I dice the PDMS slab using a knife, and punch connection holes utilizing
2 mm diameter biopsy punches (M3).
For assembly, I clean the electrode chips by rinsing successively with acetone,
methanol, isopropanol, and DI water, followed by immersion in Piranha solution for 60 s.
Both the electrodes and the microuidics are rinsed with DI water and blow-dried. I
expose both layers to oxygen plasma in a cylindrical chamber at a pressure of 1 Torr,
power of 20 W, for 30 s, in line with existing literature on the strongest glass/PDMS bond
[144]. Drop-coating the electrode chip with methanol immediately after removal from
the plasma chamber allows for alignment of the two layers under a stereomicroscope
without instantaneously forming a permanent bond. It further strengthens the ultimately
resulting bond due to the negative pressure created by methanol pervaporation. Finally,
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I fully cure the devices in a box furnace with a 15 minute ramp to 60 °C, followed by
3 hours hold time, and left to cool down naturally (E3). I verify nal geometries to be
within 10% of specications under an optimal microscope.
3.1.4 Experimental Methods
The electrodes are connected to an Agilent E4980A Precision LCR meter using spring-
loaded pins and coaxial cables. I employ an AC potential of 0.7 Vrms at a frequency of
100 kHz to read out the absolute impedance Z . The instrument is capable of a single
measurement per 5 ms, which presents a limitation for other experimental parameters.
Specically, since the electrical interaction volume is roughly V = wh (2l + д), a particle
has to reside within that volume for a comparable time. Thus, the maximum possible
total ow rate is on the order of V /5 ms, or approximately 55 µl/h.
Flow actuation is provided by two New Era NE-1002X syringe pumps, holding
plastic 1 ml syringes connected to the microuidic inlet ports using 30- or 32-gauge
needles and Tygon tubing (0.19 mm inner and 2.03 mm outer diameter; shown as E4
in Figure 3.3). The compliant nature of the PDMS and the tubing creates an excellent
friction-t seal. Although the syringe pumps are chosen for their nanometer-size stepping,
ow rates should still be maximized to provide accurate ow control. High ow rates
further reduce other artifacts such as particle settling, etc. To balance these requirements
with the upper limit given by impedance readout and the overall Re < 1 creeping ow
condition, I choose a total ow rate of Qs +Qf = 40 µl/h, varying the ratio between ows
to explore ow ratios from FR = 0.875 down to 0.075. The sample stream is provided by
1× PBS solution containing polystyrene beads of diameters /o = 6 µm and 10 µm, as well
as 10.9% w/w sucrose to match solution and particle density, minimizing particle settling.
The focus ow consists of DI water with resistivity > 17 MΩ cm.
I control ows and record data with custom graphic user interfaces developed
in LabView. For each ow condition, the experiments run for 0.5 to 2 hours to ensure
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sucient sample sizes. I analyze the data in MATLAB, employing the code in Appendix
C: MATLAB Code. It determines the background signal Zempty by rst removing obvious
peaks and outliers from the rawZ signal based on the second derivative and then applying
a 9 Hz low-pass lter. I subsequently calculate |∆Z | and detect peaks using a simple built-
in algorithm. This set of local maxima is transformed into histograms using OriginPro.
By tting a Gaussian distribution between the rst and second minima in the histograms,
I derive population averages and spreads.
3.1.5 Theoretical Analysis
As mentioned previously, the virtual aperture VA represents the critical hydrodynamic
parameter for impedance cytometry. Thus, it provides a logical starting point to begin
the theoretical analysis of systems interplay. The primary control parameter for a given
geometry is the ow ratio FR between sample and total ow rates as evidenced by the
analytical Equation Equation 3.1. While this is independent of the absolute ow rates,
the numerical model introduces diusion and is thus expected to be aected by changes
in those as well. In Figure 3.4, I plot the virtual aperture width VA as a function of ow
ratio for both models as a heat map, with values ranging fromVA = w = 50 µm (maroon)
down to 0 µm (purple). For the numerical model, the second coordinate represents the
sample ow rate Qs [130]. Two overlaid lines indicate Re = 1 (black dashes) and the
experimental regime of a constant total ow rate of 40 µl/h (solid gray, with squares
representing individual measurement conditions) well within the creeping ow regime.
Overall, lower ow ratios FR clearly correspond to better sample connement (colder
colors). At high sample ow rates or low ow ratios (upper right quadrant), the deviation
between numerical and analytical models is moreover minimal. However, diusion asserts
itself at low sample ow rates and high ow ratios. This is most obviously apparent at
the bottom of the plot, where diusion washes out the rapid color progression seen in
the analytical model. Thus, use of the analytical model has to be judicious, keeping the
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flow ratio sample to total FR
Figure 3.4: Color map of the virtual aperture width VA (from low to high as purple to
maroon) as a function of sample owQS and the ow ratio FR, as determined by numerical
modeling for wfc = 75 µm. The analytical model, independent of QS, is included at the
top. The experimental regime of constant total ow is shown by gray squares. The ow
regime of Reynolds number Re < 1 is indicated by the black dashed line and the arrow.
Adapted with permission from [130].
employed ow regime in mind.
Figure 3.5a represents a section of the above color map along the gray line of the
experimental regime, plotting VA as a function of FR for the analytical model (dotted
line), the numerical ion model (orange crosses), and the numerical cell model (maroon
circles) [130]. The deviation between the two modeling approaches can be more clearly
observed here as compared to the heat map, with the relative deviation quantied as
RMSE = 17.6%. At the diusion timescales investigated, cells should practically yield a
nearly two-phase ow solution at the experimental condition, and thus serve as a basic
validation of the numerical versus the analytical model. Indeed, the agreement is much
better in this case, at RMSE = 8.9%. This underestimation by the numerical cell model
is likely due to my speculative formulation for VA in the nite element model. The
dierence between cells and ions within the numerical regime, however, should be less
sensitive to this factor. Therefore, the overall ~25% deviation between the two can serve
as an approximate indicator of the eect size that may be expected from diusion when
subsequently looking at impedance cytometry performance.
Considering diusion eects further, Figure 3.5b shows another section of the
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flow ratio sample to total FR
Figure 3.5: Hydrodynamic analytical (dotted line) and numerical (orange crosses) models
revealing the dependence of the virtual aperture width VA (a) on the ow ratio FR in
the experimental regime (constant total ow), with numerical results for slow-diusing
cells (maroon circles) also presented for comparison; (b) on the sample ow rate QS for a
representative, xed FR = 0.25; (c) on the focus channel width wfc for a representative,
xed FR = 0.25. Adapted with permission from [130].
heat map, along a representative vertical line of constant FR = 0.25, thus showing VA
as a function of Qs [130]. As the latter increases, VA rapidly decreases from its upper
limit of VA = w down to the lower analytical solution limit. The experimental value
of Qs = 10 µl/h at this ow ratio clearly falls onto the asymptotic approach, where
an order-of-magnitude change in ow only eects minimal improvements in model
agreement.
Finally, in Figure 3.5c, I explore geometric variations in focus channel width wfc
on VA at the same representative FR = 0.25 [130]. There is a clear positive correlation
between the parameters; the scale of the y-axis, however, indicates that the eect size
is marginal compared to what even a minor change in FR can accomplish. Around the
mean, the variation in wfc here is only RMSE = 1.4%, which is below variations that can
be expected from external interfering parameters on FR such as syringe pump stepping.
The small eect size here also bears comparison to that observed in the few other works
that have considered ow focusing geometries, where changes in conuence angle altered
VA by up to 50% [131,132].
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Before proceeding to analyze the fully coupled problem, a few purely electrody-
namic considerations are of interest. In Figure 3.6, I rst consider the dependence of
the impedance signal |∆Z | as a function of the applied electrical signal frequency [130].
The impedance response is plotted for a generic reference white blood cell (red circles;
parameters from [140]), with variations considered here in diameter /o (yellow and blue
triangles), membrane permittivity εmem (green dashed and dash-dotted lines), and cytosol
conductivity σcyt (purple dashed and dash-dotted lines). This reveals three regimes with
distinct sensitivity to cell size (around 90 kHz), membrane properties (0.9 MHz), and
cytosol properties (20 MHz). The general behavior matches that expected from previous
work – which has also shown how to compensate for the cross-talk of the size parameter
into the other frequency regimes – with the specic frequency regimes particular to my
device geometry [54,141]. I also nd that other cell properties (membrane conductivity
and cytosol permittivity) do not impact the signal response, again matching expectations.
The major implication here is that a frequency of 100 kHz will be exclusively sensitive
to cell size, independent of its internal structure or properties. Thus, at this frequency,
cells and polystyrene particles can be treated equivalently, greatly simplifying device
experiments without compromising the general nature of the conclusions.
Figure 3.7a–b presents the results from the coupled hydrodynamic and electrody-
namic models both analytically (dotted lines) and numerically (symbols) [130]. Specically,
I plot the impedance signal |∆Z | for /o = 6 µm diameter particles and the population
separation ∆ |∆Z | between 10 µm and 6 µm diameter particles, both as a function of
the ow ratio FR. The data overall clearly highlights the gains in performance that
hydrodynamic focusing (i.e., decreasing FR) can provide for impedance cytometry. These
trends are also conserved in the membrane- and cytosol-sensitive frequency regimes (not
shown).
When comparing between analytical and numerical models, however, there are
obvious dierences. In the weak focusing regime of FR ≥ 0.5, the models agree reasonably
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Figure 3.6: Impedance cytometry signals |∆Z | from numerical modeling as a function of
signal frequency f for variations around the reference cell parameters (red squares) in
terms of size /o (blue/yellow triangles), membrane permittivity εmem (green lines), and
cytoplasm conductivity σcyt (purple lines). The resulting three frequency regimes are
highlighted by overlaid colored bars. Adapted with permission from [130].
well, with RMSE = 41% for ∆ |∆Z | combined with a matching trend. This contrasts with
a corresponding value of 203% in the strong focusing regime. While the numerical
model is already entering saturation in this regime, the analytical model continues to
increase and saturates only onceVA < /o, where a further decrease inVA also impacts the
eective particle volume as discussed earlier in Subsection 3.1.2. The gain in sensitivity
correspondingly decreases from up to tenfold in the analytical model down to 2.8-fold
in the numerical one. Since model agreement without ow focusing validates the basic
electrodynamic model, the large eect size has to be attributed to diusion. This now
bears comparison with the purely hydrodynamic results in Figure 3.5. The disagreement
between models in that case is limited to around 20% – an order of magnitude less than
seen here for low FR. Moreover, the deviation between hydrodynamic models only
gradually changes with FR, unlike the relatively sharp change seen here.
To consider this further, in Figure 3.7c I plot the population separation ∆ |∆Z | as a
function of sample ow rate Qs at an exemplary FR = 0.25 [130]. With increasing ow
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Figure 3.7: Analytical (dotted lines) and numerical (blue triangles, black crosses) models
of impedance cytometry performance as a function of (a–b) hydrodynamic focusing
in terms of the ow ratio FR or of (c) sample ow rate Qs at a representative, xed
FR = 0.25. Performance is shown in terms of (a) impedance cytometry signals |∆Z | for
cells of diameter /o = 6 µm and of (b–c) population separation ∆|∆Z | between /o = 10 µm
and 6 µm diameter cells. Adapted with permission from [130].
performance only gradually increases from the lower limit (where the timescales are
long enough to allow for complete interdiusion, equivalent to the numerical model in
the absence of ow focusing) toward the upper limit from analytical modeling. While
the basic positive correlation agrees with expectations, it again bears comparison to
the similar results from hydrodynamic modeling in Figure 3.5. There, experimental
conditions are within an asymptotic approach to the analytical limit; here, they do not
even clear the half-way point.
Lastly, I consider the empty channel impedance Zempty. On this parameter, both
models show excellent agreement over the entire range of FR, with only RMSE = 5.6%
deviation between analytical and numerical results. The empty channel impedance, of
course, is intimately (and inversely) linked to the eective electrical interaction volume,
and thus to VA. At the same time, the eect size from diusion here is even less than
predicted from the hydrodynamic model. Only when a particle or cell is present, however,
I nd that diusion signicantly exceeds those expectations with regards to impedance
cytometry, especially in the regime of strong focusing.
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Looking at the model assumptions, the intriguing implication of this result is that
the Equation 3.3 serves as a good approximation of hydrodynamic focusing eects in
terms of VA. For impedance cytometry, though, the dominant parameters are clearly
not accounted for correctly. To investigate this further, I construct a partial least squares
regression model from all available data in OriginPro. This multivariate analysis approach
attempts to predict an output (here, ∆ |∆Z |) based on multiple inputs (here, the t variables
for the concentration proles) without prior knowledge of their relation. In constructing
this model, one quantiable result is the relative importance of the various input variables.
This is predicted asCoset > sp ≈ Camp > ss, implying for instance that a high oset value
carries a larger penalty regarding impedance cytometry performance than my equation
accounts for. The dataset is too small and not properly designed for deeper multivariate
analysis, however.
3.1.6 Device Experiments
The theoretical considerations of the last Subsection are only truly valuable when
assessed against experimental results from my devices. I illustrate the operation and
data analysis of these in Figure 3.8 [130]. Exemplary impedance signal |∆Z | data of
/o = 6 µm polystyrene particles for the lowest investigated ow ratio FR = 0.875 is
shown in Figure 3.8a after the MATLAB processing of the raw data as described in
Subsection 3.1.4. The data reveal a highly populated background around |∆Z | = 0, as
well as distinct datapoints corresponding to passage of particles through the detector.
Clustering of these signals into a distinct band around |∆Z | = 0.16% is already apparent
visually. Transformation of these data into the histogram in Figure 3.8b, and tting
of the peak with a Gaussian distribution, easily quanties this population average as
well as the corresponding spread δ = 0.02%. Repeating such experiments with both
particle sizes and for multiple ow ratios yields data like that in Figure 3.8c for each
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Figure 3.8: (a) Representative processed experimental impedance cytometry signals |∆Z |
from /o = 6 µm diameter particles at the lowest investigated FR = 0.875. (b) Corresponding
histogram for the entire 30-minute dataset, where population average |∆Z | and spread δ
(overlaid blue triangle and error bar, respectively) can be determined from Gaussian tting
between the rst and second minima. (c) |∆Z | and δ (symbols and error bars, respectively)
for both /o = 6 µm (blue triangles) and 10 µm (red squares) particle populations for a range
of ow ratios FR from a representative device. Adapted with permission from [130].
the Gaussian histogram ts – on a logarithmic y-axis to accommodate both /o = 6 µm
and 10 µm particles – as a function of ow ratio FR. The signicant ve-fold gain in
impedance signals with hydrodynamic focusing becomes immediately apparent for both
populations, which remain clearly separated. This experimentally validates the overall
approach. Single-device results, in spite of an event count typically exceeding 1,000 for
each population average, can still suer from outliers such as the large population spreads
δ occurring here with the 10 µm diameter population at the lowest FR. Thus, most of my
analysis going forward considers data and trends across all devices and conditions.
One point of note regarding the analysis is that while the Gaussian tting serves
as a good rst-order approximation, it suers from limitations both from experimental
and theoretical perspectives. First, the data clearly displays outliers in the range of
|∆Z | = 0.3%, which can be attributed to rare coincident detection of two particles. Second,
the data also displays a strong negative skew – while some of this can be attributed to
the tail ends of the background noise distribution, a signicant part of it cannot. This
leads to the third point, which is that a Gaussian distribution is not even expected from
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underlying factors in the experiments. These are as follows: The polystyrene particles
themselves have an inherent distribution in size – assuming it is normal in terms of
diameter as implied by the manufacturer, this leads to a positive skew in impedance
signals (as these are proportional to volume); while out-of-plane particle positioning in
the channel likely follows a at distribution, this would yield a negative skew due to the
larger signals by those closer to the electrodes; most critically, the transfer function of
the LCR meter – with measurement time on a similar timescale as particle transit time –
introduces a dominant negative skew.
Keeping these limitations in mind, I proceed to compare theory and experiments
in Figure 3.9a, specically regarding impedance signals |∆Z | for /o = 6 µm diameter
particles [130]. Experimental data is plotted for each device (symbols), alongside both
analytical (dotted line) and numerical (dashed line) models. To emphasize trends, the
y-axes are scaled by a factor of 3, which I will discuss further below. Considering just
the experimental data, these match the observations in Figure 3.8c, revealing an increase
in signals from |∆Z | = 0.17% up to 0.87% at a low FR = 0.125.
Comparing models and experiments in terms of signal magnitude shows that the
former exceed the latter by a factor of about 3 (±0.5 depending on the model) in the
weak focusing regime, in line with the axis scaling employed. I attribute a large part of
this to the LCR meter transfer function mentioned earlier: Besides introducing negative
skew to the signal distribution, having the measurement and particle transit on similar
timescales (cf. Subsection 3.1.4) also causes transient averaging. With transient numerical
simulations, I estimate this to account for a factor of approximately 1.7. The remainder
of the discrepancy is likely due to parasitic eects primarily from the unshielded on-
chip connection traces and contact pads. Moreover, the Helmholtz model potentially
underestimates the ionic double layer capacitance.
The trends in the experimental and model data, however, allow for intriguing
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Figure 3.9: (a) (left axis) Experimental impedance cytometry population averages |∆Z | of
/o = 6 µm diameter particles (symbols) from all LOCs as a function of the ow ratio FR.
Each data point here represents an average of at least 1,000 particle passages. Connecting
solid lines are visual guides only. (right axis) Corresponding analytical (dotted) and
numerical (dashed) model predictions are overlaid, scaled by a factor of 3 to highlight
trends. (b) Population separation ∆ |∆Z | between /o = 6 µm and 10 µm as an average
across LOCs (crosses; left axis), with corresponding models overlaid scaled by a factor
of 3 (lines; right axis). Error bars represent standard errors of the mean. (c) Average
relative population spread δ/|∆Z | corresponding to the population averages in a across
all devices (hexagons) shown separately for clarity. Error bars represent standard errors
of the mean. Adapted with permission from [130].
trend somewhat more closely than the numerical one for strong focusing. It appears
that while the analytical model provides an upper bound to experimental impedance
cytometry performance, the numerical model provides a lower one. It is likely neglected
higher-order eects, such as the direct particle–ow eld interaction, that ultimately
account for an experimental trend inbetween the limiting model cases.
In Figure 3.9b I present the aggregate data on population separation ∆ |∆Z | across
all devices as a function of ow ratio FR [130]. Like the previous plot in |∆Z |, both models
are overlaid with a separate y-axis scaled by a factor of 3. Experiments again reveal a
robust increase from ∆ |∆Z | = 0.48% to 2.65%, with a trend falling inbetween that of the
numerical and analytical models. Indeed, the interpretation follows practically the same
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lines as that above, providing additional validation in the form of an independent set of
data. Both results showcase interesting dierences between experiments and theory, and
moreover establish the benets of employing hydrodynamic focusing with impedance
cytometry in terms of sensitivity.
The population spreads δ in Figure 3.9c correspond to the averages from (a),
shown here separately across all devices for clarity and to highlight other important
characteristics [130]. Specically, displayed in relative terms as δ/|∆Z |, they appear to
be constant and FR-independent at a value of 16%. I statistically conrm this with linear
regression model ANOVA and its insignicant p-value of 0.15. This helps in attributing
the observed population spreads to various phenomena. An FR-dependence would point
to ow-related phenomena such as syringe pump stepping, where very low sample ow
rates Qs at the lowest FR would be expected to increase noise levels. Similarly, increasing
absolute impedanceZ with decreasing ow ratio could introduce additional measurement
noise. Neither appears to be the case. Instead, two inherent geometrical factors appear to
dominate: First, the intrinsic particle size distribution, specied by the manufacturer as
22% in terms of volume. Second, the variability in out-of-plane particle positioning. For a
similar design, Gawad et al. predict around δ/|∆Z | = 30% for /o = 10 µm diameter particles
[54]. Thus, my particle spread values in these experiments compare quite favorably to the
underlying physical constraints. I further point out that while the spreads are signicant,
most of the broader conclusions here are based on the population averages and their
much smaller related standard errors (< 5%).
Considering observed variability, another factor that proves interesting to consider
is inter-device variability such as seen inFigure 3.9a. While the trends are similar, I still
nd a relative RMSE = 9.5% across all ow ratios FR. This could point to one of the
obvious dierences between them – focus channel width wfc, the geometric parameter
of interest. Although modeling predicted minimal impact, this still bears experimental
consideration. Thus, separately for each FR condition, I analyze |∆Z | as a function of wfc.
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Employing linear regression ANOVA, I do not nd a signicant trend, with the average
p-value (across all FR) at p̄ (wfc) = 0.40. This is in line with the models, but leaves the
observed device variability unaccounted for.
Diusion-related parameters are natural next candidates to consider, based on the
observations thus far. Of particular importance in this regard is the distance between
the ow focusing junction and the measurement electrodes. A longer distance equals a
longer diusion time and thus a less well dened VA. Although designed to be constant
at d = 170 µm, manual alignment of PDMS and glass yields some variability in this regard
within the 10% tolerance criterion followed overall. Interestingly, I do not observe a
correlation directly between d and impedance cytometry performance in terms of |∆Z |;
instead, I nd one in terms of a modied distance d′ = d + 1
2
w fc, i.e. measured from
the center of the focus junction. This is illustrated in Figure 3.10, where population
averages are plotted as a function of this parameter for each ow ratio FR [130]. A linear
trend with |∆Z | decreasing toward larger d′ is clearly apparent particularly in the strong
focusing (low FR) regime, where diusion eects would be most pronounced due to the
narrower VA. Employing the same type of ANOVA as above, I conrm this statistically.
The average p̄ (d′) = 0.06. is slightly above the traditional signicance level; however,
d′ is the only parameter where p-values are consistently less than 0.05 for FR < 0.75.
The other parameters considered are p̄ (d) = 0.22, p̄ (d +wfc) = 0.13, and p̄ (h) = 0.93.
The latter, variable due to inhomogeneous photoresist thickness in spin-coating, could
also have been expected to impact cytometry performance by altering the electrical
interaction volume as well as changing ow behavior.
Finding the center-to-center distance d′ (rather than other distance parameters) to
play a role aligns with the inertial eects described in previous work on hydrodynamic
focusing geometry [131,132]. Such eects can be expected to be most prominent in the
region of highest ow velocity, i.e. the channel center. The nding also implies that the
focus channel width wfc does in fact play a role in cytometry performance, albeit a minor
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Figure 3.10: Experimental impedance cytometry population averages|∆Z | of /o = 6 µm
diameter particles recorded using dierent LOCs as a function of the distanced′ = d+ 1
2
w fc.
The geometrical parameter is highlighted in the schematic drawing of the device layout.
FR is listed on the left for each set of data and decreases from 0.875 (black squares) to
0.125 (purple diamonds). Linear ts to the data are shown as dotted lines, and p-values of
corresponding ANOVA models are listed on the right. Adapted with permission from
[130].
one. The general correlation of distance with |∆Z | aligns with the other ndings in my
work on the importance of diusion in cytometry and further reinforces this notion. I nd
that the impact of ionic diusion in microuidics generally seems to be underappreciated,
with only few works on impedimetric systems devoting attention to this phenomenon
[126,145]. Indeed, even considering the traditional measure of the importance of diusion
over convection – the Péclet number Pe = 2 (Qs +Qf ) /(w + h)Dion = 189 – leads to
the expectation of negligible diusion eects, being much larger than 1. In the systems
interplay between hydrodynamic focusing and impedance cytometry, however, my work
shows that this is clearly a misplaced assumption.
3.1.7 Synopsis
I presented the rst in-depth study of systems interplay between in-plane hydrodynamic
focusing and impedance cytometry. From a performance standpoint, I demonstrated
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up to ve-fold improvement in size sensitivity with DI water sheath ows. I explored
both analytical and numerical models of the system to compare the experimental data to.
The models predicted negligible impact of the focus channel width on performance, but
the numerical model revealed signicant impact of diusion on impedance cytometry
performance in spite of a high Péclet number. I found experimental trends to actually
fall between the two modeling approaches, which likely serve as upper and lower limits.
Nevertheless, I observed the impact of diusion experimentally in the dependence of
cytometry performance on the distance from the focusing junction – specically its
center, likely related to inertial ow eects.
3.2 Reagent-Free Osmotic Lysis of Erythrocytes
The use of various reagents in existing white blood cell counters to eliminate the high red
blood cell background, and the associated downsides for a point-of-care device in terms
of packaging, have been covered in Subsection 1.3.3. An appealing alternative approach
to erythrocyte lysis relies simply on pure water – a compound that is cheap, quite stable,
and can even be produced on-site in resource-poor environments by distillation. This
type of osmotic lysis is well-accepted for benchtop ow cytometry [146]. It relies on the
higher resilience of white blood cells compared to red blood cells in the presence of a
strong osmotic pressure gradient ∆P . In bulk solution, while practically all erythrocytes
are ruptured after an exposure time of t = 30 s, leukocytes can survive up to t = 120 s in
pure water [147].
A few researchers have previously studied this approach with a focus on erythrocyte
lysis [148,149] and on recovery of and potential changes in leukocytes [150]. In the former,
both Sethu et al. and Zhan et al. employ simple PDMS-on-glass microuidics, wherein
whole blood and lysis agent combine at a junction and then mix by diusion as the ow
continues through a serpentine channel, with lysis eciency monitored optically. Both
groups nd lysis eciency to depend mainly on the exposure time t , with complete lysis
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at t = 15 s. In terms of the osmotic pressure gradient ∆P , both demonstrate an increase in
the required lysis time depending on the ratio of water to blood ow rates – the increase
is observed for ratios of less than 5:1 (Sethu et al.) or less than 10:1 (Zhan et al.). In
later work, Sethu et al. conrm that osmotic microuidic lysis is advantageous over bulk
reagent-based lysis both in leukocyte recovery and cell activation, employing a device
modied to enhance mixing of solutions by convection.
Although some critical aspects of microuidic osmotic lysis have been characterized,
integration with impedance cytometry has not been studied. With these integrated
systems, two opposing optimization criteria come into play: Maximizing water ow to
achieve a sucient osmotic pressure gradient for ecient erythrocyte lysis, yet at the
same time minimizing it to keep the absolute measured impedance Z low. Although
the solution conductivity σmed is a negligible factor in the models for |∆Z | presented in
Section 3.1, high Z are inherently more dicult to measure. My work thus aims to study
the relevant sub-system interplay by considering a range of exposure times and osmotic
pressure gradients.
3.2.1 Design Overview
My design, shown in Figure 3.11, employs co-planar microelectrodes at a distance L =
70 mm, 135 mm, or 200 mm downstream from a junction, where the blood sample stream
(ow rate Qs) is met perpendicularly by two streams of DI water (combined ow rate
Ql). To minimize clogging, the channel width is chosen as w = 120 µm, except in the
measurement region, where it reduces to 50 µm to enhance sensitivity. The device
dimensions are otherwise identical to those in Section 3.1. The same applies to the
ow – I conduct all experiments under the condition of Qs +Ql = 40 µl/h. At this total
ow rate, the three lysis channel lengths provide lysis exposure times of t = 15 s, 30 s,
and 45 s. While laminar ow does not allow for rapid mixing, the interdiusion time
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Figure 3.11: Photograph of my device. Right: Illustration of the microuidic channel
variations investigated in this study. Bottom: Micrographs of lysis inow and impedance
measurement regions, with overlaid hydrodynamic nite element model (DI water lysis
ow (green) and blood sample ow (red; cells and ions) at FR = 0.25). Adapted with
permission from [151].
ratio of lysis to blood ow rates, I can adjust the osmotic pressure gradient ∆P . Analogous
to Equation 3.1, I quantify this in terms of FR = Qs/(Qs +Ql ). I can also set ∆P = 0 by
replacing the DI water lysis ow with PBS. Thus, I am exploring two independent key
parameters for osmotic lysis with my design.
3.2.2 Experimental Methods
For device fabrication, I refer to Subsection 3.1.3, with the only dierence being in
the utilization of the photomask 6.4 shown in Appendix A: Photomasks to pattern
the microuidic mold (although the mask includes hydrodynamic focusing features,
the respective channel inlet is not opened up in this study, rendering them inert).
Instrumentation is similarly described therein. The lysis ow consists of DI water with
resistivity > 17 MΩ cm, or 1× PBS for negative controls. For the sample ow, I obtained
95
heparinized whole blood from a blood bank, ltered through a 70 µm mesh size cell
strainer prior to experiments. While in the particle experiments of the previous Section it
was possible to employ sucrose for density matching, such an approach would cause cell
damage from hyperosmotic conditions as well as decrease the achievable osmotic pressure
gradient for any given ow ratio. Thus, cell sedimentation in the vertically mounted
syringes becomes a concern, leading to hyper-concentration of cells. To circumvent this,
I dilute the blood 1:3 with commercial human serum and supplement the solution with
5 mM ethylenediaminetetraacetic acid.
I again control ows and record data with custom graphic user interfaces developed
in LabView. For each ow condition, the experiments run for 0.5 to 2 hours to ensure
sucient sample sizes. I analyze the data in MATLAB, employing the code in Appendix
C: MATLAB Code. Due to the signal approaching (or, for some conditions, reaching)
saturation, the algorithm utilized with particle experiments – which assumes sparse
peaks – is not capable of determining the background signal Zempty here. Instead, an
image erosion algorithm derives the signal oor, subsequently smoothed by a moving
average lter. Using this background to calculate |∆Z |, I detect signal peaks with a simple
built-in algorithm. Then, I employ a scaled version of the analytical electrodynamic
model from Subsection 3.1.2 to express data in terms of equivalent spherical diameter
/o instead of |∆Z |. Histograms are obtained and tted as previously described, except I
normalize these to the total number of counts to account for the unknown input cell
density from settling.
3.2.3 Impact of Flow Ratio and Lysis Time on Lysis Eciency
In Figure 3.12, I illustrate the data analysis with two exemplary signal distributions
recorded in my devices, displayed both in terms of measured impedance signals |∆Z | as
well as in terms of the model-derived cell diameter /o [151]. Both experimental conditions
shown exhibit clear Gaussian distributions (dotted lines) that can be represented in the
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Figure 3.12: Exemplary impedance distributions in terms of |∆Z | or /o (dotted lines),
normalized by total counts. Fitted Gaussian N -proles (symbols and error bars) are
overlaid, and the derivation of characteristic cell size prevalences Ñ (shaded) is illustrated.
Reproduced with permission from [151].
form of an N -prole (symbols and error bars) – the population average and spread
obtained from tting the data. A second relevant parameter is the characteristic
prevalence Ñ , used to describe the prevalence of erythrocyte-characteristic and leukocyte-





Illustrated with red and blue shaded overlays for red and white blood cell types in the
gure, it quanties the sum over the histogram counts N within a standard error of the
respective characteristic cell size.
Considering N -proles rst, I plot these as a function of the ow ratio FR in
Figure 3.13 [151]. The graph shows data for all three lysis times (colored triangles and
squares) as well as a negative control utilizing buer instead of water (black circles). The
dierence between osmotic lysis solutions and the negative control is the most apparent
feature of this gure. It further contains many more facile conclusions regarding dierent
regimes. The regime of ow ratios FR ≤ 0.25 holds the central conclusion: Here,
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Figure 3.13: Signal distributions in terms of /o for a range of FR and t (colored squares and
triangles), as well as negative control (black circles). Dotted lines are shown for guidance
only. Reproduced with permission from [151].
the control saturates at signals corresponding to an equivalent spherical cell radius or
/o = 7.8 ± 0.2 µm for ow ratios FR ≤ 0.25. Allowing for their distinctly non-spherical
shape, this size is in close agreement with the size of erythrocytes [45]. It is also in sharp
contrast to active osmotic lysis with exposure times of t ≥ 30 s. At the high osmotic
pressure gradients in this ow regime, combined with the long exposure times, signals
saturate at /o = 11.2 ± 0.2 µm, matching expected leukocyte diameters of 10–12 µm. The
stark dierence relative to the control, combined with the saturating behavior, appears
to conrm that the maximum erythrocyte lysis eciency is achieved in this regime, in
general agreement with previous work [148–150].
Outside this regime, the control bears a further look. The “lysis” ow rate here
does not aect the osmotic pressure gradient which remains constant at ∆P = 0, yet the
observations clearly deviate from the saturation value at low ow ratios. However, the
decreasing ow ratio here does provide further sample dilution. Without such dilution
at low ow ratios, I hypothesize that the high abundance of red blood cells causes
measurement overload with multiple cells within the detection volume simultaneously,
leading to unrealistically high observed values of /o. This applies to conditions of FR = 1
or lysis time t = 0 in general.
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For the ow ratio FR = 0.5, osmotic lysis at all exposure times shows a sharp
increase to /o = 15 µm, while the control already trends to lower values. Thus, though
signal saturation is clearly still a factor, I believe that the low osmotic pressure gradient ∆P
here exacerbates the situation by causing signicant cell swelling while being insucient
to cause rupture. This is further supported by the signicantly larger population spreads.
Lastly, at the shortest lysis exposure time of t = 15 s, saturation is not achieved even at at
the lowest ow ratio, with the signal strongly trending toward that of the control, and thus
a signal dominated by erythrocyte-characteristic cell sizes. Since the osmotic pressure
gradient appears to be sucient for lysis, it seems the exposure time is not, leaving
a signicant number of erythrocytes intact and thus leading them to again ultimately
dominate. This is broadly in line with previous literature reporting t ≥ 15 s as the
minimum lysis time [148,149].
While both for t = 15 s and in the FR = 0.5 case, erythrocyte lysis is not achieved,
I need to emphasize the diering underlying hypotheses. This mechanistic insight is
importantly a direct result of the on-chip monitoring capabilities – optical lysis monitoring
via hemoglobin release as employed by Zhan et al., for instance, would likely not be able
to dierentiate these cases [149]. I also need to note, however, that my experimental
design suers from a lack of independent (optical) validation. My hypotheses are thus
based on combining the previous observations by Zhan et al. and Sethu et al. with my
impedimetric observations of diering signal behavior at dierent lysis times and an
overall non-linearity in terms of ow ratio (thus ruling out artifacts from changes in
absolute impedance Z ).
In Figure 3.14, I consider the alternative analysis approach mentioned earlier,
employing the characteristic prevalences Ñ of red and white blood cell-equivalent sizes
in the measured signal distributions [151]. Specically, I plot the dierential ÑWBC− ÑRBC
as a function of the ow ratio between lysis and sample ows for the same conditions
as considered previously. This analysis yields positive values when white blood cell-
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Figure 3.14: Dierential prevalence of white- vs. red blood cell characteristic sizes for
a range of FR and t (colored squares and triangles), as well as negative control (black
circles). Dotted lines are shown for guidance only. Reproduced with permission from
[151].
equivalent signals dominate strongly over red blood cell-equivalent ones, and vice versa.
The trends observed here agree with those in Figure 3.13, corroborating the conclusions.
The supposedly white blood cell-dominated signal for t = 0 or a ow ratio of 1 can be
attributed to the saturation artifact. For t = 15 s, incomplete lysis is again in evidence,
as is partial lysis at a ow ratio FR = 0.5. In the regime of high lysis times t > 15 s and
low ow ratios FR < 0.5, leukocyte-characteristic signals dominate strongly, in sharp
contrast to the erythrocyte-characteristic signals in the control. To compare these two,
the ratio rather than the dierence between characteristic prevalences Ñ provides a












This considers how common erythrocyte-characteristic signals are compared to white
blood cell-characteristic ones with lysis as compared to the control, and exceeds the 99.5%
criterion typically employed for quantifying successful erythrocyte lysis [148].
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3.2.4 Synopsis
I explored the parameter space for osmotic lysis of erythrocytes when integrated with
impedance cytometry. I identied the minimum requisite lysis time and osmotic pressure
gradient to eliminate their dominant background signal in white blood cell measurements.
The impedance measurements furthermore directly reected distinct mechanisms when
either both parameters or just the lysis time are insucient. Within the lysis regime, I
found osmotic lysis of red blood cells to be highly ecient.
3.3 Chapter Summary
In this Chapter, I have explored the integration of critical sub-systems needed for white
blood cell counting: impedance cytometry, hydrodynamic focusing, and osmotic lysis.
My study of the former two has highlighted the potential for an up to 5-fold improvement
in sensitivity by employing DI water sheath ows to provide a virtual (rather than
physical) aperture. While critical, the novelty of my work lies less in this result than in
the breadth and depth that I have considered systems interplay in. I have constructed
the rst integrated analytical and numerical models for impedance cytometry with
hydrodynamic focusing. In considering discrepancies between them, as well as with
experimental results, I have shed light on the importance of diusion phenomena in this
system despite its large (> 100) Péclet number. While adversely aecting performance in
this case, diusion is critical for osmotic lysis of erythrocytes. I have demonstrated that
for a regime of sucient osmotic pressure gradient and exposure time, DI water is over
99.9% eective in on-chip red blood cell lysis. By studying the available parameter space,
I have identied dierent modes of lysis failure when the necessary conditions are not
met, and importantly demonstrated that osmotic lysis does not interfere with impedance
cytometry. Overall, I have thus shown that the sub-systems are inherently compatible, a
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critical prerequisite for further integration as pursued in Chapter 4.
Chapter 4
Development of Integrated Clozapine Sensor & White Blood Cell Counter
With clozapine sensing addressed in Chapter 2, and Chapter 3 exploring the sub-system
compatibility between impedance cytometry and hydrodynamic focusing or osmotic
lysis, the overall microsystem integration for concurrent clozapine and white blood cell
monitoring remains. Two broad strategies are available, each with potential advantages
and pitfalls: First, copying typical laboratory procedures by applying blood/plasma
separation to connect the cellular/acellular sensing modalities in parallel. Second,
integration of both sensors in series, with the clozapine measurement conducted directly
in whole blood. The latter approach yields a simpler and thus ultimately more robust
microuidic device; the former provides the electrochemical sensor with a less complex
matrix.
In this Chapter, I explore both approaches for overcoming remaining challenges in
handling whole blood samples for concurrent cellular/acellular sensing. In Section 4.1, I
study plasma skimming as a means to provide blood/plasma separation, with a label-free
immunoassay serving as a proof-of-concept case study. Although the approach is not new,
this is its rst application to a true whole-blood sensor. With limitations outweighing
benets, I proceed to implement the series-type systems integration in Section 4.2. I
demonstrate that this fully integrated device is indeed capable of concurrent clozapine
and white blood cell analysis, a signicant step toward point-of-care monitoring of
clozapine treatment in schizophrenia.
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4.1 Evaluation of Plasma Skimming for Blood/Plasma Separation in a
Proof-of-Concept Immunoassay
As mentioned in Subsection 1.3.4, plasma skimming has been presented as a lab-on-a-chip
blood/plasma separation approach with a unique combination of advantages: It relies
solely on hydrodynamic forces, it does not adulterate or dilute either fraction of the
sample, it can operate continuously, it is capable of handling whole blood, and it has
successfully been implemented in a protein biosensor [78]. Other approaches tend to rely
on external forces (centrifugation), are not capable of continuous ow (sedimentation),
or require dilute blood samples (microposts). Especially the latter two capabilities are
critical features for concurrent clozapine and white blood cell monitoring, however, due
to the very nature of cytometry relying on a continuous ow of blood cells, and clozapine
already being a low-concentration analyte (dilution therefore being counterproductive).
Plasma skimming relies on a combination of biophysical eects observed in the
microvasculature: The Zweifach–Fung eect (at bifurcations, cells will follow the branch
with the higher ow rate), the Fahraeus eect (the apparent cellular fraction of blood is
lower in a capillary than in a large vessel), and the cell distribution within capillaries (red
blood cells favor the center of the ow, with white blood cells favoring vicinity to the
walls) [152–155]. While these phenomena are not fully understood, they can be replicated
in microuidics. Combined with laminar ow eects, they allow for the controlled
“skimming” of the wall-adjacent cell-free layer of the blood stream through side channels
that can exceed the dimensions of the cells themselves as initially demonstrated by Yang
et al. [155]. The only requirement is that the ow rate Q through the main channel needs
to be at least six-fold higher than through those side channels. This ow rate condition is
most readily understood when considering the streamlines that the cells are traveling on
as illustrated in Figure 4.1a. Here, with the top channel ow rate four times higher than
the bottom one, only cells (II) on streamlines below the critical one (III) can enter the low
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Figure 4.1: Plasma skimming. (a) Illustration of the critical streamline, where streamlines
above (I) enter the high ow rate channel, and only those below (II) the low ow rate
one. (b) Photograph of the blood plasma separation region in a plasma skimming device
during infusion of debrinated sheep blood (36% hematocrit) through the whole blood
inlet (top). Reproduced with permission from [155].
ow rate channel. As the ratio between ows increases further, the critical streamline
moves even closer toward the wall until – due to their nite diameter – no cells can
occupy lower streamlines.
Since ow rates are related to uidic resistances via pressure as P = QR, a ow
ratio requirement of Qcells/Qplasma ≥ 7 directly translates to Rcells/Rplasma ≥ 7 for an
infusion-type ow. The necessary conditions for plasma skimming can thus be satised
solely by designing the channel geometry (height h, width w , length L) to provide the


















Obviously, the ow condition also limits the plasma recovery eciency of such a
single-channel approach. Therefore, a uidic network with multiple bifurcations such as
the one in Figure 4.1b is typically employed, where the aforementioned conditions are
met at each network node [79,155]. Due to the symmetry between the pressure equation
and Ohm’s law U = IR, electrical circuit simulation tools can be employed to derive the
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relevant solution and design.
Upon closer examination, the literature on plasma skimming also oers two
limitations: The initial study by Yang et al. utilizes debrinated sheep blood, wherein cell
sizes and ow properties can dier from human blood, and experimental results are only
presented up to a hematocrit level of 36%, well below the 45–50% typical in humans [155].
The biosensor application study by Fan et al. employs human blood samples, but diluted
almost 10-fold upon collection [79]. Thus, while plasma skimming appears promising
to facilitate concurrent cellular/acellular sensing, a validation study for whole human
blood is initially called for. I choose to carry this out in a proof-of-concept immunoassay
– while I ultimately aim at an electrochemical sensor for a small-molecule analyte, the
impact of a stand-alone whole-blood immunoassay would arguably be larger, and the
particular nature of the sensor is inconsequential for this study.
4.1.1 Background: Impedimetric Immunoassays utilizing Tobacco Mosaic
Virus-Like Particles
In his thesis, my colleague Dr. Faheng Zang presented a highly sensitive immunoassay
approach based on impedimetric sensing combined with Tobacco Mosaic Virus-like
particles (TMVLP) as biorecognition elements [156]. Tobacco Mosaic Virus is a plant
virus comprised of 2130 identical coat proteins helically arranged around its central single-
stranded RNA [157]. This gives it a well-dened high-aspect-ratio nano-rod structure
with a diameter of 18 nm and a length of 300 nm. Genetic engineering allows for adding
surface-binding peptides such as cysteine for self-assembly onto gold, as well as receptor
peptides for biorecognition. Deprived of its RNA, the engineered coat proteins can be
expressed in bacteria to form TMVLP – retaining the high aspect ratio of the original
virus as shown in Figure 4.2 while adding novel functionalities and allowing for scale-up
through traditional biotechnological processes. These TMVLP structures can thus serve
as exceedingly eective bioreceptors, providing high surface density as well as simple
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Figure 4.2: 3D schematic of a TMVLP segment (left) with helical arrangement of coat
proteins (center) highlighting the native structure (gray) as well as the genetically
engineered cysteine residues (yellow) and FLAG-tag sequences (blue). Reproduced with
permission from [158].
device integration through self-assembly.
In typical immunoassays such as the gold-standard ELISA (enzyme-linked
immunosorbent assay), labeling with a secondary antibody is required after the target
antibody binds to the immobilized antigen. The secondary antibody is linked to an enzyme
that – upon addition of its substrate – produces a visual change that amplies the original
detection event and is easily read out. In contrast, the high receptor density of TMVLP
allows for direct, label-free detection. With the FLAG-tag (peptide sequence DYKDDDDK)
as a receptor for the anti-FLAG antibody, a detection limit of 55 pM was demonstrated
in buer samples [156]. This relied on impedance-based detection, somewhat akin to
the far-eld impedance sensing of white blood cells described in Section 3.1. Here, the
antibody binds to the TMVLP immobilized on interdigitated electrodes (IDEs). It displaces
electrolyte and therefore alters the local eective permittivity, conductivity, and ionic
concentration, all relevant factors in the measured impedance.
4.1.2 Design Overview
My system design is shown as a block diagram in Figure 4.3. The lab-on-a-chip device
itself consists of two layers: The interdigitated electrode array (covering an area of






















Figure 4.3: Block schematic of the impedimetric immunoassay system. (a) Micrograph
of plasma skimming during operation. The cells (red) continue in the main channel
toward the waste outlet, while plasma (clear) is skimmed o toward the IDEs. (b) False-
color electron micrographs showing TMVLP coating on two gold IDE ngers, with
high-magnication view in the inset. Reproduced from [159].
sensor [158]. These IDEs serve as the transducer for the biosensor, with the TMVLP
coating assembled on top acting as the biorecognition element. The microuidics feature
plasma skimming channels leading to that array, branching o the central blood ow
channel. While the cells stay within that channel, a small fraction of plasma is intended
to go into the biosensor chamber. The height of the channels is chosen in line with the
20 µm utilized in Section 3.1, with systems integration in mind. Channel width and length
serve as optimization parameters for plasma skimming explored in Subsection 4.1.4.
Toward a truly portable, label-free immunoassay, important design components
are moreover the ow actuation and the signal readout. Both can add signicant bulk and
cost to a point-of-care system. With only a single inlet and – apart from a very high upper
limit for shear stress based on cell lysis – no dependencies on absolute ow rate, I choose
to rely on manual pressure-based actuation. For impedance readout, I employ a board-
scale LCR meter, the AD5933 [160]. With these components, the system signicantly
reduces equipment requirements compared to previous work on whole-blood ELISA [79].
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4.1.3 Experimental Methods
The optimization study described here yields a number of improvements in methodologies,
particularly relating to fabrication and to handling of whole blood samples. Whole blood
– with acid-citrate-dextrose (ACD) anticoagulant, recommended for cell viability during
storage – is obtained from a blood bank and ltered through a 50 µm mesh size cell strainer
prior to experiments. Fabrication methodology broadly evolved from that described in
Subsection 3.1.3 to that in Subsection 4.2.2 over the course of the optimization study.
Patterning of the microuidic molds relied on photomasks 6.5 and 6.6 shown in Appendix
A: Photomasks. For plasma skimming optimization, the microuidics are bonded to
unpatterned glass slides for observation studies under an optical microscope.
For the impedimetric immunoassay, the microuidics are bonded to borooat chips
patterned with IDEs. These electrodes are connected o-chip using spring-loaded pins to
either an Agilent E4980A Precision LCR meter or an Analog Devices AD5933 impedance
analyzer board. I employ an AC potential of 0.14 Vrms to conduct frequency sweeps
in the range of 0.02–200 kHz or 0.5–5 kHz, respectively, and read out the impedance
Z . The AD5933 relies on a reference resistor for its measurements, and further requires
calibration to a second known resistor to provide absolute impedance values. I choose
both of these resistors at 1 kΩ, broadly in line with the expected impedance magnitudes.
The frequency ranges are chosen based on instrument capabilities. Data recording in the
impedance studies rely on a custom graphic user interfaces developed in LabView for the
LCR meter, and on as-provided software by Analog Devices for the AD5933.
The on-chip ELISA and direct measurement procedures are schematically illustrated
in Figure 4.4. After device assembly, the electrodes are pre-conditioned by running
frequency sweeps continuously over 5 minutes in 1× Tris-buered saline (TBS).
Subsequently, I pipette 10 µl of 0.1 M PB containing 0.2 mg/ml genetically modied
TMVLP into the PDMS chambers over the IDEs. Covering the chambers with a slab of
PDMS, I allow the TMVLP to self-assemble on the IDEs over 18 hours, followed by 2 hours
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Figure 4.4: Sketch of procedures for on-chip ELISA (left) and direct, label-free detection
(right). À TMVLP assembly, measure baseline; Á Plasma skimming, target FLAG antibody
binding (pink); Â Secondary antibody introduced; Ã Enzyme substrate introduced to
produce precipitate (purple). Adapted with permission from [158].
on a hotplate at 35 °C with the PDMS slab removed À. This evaporation step serves to
concentrate the TMVLP to create the very dense layer observed in Figure 4.3. Excess,
unbound TMVLP is rinsed o with TBS. The microuidics are then lled with commercial
human serum along with the measurement chamber, which is now connected to a waste
outlet with tubing. Subsequently, whole blood samples containing 0 (negative control)
or 150 nM (positive sample) of anti-FLAG antibodies are injected through the inlet for
∼ 5 minutes, and plasma skimming is monitored through a microscope. For the direct,
label-free experiments, measurements are obtained 2 hours later to allow for equilibration
of antibody–antigen binding Á. For on-chip ELISA, the chamber is opened up again
and the plasma rinsed out with TBS. I proceed to pipette in a 1:10000 dilution of the
secondary, enzyme-linked goat anti-rabbit IgG (whole molecule)-alkaline phosphatase
antibody and allow it to incubate for a further 2 hours Â. After another TBS rinse, the
substrate (nitro-blue tetrazolium chloride and 5-bromo-4-chloro-3’-indolyphosphate p-
toluidine salt; NBT/BCIP) is added to the chamber and allowed to react for 6 hours Ã.
Experiments conclude with a nal TBS rinse prior to the measurement.
4.1.4 Plasma Skimming Optimization
As mentioned earlier, eective plasma skimming relies on designing channel geometries
such that Rcells/Rplasma ≥ 7, for a network with multiple plasma skimming channels
satised at each node. Since the relevant R at each network node is governed by all
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downstream ow resistances, the equations become quite complex for the rst nodes
in the network, and electrical circuit simulation tools become very useful. For initial
analysis, however, I will simply consider the nal node, where the problem reduces to
only two resistances Rplasma and Rcells. Assuming a given uniform height h, the remaining
four variables – width and length of each channel – leave a lot of freedom in satisfying
the required ow condition. As a starting point, I consider the initial design by Yang et
al., for which they specify h = 10 µm, L = 5 mm, combined with wplasma = 9.6 µm and
wcells = 154 µm [155]. Calculating Rcells/Rplasma here interestingly yields a value of 38
– certainly satisfying the necessary ow condition, but far removed from their noted
design target of 9.
My design optimization study thus takes two approaches: First, a purely model-
based one. Second, one based mostly on variations of the published design. Given
my channel height of h = 20 µm, I choose Lplasma = 5 mm, wplasma = 10 µm and
Lcells = 37.5 mm, wcells = 120 µm. The widths are selected in line with Yang et al.’s
design for the plasma channels, and with my own osmotic lysis work for the cell channel.
Based on electrical network analysis, the interconnecting segments can be designed as
Lmain = 300 µm, wmain = 25 µm, yielding the overall geometry shown in Figure 4.3a.
This design is mathematically equivalent to the design parameters given by Yang et al.,
with Rcells/Rplasma ≥ 8.3. The design allows for increasing this ratio further simply by
shortening the cell channel (by punching the outlet closer to the skimming junction).
The second design is a direct adaptation from Yang et al.’s design, with L = 5 mm,
wplasma = 10 µm, wcells = 154 µm, and an increased height of h = 20 µm. This design,
illustrated in Figure 4.3b, features a high resistance ratio of Rcells/Rplasma ≥ 83. Design
variations with wplasma = 13 µm or wcells = 118–200 µm allow for exploring a range of
43–110.
Initial experiments with ACD whole blood supplemented with heparin yielded an










Figure 4.5: Plasma skimming designs. The geometries shown are derived (a) from the
model given by [155], and (b) from their design used in experiments, as described in the
text.
as those indicated in Figure 4.6 blocking the channels, particularly in the narrow region
ofwmain = 25 µm where the plasma skimming channels branch o. Such aggregates were
previously observed also in the osmotic lysis study in Section 3.2; the wider channels and
lower hematocrit, however, meant that such aggregates rarely resulted in complete device
failure. As the blood samples are ltered through a 50 µm mesh prior to experiments,
formation has to occur inside the device. My initial hypothesis was blood coagulation,
and I thus attempted to address this by increasing the concentration of heparin, or
supplementing it with another anticoagulant, ethylenediaminetetraacetic acid (EDTA).
Especially the increase of the heparin concentration, however, only worsened the issue.
This led me to the alternative hypothesis that the observed aggregates are not blood clots,
but due to platelet aggregation. This phenomenon is a very early step in the complex
coagulation cascade and is in fact enhanced by heparin (it prevents coagulation only
by interfering further down in the cascade) [161]. Eliminating heparin and employing
only EDTA as a supplementary anticoagulant indeed reduced the incidence of such
aggregates, but did not eliminate it. Although EDTA interferes with the coagulation
cascade at a much earlier stage than heparin by sequestering calcium ions, this action
appears insucient to prevent platelet aggregation in microuidic devices.
To address platelet aggregation, a review of the literature yields two classes of
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Figure 4.6: Exemplary micrograph of a device inlet showing aggregates (circled) observed
for heparinized whole blood.
chemical agents: antiplatelet pharmaceuticals that aim to prevent aggregation, and
thrombolytics that attempt to dissolve aggregates that have already formed [162]. The
latter class is comprised of enzymes that generally activate native plasminogen by
converting it to plasmin, which in turn can degrade the brin that is central to platelet
aggregates’ structural integrity. In this class, I select streptokinase due to its wide
availability also for laboratory use. The class of antiplatelet drugs is signicantly broader,
encompassing molecules that interfere with a range of signaling pathways in platelet
aggregation. The choice here is simplied as many of the available drugs are in fact
prodrugs that rely on rst-pass metabolism for conversion into an active form, rendering
them ineective for device use. The active forms themselves are typically unstable
and/or commercially unavailable. Thus, I choose ticagrelor and tiroban. The former
acts as a P2Y purinoceptor 12 antagonist, a protein that is intimately involved with early
signaling in platelet aggregation. Tiroban, on the other hand, is an integrin αIIbβ3
antagonist, directly interfering with the structural aggregation proteins. In combination
with EDTA, these compounds signicantly reduce the observed platelet aggregation and
enable experiments with whole blood.
The device materials themselves of course also play a role in not only platelet
aggregation but more broadly whole blood handling in microuidics. PDMS is inherently
hydrophobic, and though the oxygen plasma treatment during device assembly renders
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it hydrophilic for bonding, this is a temporary eect [163]. With biological uids, this
hydrophobic nature leads to non-specic surface fouling with proteins and cells (to yield
an energetically preferential more hydrophilic surface in contact with the aqueous liquid).
This can not only enhance aggregation and clotting problems as described above, but
also sequester protein analytes out of solution before they reach the sensor. Thus, I
implement pre-treatment of the PDMS channels with a 3% solution of Pluronic F-68, an
amphiphilic polymer with a short central hydrophobic section that binds strongly to
PDMS via hydrophobic interactions, and long hydrophilic tails that yield an eective
hydrophilic surface. This particular polymer has been shown to be superior over other,
similar treatments [164].
With these improvements in blood handling in place, I proceed to observation
studies in the plasma skimming channels. From the exemplary blood ow micrographs in
Figure 4.7 it becomes apparent that the model-guided design in (a) fails in preventing blood
cells (red) from entering the plasma skimming channels. The situation is signicantly
better, though not optimal, in the geometry-matched design (b), where the rst three
channels remain clear (the thin red lines delineating the channels are due to optical
artifacts), with cells only increasingly penetrating the ones further downstream. These
results clearly highlight that the postulated condition of Rcells/Rplasma ≥ 7 is insucient
for successful plasma skimming. Considering plasma skimming at higher resistance ratios
further, I hypothesize that the evident lack of corner denition at the plasma skimming
junctions is responsible. This rounding allows streamlines to penetrate further into the
channels than their width would suggest, ultimately leading to a skimming breakdown.
This lack of denition is likely caused by employing a transparency mask for fabrication,
where the line width resolution limit of 10 µm matches the plasma channel design width.
Thus, I repeat experiments with the geometry-matched design, and variations
thereof, in a fabrication process modied to employ a much higher (1.5 µm) resolution
chrome mask 6.6 (Appendix A: Photomasks) to yield sharper corners. Indeed, the failure
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Figure 4.7: Optical plasma skimming observations with whole blood in model-derived (a)
and geometry-matched (b) designs.
mode observed previously – with increasing streamline penetration into downstream
nodes – is eliminated here. However, performance remains highly variable. In testing
a large number of these devices with the aforementioned variations in geometry, no
clear dependency of eciency on blood channel width becomes apparent. Two modes of
failure dominate: Total blockage of the device with an aggregate, a challenge that cannot
entirely be overcome for extended operation even with the procedures described above,
and transient passage of aggregates or cell clusters. The latter does not completely prevent
the device from being utilized. However, it drastically changes the ow resistances in the
device, leading to preferential ow of cells also through the plasma skimming channels. I
observed that this mode of failure was signicantly less likely in devices employing only
three instead of ve skimming channels, where the balance of resistances is less prone
to disruption by such transients. While this reduces the plasma skimming eciency, I
decided this was the optimal design for subsequent use as seen in Figure 4.3a. Due to
high variability in the geometry variation experiments, no denite new design guideline
could be derived, except that the lower limit for Rcells/Rplasma is clearly above 7, though
likely below 40, matching the experimental (but not theoretical) ndings by Yang et al.
With the selected optimal design, I still observe a device failure rate around 20%
over the course of 5 minutes of plasma skimming operation, with the likelihood of failure
trending toward 100% for use beyond 15 minutes. While this is shown to be acceptable for
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the immunoassay below, an integrated downstream white blood cell counter will likely
require operation durations toward the longer end of that range, particularly in a research
setting. This makes the approach unsuitable for further integration in a cellular/acellular
sensing system.
4.1.5 Label-free Antibody Detection in Whole Blood
With the optimized plasma skimming design, I proceed to conduct impedimetric
immunoassay experiments. Initially, I simply consider the TMVLP coating step, observing
an increase in impedance magnitude of 143±23% over the IDEs’ respective bare impedance
at 2 kHz. While I record frequency sweeps at each step of the experiment, I nd this
frequency to be the most sensitive. For the LCR meter, lower frequencies show even better
signal-to-noise ratios. However, due to limitations of the on-board clock in the AD5933, its
signal degrades severely below 2 kHz. The general frequency range agrees with previous
ndings that changes in ionic double-layer capacitance (dominant at this and lower
frequencies) hold the most information for this format of impedimetric immunoassays
[158]. The signicant increase in signal specically with TMVLP coating veries sensor
functionality as well as functionalization, and is also in line with previous experiments.
To test immunoassay capabilities, I manually inject whole blood (control), or whole
blood spiked with 150 nM anti-FLAG antibody, through the blood channel, skimming
o plasma into the sensing chamber. As illustrated in Figure 4.4, I follow two sets
of measurement procedures: First, a traditional labeled on-chip ELISA for validation.
Second, the direct, label-free measurement. As on a traditional well plate, on-chip ELISA
employs a secondary antibody linked to an enzyme that produces a colorimetric signal
from a substrate. The same process can also be read out impedimetrically, since the
color indicator forms an insoluble deposit on the electrodes, yielding a drastic change in
impedance. Due to the requisite incubation times at each step, the process takes on the
order of 10 hours. Additionally, the intermediate rinsing steps require manual interaction
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and pipette access to the measurement chamber. At the end, I measure the impedance
again in TBS and compare to a baseline TBS measurement immediately after TMVLP
assembly.
In Figure 4.8, I display this change in impedance for whole blood with and without
the target antibody. To validate the portable instrumentation, I conduct the measurements
both with a precision LCR meter (yellow) as well as the AD5933 (blue). The impedance
drastically increases compared to the baseline for all conditions, with the highest signals
observed in the presence of the target antibody. The impedance change even in the
absence of antibodies is a clear indication of non-specic binding of plasma proteins
and/or label antibodies. Variability in these factors, as well as in blood sample volume
due to the manual injection process, likely accounts for the high standard deviations
observed overall. Still, the 52% additional signal measured with the LCR meter in the
presence of antibody (versus its absence) proves signicant (p < 0.1). The lower +36%
recorded with the AD5933 do not meet that criterion. This signicantly lower signal
compared to that of the LCR meter can be explained by a saturation eect. The AD5933
requires an initial choice of reference and calibration resistors in line with the expected
subsequent impedance signals. The further the signal deviates from these resistor values,
the less accurate the measurement becomes. The almost 2-fold change in impedance as
measured by the LCR meter easily exceeds that range.
The above observations bear comparison also to the visual observations in Figure 4.9.
These micrographs show exemplary IDE surfaces at the end of the ELISA procedure, with
signicant yet highly variable reaction product deposition (black) on the electrodes when
antibody was present in the blood samples. In the absence of target antibody, non-specic
deposition is still visible. These results validate the experimental procedure itself, and
align with the ndings based on impedimetric readout above.
For the direct, label-free measurement (cf. Figure 4.4) the procedure simplies
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ELISA
 LCR meter (p<0.1)
 AD5933 (p>0.1)
Figure 4.8: On-chip ELISA. Percentage change in impedance magnitude versus baseline
for human whole blood samples (n ≥ 2 each; p-values from ANOVA) with or without
target, measured using high-precision LCR meter or AD5933 in buer solution after Ã.
Adapted from [159].
the overall assay time reduces to around 2 hours. Moreover, no rinsing is required, and
thus no added manual interaction. I compare the impedance measurement at the end (i.e.,
in skimmed plasma) to one in commercial human serum conducted immediately after
TMVLP assembly. Employing serum instead of TBS here as the baseline is intended to
more closely mimic the electrolyte present for the nal measurement.
I plot these changes in impedance for the direct measurements with the LCR meter
(green) and the AD5933 (red) in Figure 4.10. Here, all measurements interestingly display
a decrease in signal compared to the baseline. I attribute the overall negative magnitudes
to the remaining dierence in dielectric properties between the skimmed plasma and the
baseline commercial serum. More importantly, however, the signal in the presence of
the target antibody is 10% greater than in the controls for both instruments – a value
that also is signicant for both instruments (p < 0.1). The variance is greatly reduced
compared to on-chip ELISA, in line with the hypothesis of compound variability from
the many steps involved there. Looking at the dierence between the two instruments, I
nd only a constant 2% oset from between them. The lower overall signal range here of
∼ 20% (compared to the 100% in on-chip ELISA) is clearly favorable for the AD5933. This
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whole blood w/ 0 nM target antibody
whole blood w/ 150 nM target antibody
Figure 4.9: On-chip ELISA. Micrographs of two exemplary IDEs each after step Ã for
blood samples without (top) or with (bottom) anti-FLAG target antibody. The label
enzyme reaction product appears as a dark precipitate on the gold IDEs. Adapted from
[159].
validates the feasibility of implementing a truly portable and integrated immunoassay
system.
4.1.6 Synopsis
I explored plasma skimming as a strategy for whole blood fractionation. My work
identied discrepancies between theory and experiments from previous work on the
topic and revealed that model-derived guidelines for design are insucient. I employed
an optimized design to implement a proof-of-concept impedimetric immunoassay and
demonstrated for the rst time direct, label-free detection of antibodies in whole blood
with a fully portable system. I found that plasma skimming is suitable for such short-term
blood/plasma separation processes, but that high device failure rates present a barrier to

























Target Antibody Concentration (nM)
                     label-free
LCR meter (p<0.1) 
             AD5933 (p<0.1) 
Figure 4.10: Direct, label-free detection. Percentage change in impedance magnitude
versus serum baseline for human whole blood samples (n ≥ 2 each; p-values from ANOVA)
with or without target, measured using high-precision LCR meter or AD5933 after Á.
Adapted from [159].
of the experiments, I developed suitable procedures for handling whole blood samples,
minimizing platelet aggregation and device biofouling.
4.2 Concurrent Clozapine & Cell Sensing in an Integrated Device
With a parallel integration of clozapine and cell sensing through plasma skimming
infeasible based on the results of the previous Section, I instead pursue a series integration
approach for my system – direct measurement of clozapine in whole blood in the
incoming sample stream, and downstream white blood cell detection. As discussed
in Subsection 1.3.4, molecular sensors for whole blood typically employ a blood/plasma
separation step due to interference concerns. Direct sensing based on redox activity,
however, is one of the few transduction modalities where the presence of blood cells
will not cause obvious interference issues – signals are generated by electrochemical
reactions at the electrode surface, and cells are not expected to yield such, or at least no
more so than serum alone. At a fundamental level, cells of course reduce the eective
concentration of all analytes by a factor of 2 at typical hematocrit values around 50%,
and diusion behavior of analytes may be aected. Still, the chitosan-CNT/graphene
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redox catalysis system is shown to be highly selective and sensitive in clinical serum
samples in Chapter 2, suciently so that direct detection of clozapine in whole blood is
worth investigating.
At the same time, translation of the subsystem integration ndings from Chapter
3 into a functional white blood cell counter requires further renements. The previous
Section addresses some of these with regard to whole blood handling. The major one,
however, is with regards to instrumentation: The low sampling rate of the LCR meter
already imposed limitations on the earlier studies; the combined system would exceed
them. White blood cell dierentiation will require well-dened signal peaks for each
cell, dual-frequency measurements as discussed in Subsection 1.3.3, and higher total ow
rates (due to the multiplicative ow ratio requirements from lysis and focusing). Such
rapid and highly accurate readout of electrical signals is the domain of lock-in ampliers,
which however require additional circuitry to enable impedance measurements.
Here, I present my design for an integrated microsystem for concurrent
acellular/cellular marker detection, incorporating renements from and upon all
preceding Chapters. I rst evaluate dierent instrumentation options for impedance
cytometry in this device. Finally, I validate the overall concept using human whole blood
samples spiked with clozapine.
4.2.1 Design Overview
My design, schematically illustrated in Figure 4.11, is a combination of a planar three-
electrode electrochemical cell and the designs employed in Chapter 3. The sample stream
(ow rate Qs) passes from the clozapine detection chamber to a lysis junction, where
the blood is exposed to DI water (combined ow rate Ql), causing erythrocyte rupture
during passage through the serpentine channels. Immediately prior to the impedance
cytometry electrodes, the stream is hydrodynamically focused by additional DI water
ows (combined ow rate Qf ).
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Figure 4.11: Schematic rendering of the integrated microsystem developed in this thesis.
The electrochemical cell employs a chitosan-CNT/graphene (1%/1%) working
electrode, its 2 mm diameter chosen to be equivalent to that of the commercial disk
electrodes. It is encircled at a distance of 300 µm by a 400 µm wide gold counter electrode
over a 270° arc, and a gold pseudo-reference electrode over an arc of 30°. While such a
reference is less stable than Ag/AgCl, it proves sucient for experiments and simplies
fabrication signicantly. The microuidic dimensions match those given in Chapter 3.
The impedance cytometry electrode design is changed signicantly to accommodate
dierential measurements (cf. Subsection 4.2.4): Instead of a simple pair, I employ a
central source (or ground, depending on the instrumentation circuitry) electrode anked
by two ground (source) electrodes, all with width and spacing of l = д = 25 µm. The
anking electrode traces are designed for matching length so the signal divides equally
between the two conduction paths. Moreover, based on the observations in Section 3.1
on the placement distance d from the focusing junction, this is minimized to 50 µm, close
to the minimum achievable with manual alignment of the layers.
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4.2.2 Device Fabrication
As with the earlier-generation devices in Chapter 3, the design is implemented in two
physical layers – the coplanar electrodes on glass, and the microuidics in PDMS.
Compared to the previous devices, however, I implement a number of improvements in
the fabrication process ow here, schematically illustrated in Figure 4.12. After 1 minute
immersion in Piranha and dehydration for at least 5 minutes, I rst spin-coat a layer of
negative Futurrex NR9-1500PY photoresist (3 s ramp, 3000 rpm, 30 s hold) on a borooat
glass wafer, followed by a 60 s bake at 150 °C. The photomask 6.7 shown in Appendix A:
Photomasks and printed on transparency lm is used to expose the resist to 245 mJ/cm2
UV light (adjusted from standard processing parameters to account for the transparent
wafer), followed by a 60 s bake at 100 °C. I develop the resulting patterns for at least 25 s
in RD6 developer, diluted with DI water 3:1, followed by incremental 5 s immersions
guided by pattern inspection under a microscope (E1). Next, I deposit 20 nm chrome,
functioning as an adhesion layer, and 200 nm gold utilizing e-beam deposition (E2).
Finally, the extraneous metal is lifted o by immersion of the wafer into acetone for
∼ 30 minutes, assisted by agitation and brief ultrasonication as needed (E3). Compared to
the wet etching approach employed previously, lift-o yields better edge denition and
eliminates residual gold sometimes left in wet etching due to photoresist scum. To protect
the structures from scratches during the subsequent wafer dicing, the entire wafer is
processed with Shipley 1813 photoresist as described in Subsection 3.1.3, only utilizing a
ood exposure with a 3-fold higher dose and omitting development.
For the microuidics, I repeat the Futurrex photolithography on a dehydrated
Piranha-cleaned blank silicon wafer with two important changes: The exposure dose
is reduced to 190 mJ/cm2 for the reective substrate, and the photomask 6.4 shown in
Appendix A: Photomasks (again on transparency lm) is utilized (M1). After development,
I transfer the pattern into the silicon by deep reactive ion etching (DRIE; M2). The process


















Figure 4.12: Abbreviated fabrication process ow for the nal-generation devices
described in the text.
photoresist by successive rinsing with acetone, isopropanol, and methanol (M3). The
advantages here over an SU-8 process are the shorter duration (due to the long bake times
for SU-8) as well as improved corner denition (due to the thinner resist) and increased
resilience of the features.
Subsequent preparation of the wafer with alconox, PDMS molding, and device
assembly follow the previously described procedures in Subsection 3.1.3 (M4 & E4). The
one process alteration is that I employ a 5 mm diameter biopsy punch to create the
electrochemical measurement chamber. This necessitates a thicker PDMS layer to later




O-chip connections are implemented using spring-loaded pins to a Bio-logic VSP-300
potentiostat for electrochemistry as well as to the impedance readout instrumentation
described in Subsection 4.2.4. For the working electrode modication (E5), I disperse
carbon nanotubes and graphene at 1% w/v each in chitosan solution by ultrasonication
for 45 minutes, preceded and followed by brief vortex mixing. Immediately thereafter,
solution is pipetted into the 5 mm diameter chamber, and a constant cathodic current of
32 A/m2 applied for 90 s between the on-chip working electrode and a coiled platinum
wire electrode immersed in solution. Excess material is allowed to diuse away with the
electrode immersed in DI water, followed by PB prior to experiments. The measurement
chamber is sealed o prior to experiments using a short piece of large-diameter Tygon
tubing (1.6 mm inner and 4.8 mm outer diameter), which creates a microuidic inlet port
with dimensions similar to those at the others directly punched into the PDMS.
For experiments, the device is mounted in a custom-built Faraday cage on spring-
loaded pins with the requisite external connections as pictured in Figure 4.13. The
uidic inlets are connected to New Era syringe pumps (NE-1002X, or NE-300 for the ow
focusing inlet) holding 1 ml syringes using Tygon tubing (0.19 mm inner and 2.03 mm
outer diameter; E6). The device is primed with a solution of 3% Pluronic F-68 in water,
followed by a rinse with PBS. The actual sample stream consists of whole human blood
samples with ACD anticoagulant obtained from a blood bank and pre-treated according
to the procedures in Subsection 4.1.4. The lysis and focus ows consist of DI water with
resistivity > 17 MΩ cm.
I control ows and record data with custom graphic user interfaces developed in
LabView. For each ow condition, the experiments run for approximately 30 minutes. I
analyze the data in MATLAB, employing the code reproduced in Appendix C: MATLAB
Code. Here, the data is drastically dierent from that obtained by the LCR meter in























Figure 4.13: Photograph of the experimental setup. The fully integrated microsystem is
mounted on spring-loaded pins inside a custom Faraday cage. Shielded cables connect to
the voltage signal input and the dierential current readouts. Unshielded wires provide
connections to the electrochemical working, reference, and counter electrodes. Fluidic
tubing is routed to three pump-mounted syringes (food coloring to highlight ows:
sample – red; osmotic lysis – green; hydrodynamic focusing – blue) and a waste reservoir
(black).
nature of the measurements. The algorithm rst translates the measured currents into
dierential impedance signals ∆Z using the respective input voltages. The background
signal – for dierential measurements devoid of information and only indicative of
parasitic eects in the wiring – is determined by applying 40 Hz moving average and
20 Hz low-pass lters and is subtracted out. Downsampling to 25 kHz removes signal
uctuations and reduces storage and memory requirements. True peaks in the cleaned-up
∆Z signal are detected using a wavelet-based algorithm adapted from Caselli et al. and
Evander et al. [124,165]. The high-frequency signals are corrected for size-based eects
with simple division by the low-frequency signals [54].
4.2.4 Impedance Instrumentation
A lock-in amplier, as mentioned earlier, is the ideal instrument for high-sampling-
rate measurements of AC signals – specically, of voltages. With AC signal sources
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also generally being voltage sources (Vstim), current-to-voltage conversion is needed
to measure an impedance Z with a lock-in amplier. Three approaches, illustrated in
Figure 4.14, are broadly available for that purpose. First, a simple ratiometric one, wherein




sensitivity to small impedance signals ∆Z  Z – the true parameter of interest for an
impedance cytometer – is greatest when Z ≈ Z1. This presents an obvious limitation with
regard to dynamic range. The second approach retains this limitation, but still presents a










Thus, it yields a dierential measurement between Z and a reference impedance
ZR. The usefulness for an impedance cytometer becomes apparent if ZR is another pair
of electrodes in the cytometer – assuming that only one set of electrodes is occupied by
a cell at any given time, this circuit gives practically direct access to ∆Z . It eliminates
background impedance noise, e.g. due to uctuations in the environment, and allows for
more sensitive measurements due to the limited dynamic range of the lock-in amplier.
With a ratiometric approach, a large voltage measurement range is needed to detect a
small superimposed signal; with a Wheatstone bridge, a more sensitive range matching
the actual signal magnitude can be applied. As mentioned in Subsection 1.3.3, this is at
the heart of the approach taken by Gawad et al. [54].
The third technique addresses the dynamic range limitation of both of the
above. The transimpedance approach employs an operational amplier and a feedback
impedance ZF to convert the current IZ into Vout = Vstim × ZF/Z . At least in theory, this
circuit is purely “linear” with respect to its response to additional impedance signals
∆Z , i.e. the reference impedance can be chosen for maximum gain independent of Z .
The concept can be expanded to dierential measurements by simply employing two
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Figure 4.14: Three circuits to measure changes in impedance as a voltage. (a) Ratiometric
circuit, (b) Wheatstone bridge circuit, (c) transimpedance amplication circuit. Adapted
from [166].
transimpedance ampliers for two electrode pairs, and connecting them to the dierential
inputs of the lock-in amplier. This is the route taken by Holmes et al. [54].
For my own work, I employ a Signal Recovery 7280 lock-in amplier that
distinguishes itself by its dual-frequency measurement capabilities. As it lacks a fast,
built-in computer interface, I utilize a National Instruments PCI-6221 data acquisition
card to record signals from its analog outputs at a sampling rate of 125 kHz. One signal
source is built into the lock-in amplier; the second frequency is provided by an Agilent
33220A function generator connected in series. In line with Figure 3.6, I choose the signal
frequencies of 90 kHz and 900 kHz to assess cell size and membrane properties. The
output voltage levels and lock-in input ranges are chosen to maximize signals, limited by
constraints of avoiding source signals greater than 0.8 Vrms due to hydrolysis, the 1 V
input limit of the lock-in, and the need for matched voltage ranges at both frequencies.
The lock-in amplier time constants are selected as short as possible – at 90 kHz, a
single period equates 11 µs, and at least a few periods are required for measurement,
yielding a limit of 50–100 µs. While the discussion here referred to two electrode pairs
for dierential measurements – one for the signal, one for the background – only three
electrodes with equal width and spacing are required in practice. For the bridge circuit, the
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Figure 4.15: Circuit employed for impedance measurements in this work and described
in the text.
central electrode can serve as a common ground, with the anking electrodes providing
the two source legs of the bridge. For the dierential transimpedance circuit, the central
electrode can serve as the source, with the anking electrodes providing two equal ground
connections.
The bridge circuit is initially very appealing due to its implementation simplicity,
requiring only an additional voltage divider. Ideally it should be chosen with at least
50 kΩ, around the magnitude of the empty channel impedance without ow focusing.
However, I experimentally nd that a divider of 1 kΩ provides better signal-to-noise ratio
– as previously noted by Gawad et al., this is due to parasitic capacitance eects in the chip
connections and traces [54]. This indeed allows for highly accurate ∆Z measurements
and particle analysis. The major limitation of this approach only becomes clear when
considering hydrodynamic focusing. The added DI water sheath ows will increase not
only the inherent impedance signals ∆Z but also the empty channel impedance, increasing
the mismatch with the voltage divider. Adding the Wheatstone bridge Equation 4.2 into
the (conservative) analytical model in 6.1 shows that the gain in ∆Z is more than canceled
out by this dynamic range limitation of the circuit. As expected, experiments reveal an
even more pronounced loss in sensitivity around 20% at a ow ratio of FR = 0.5, in line
with the experimental trend lagging behind the analytical one in Section 3.1.
Thus, I implement the dierential transimpedance circuit as shown in Figure 4.15,
with two Femto HCA-2M-1M low-noise transimpedance ampliers featuring a gain
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Figure 4.16: Representative processed experimental impedance cytometry signals ∆Z
from /o = 6 µm diameter particles.
of ZF = 1 MΩ. The linear response characteristics indeed predict that the gain in
sensitivity from hydrodynamic focusing is conserved with the readout. The exemplary
bead experiment recording in Figure 4.16 (after the MATLAB processing described in
Subsection 4.2.3) highlights the stable and low-noise nature of the set-up, with each
bead producing a distinct, roughly symmetric pair of peaks as it passes over the “signal”
and “background” electrodes. The MATLAB processing mainly serves to eliminate the
oset from zero that is present in the raw data, caused in large part by source signal
leakage via capacitive and inductive coupling into the readout channels. As the wiring
for the two readout channels features slightly dierent geometrical orientation with
respect to the input wire, this is not entirely compensated for by the dierential nature
of the measurement. Improved wire shielding serves to minimize these contributions,
but cannot entirely eliminate them.
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4.2.5 Results and Discussion
First, I evaluate the clozapine sensing capabilities in the integrated device. Figure 4.17
shows the DPV signals obtained from whole blood (negative control) or from blood spiked
with 100 µM clozapine owing through the device. I start the measurements immediately
after the chamber is completely lled with blood, after which I reduce the ow rate to
around 1–10 µl/h. Both samples show a pronounced peak around +0.2 V, corresponding
to the background signals previously observed with serum samples or uric acid (cf.
Subsection 2.3.2 and Subsection 2.1.6). It is worth noting that, due to the lack of a true
reference electrode in this system, the peak positions shift compared to measurements
taken with an Ag/AgCl reference electrode, including between devices and measurements.
For this, the background peak actually becomes benecial, providing a built-in reference
that the potential scale can be adjusted to. In the presence of clozapine, a second peak
appears around its expected potential of +0.37 V, well removed from the purported uric
acid peak. Overall, the characteristic signals are very similar to those obtained in clinical
serum samples; whole blood does not appear to have a direct impact on electrochemical
measurements. Only the clozapine peak signal magnitude is reduced compared to serum
observations – 4.38 µA here, compared to an expected 3.37 µA (calculated from the average
of the chitosan-CNT and chitosan-graphene serum calibration curves in Figure 2.22). I
propose two hypotheses: First, the chitosan-CNT/graphene fabrication process clearly
proceeds dierently in the more constrained environment present here, as evidenced by
the higher current density required to form stable lms. The lm deposition parameters
may thus require further optimization to achieve sensitivity closer to that of the macro-
scale electrodes. However, this is proven less likely by the similar signals I observe for
Fc in both micro- and macro-scale settings. The second hypothesis relates to blood as
a matrix, where the added volume of the blood cells may restrict diusion. Perhaps
more importantly, approximately 30% of clozapine also partitions into red blood cells,
which – akin to protein binding – reduces the available concentration for electrochemical
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potential vs. Au pseudo-reference (V)
Figure 4.17: Clozapine detection in whole blood. Dierential pulse voltammograms from
human whole blood (red dash), and blood spiked with 50 µM clozapine (black solid),
owing over chitosan-graphene/CNT electrodes inside the microsystem.
detection [18]. This magnitude closely matches the ~25% reduction in current compared
to serum-based calibration curves, suggesting the volume taken up by the red blood
cells does not play a signicant role, at least in a micro-environment. Accounting also
for protein binding, while 100 µM clozapine were spiked into the blood and ∼ 70 µM
remain in the liquid fraction, only approximately 4 µM are available for sensing (not
bound to proteins). After blood/plasma separation, these values would all increase by an
additional factor of approximately 2. While the exact total serum concentrations (sum
of protein-bound and free; reported by gold standard HPLC/MS/MS) is thus not known
for my experiments here, it still appears that the sensitivity of chitosan-CNT/graphene
electrodes is generally compatible with the clinical range even with whole blood samples
inside my integrated microsystem.
For the impedance cytometer, I show two important control experiments in
Figure 4.18. I plot dierential signal magnitudes ∆Z as a two-dimensional scatterplot,
with the 90 kHz low-frequency, size-sensitive signal on the x-axis, and the 900 kHz high-
frequency, membrane-sensitive signal on the y-axis (normalized by the low-frequency
signals to eliminate the cross-sensitivity seen in Figure 3.6). The colors correspond to the
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Figure 4.18: Impedance cytometry controls. Scatterplots of impedance signals ∆Z at
90 kHz (x-axis; size-sensitive) and 900 kHz (y-axis; membrane-sensitive; corrected for
size-based eects), with colors corresponding to the local event density from low (blue)
to red (high), for (a) /o = 6 µm polystyrene particles or (b) 2,000-fold diluted whole blood.
Both samples are in buer solution, with the lysis solution also switched to PBS (no lysis).
density of events in a given area of the plot, from low (blue) to high (red). In Figure 4.18a,
I present data collected from a sample containing 6 µm diameter polystyrene beads in
electrolyte (with a lysis ow also consisting of PBS) making this the two-dimensional
equivalent of Figure 3.8. The high density population around {0.015, 4} can easily be
attributed to the beads, and the smaller population around {0.025, 4} agrees well with the
expected signal from clusters of two beads. Compared to the analogous experiment in
the previous Chapter, the populations here are much more clearly delineated, reecting
the impedance readout improvements described in Subsection 4.2.4.
The dierential capabilities of the integrated microsystem are illustrated by
comparing the bead signals to Figure 4.18b, where I show signals recorded from a whole
blood sample diluted 2,000-fold in buer (again with a PBS lysis ow). Thus, erythrocytes
remain intact, and are diluted to a suciently low level to measure individually. In this
scatterplot, a dominant population is obvious around {0.01, 1.5} corresponding to the
highly abundant red blood cells. This assignment is based on erythrocytes being the main
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component in this sample, and by comparing the size-sensitive low-frequency component
to that from the /o = 6 µm particles (which are expected to have a slightly lower volume)
in (a). The signicantly lower membrane-sensitive signal component is also expected for
cells due to their core-shell nature, and clearly dierentiates them from the solid-core
beads. The long tail at {..., 1.5} is likely due to erythrocyte clustering and coincidence –
akin to the particle observations, such events only increase the measured low-frequency
component compared to single cell/particle detection. The nal interesting feature in
this plot is the low-density yet distinguishable cluster of signals around {0.02, 1}. This
is attributable to leukocyte signals, which are 1,000-fold less abundant compared to
the erythrocytes, roughly matching the ratio in event counts here, and are expected to
present lower signals in the high-frequency component. I should note that certainty of
such assignments would require independent optical validation of the respective cell
passage events, which my experimental design does not allow for. However, the existing
bodies of literature on hematology and impedance cytometry provide a solid foundation
to analyze my data.
In Figure 4.19, I nally consider the same whole blood sample from the clozapine
measurement in Figure 4.17, further analyzed in the impedance cytometer for white blood
cells after undergoing on-chip osmotic lysis. The marked dierence in signal distribution
compared to both control experiments is immediately obvious. Three populations (I-III)
can easily be identied. Based on a comparison with the dilute whole blood control
in Figure 4.18, I attribute cluster (I) to surviving erythrocytes and associated debris,
with the latter presumably also accounting for the tail of signals toward the upper left
quadrant. The clusters (II) and (III) with smaller high-frequency signals in turn most likely
correspond to leukocytes. Unlike the control experiment, however, most red blood cells
have been lysed, more clearly revealing the putative white blood cell signals. I should note
that the comparison with the dilute whole blood sample has to remain qualitative; the
quantitative values on both axes depend on the conductivity of the electrolyte (which does
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Figure 4.19: White blood cell monitoring. Scatterplots of impedance signals ∆Z at 90 kHz
(x-axis; size-sensitive) and 900 kHz (y-axis; membrane-sensitive; corrected for size-based
eects), with colors corresponding to the local event density from low (blue) to red (high),
for a whole blood sample with on-chip, reagent-free DI water lysis. Due to the complexity
of the plot, mild data smoothing was applied for better visualization.
not cancel out for the ∆Z measured here as opposed to the |∆Z | analyzed in the previous
Chapter). This is altered drastically with osmotic lysis from DI water, as compared to
buer solution in the control.
Looking more closely at the leukocytes, cell populations likely corresponding to
white blood cell sub-types can be distinguished. Cluster (II), just slightly higher on the
size-sensitive x-axis than the red blood cells, matches well with the expectations for
lymphocytes. Cluster (III) corresponds to much larger cells, and therefore matches well
with granulocytes. Finally, the less numerous population (IV) with similar sizes to those
in (III), but larger high-frequency component, can tentatively be assigned to monocytes.
While the overall distribution largely agrees with that observed by Holmes et al. for
puried cell populations and without hydrodynamic focusing, the population (IV) is
notably absent in their experiments [55]. Interestingly, Han et al., do observe such a
low-density tail when employing reagent-based lysis (albeit at smaller, instead of larger,
high-frequency ratios compared to granulocytes) [56]. Therefore, it appears that DI water-
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based osmotic lysis combined with hydrodynamic focusing is capable of yielding enhanced
population dierentiation akin to reagent-based approaches. In combination with the
upstream electrochemical clozapine detection, the results here clearly demonstrate the
concurrent cellular/acellular monitoring capabilities of my system.
4.2.6 Synopsis
I presented the rst integrated microsystem for concurrent cellular/acellular sensing
in whole blood samples. This was enabled by series integration of the highly sensitive
electrochemical chitosan-CNT/graphene clozapine sensor and the impedance cytometer
with osmotic lysis and hydrodynamic focusing. For the redox catalysis system, I
demonstrated that utilization directly in whole blood samples is feasible, and performance
does not degrade signicantly compared to serum samples, with signal losses fully
explained by the lower available clozapine concentration in identical volumes of blood
and serum. For impedance cytometry, I evaluated readout and measurement circuitry to
enable dierential blood cell characterization. The overall performance of the system
was validated with whole blood samples spiked with clozapine, showing data for both
analytes from the same lab-on-a-chip.
4.3 Chapter Summary
In this Chapter, I have explored the microsystems integration for concurrent cellu-
lar/acellular sensing in parallel and in series. For the former, I have investigated
plasma skimming in a proof-of-concept immunoassay with impedimetric readout. I
have employed this fully portable microsystem for the direct, label-free detection of
150 nM antibodies from whole blood samples, a rst in the literature. My preceding
plasma skimming optimization study has revealed discrepancies in the existing literature
on the topic, and has shown that long-term operation is infeasible with the pursued
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design approach. In the process, I have also derived proper strategies for handling
whole blood samples in glass/PDMS microuidic devices. Based on these results, I have
pursued series integration of the sensing modalities. In this fully integrated microdevice,
I have demonstrated direct electrochemical detection of clozapine followed by impedance
cytometry to obtain white blood cell counts from the same blood samples. With these
results, I have conrmed the feasibility of concurrent cellular/acellular monitoring with




• Novel chitosan-enabled approaches to detect clozapine
– Suitable for miniaturization
– Thorough understanding of material & electrochemical parameter space
∗ Reusability, storage, diusion, reaction kinetics, alternative electrode materials, . . .
– Detection limits compatible with clinical requirements
– First example of direct redox detection in serum
– Selectivity studies reveal advantages and drawbacks of both chitosan-catechol and
chitosan-CNT/graphene
• First systems integration studies of hydrodynamic focusing and osmotic lysis with
impedance cytometry
– Focusing increases sensitivity up to 5-fold
∗ Integrated models developed
∗ Geometry variations investigated
∗ Importance of diusion highlighted
– Osmotic lysis compatible and 99.92% ecient
∗ Various failure regimes identied from online detection capabilities
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– Enables label and chemical-free impedance cytometry towards point-of-care white
blood cell counting
• First system for label-free concurrent cellular/acellular monitoring in whole blood
– Found plasma skimming unreliable for continuous operation
– Developed protocols for whole blood sample handling
– Performance of redox catalysis system is conserved at the micro-scale and for whole
blood samples
– Impedance cytometer with osmotic lysis and ow focusing capable of dierential
white blood cell analysis
• Integrated system demonstrates feasibility of point-of-care monitoring for clozapine
adherence, ecacy, and safety
5.2 Summary
My dissertation has presented a study of microsystems integration towards point-of-care
monitoring of clozapine treatment for adherence, ecacy, and safety. I have initially
investigated distinct novel electrochemical techniques to measure clozapine in complex
biological samples by leveraging biomaterials to enhance selectivity and sensitivity. I have
further studied the systems interplay between key components in label- and reagent-free
white blood cell counters – impedance cytometry, hydrodynamic focusing, and osmotic
lysis – in depth. Furthermore, I have evaluated integration approaches for concurrent
detection of both these cellular and acellular biomarkers. Leveraging the knowledge
gained from these eorts, I have implemented and validated the series-type integration
approach shown in Figure 5.1 to for the rst time concurrently monitor clozapine and
white blood cells in whole blood samples.
For clozapine detection, I have employed the biopolymer chitosan as a facile matrix
to confer sensing functionalities. I have demonstrated that the redox cycling system,
where catechol is grafted to the chitosan to allow for repeated oxidation and reduction of
clozapine, yields signicant gains in sensitivity and detection limit. These advantages
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Figure 5.1: Schematic rendering of the integrated microsystem developed in this thesis.
are conserved even in complex biological samples like human serum, with an LOD
below the lower therapeutically relevant limit of 1 µM. By investigating diusion and
electron transfer mechanisms, I have shown that the lms further confer selectivity
between clozapine and its highly analogous metabolite norclozapine due to electrostatic
interactions. Other aspects relevant to lab-on-a-chip integration, such as the impact
of lm storage and the electrode material, have also been assessed. As an alternative
approach, I have presented chitosan composite lms with CNTs and/or graphene. This
redox catalysis system has been shown to drastically enhance the sensitivity and detection
limit of clozapine, again to below 1 µM in clinical samples, as well as the selectivity with
respect to the dominant endogenous interferent uric acid.
Regarding white blood cell counting, I have explored the systems interplay between
impedance cytometry and hydrodynamic focusing. The extensive study in models as
well as particle experiments has validated the approach to provide an up to 5-fold gain in
sensitivity due to the virtual aperture from non-conductive sheath ows. Compared to a
physically smaller channel, this signicantly reduces the risk of channel clogging from
larger cells or aggregates. Furthermore, diusion has been shown to play an important
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role in the performance of this integrated system, in spite of a high Péclet number.
Focus channel geometries, on the other hand, have been shown to only be of secondary
importance. I have also explored integration of impedance cytometry and osmotic lysis.
I have assessed the conditions necessary and sucient for lysis of erythrocytes with DI
water, and found it up to 99.9% eective. Overall, the approach has been shown to enable
white blood cell analysis without the need for either labels or reagents.
For a fully integrated microsystem solution, I have considered two approaches
for concurrent cellular and acellular whole blood monitoring. I have studied parallel
integration employing plasma skimming – exploiting purely hydrodynamic phenomena
for blood/plasma separation – in a proof-of-concept label-free impedimetric immunoassay.
For a manually actuated lab-on-a-chip with portable readout electronics, detection of
150 nM antibodies in whole human blood has been demonstrated for the rst time. I
have further derived procedures to minimize blood clotting and platelet aggregation
inside traditional microdevices for extended research use. However, plasma skimming
has been found to have a brief functional lifetime even under optimized conditions.
I have thus implemented series integration, where whole blood enters a clozapine
sensing chamber and continues into the white blood cell analyzer. For the latter, I have
evaluated instrumentation options with regards to system compatibility, particularly
concerning the decreasing conductivity from hydrodynamic focusing. In the integrated
microsystem, detection of clozapine spiked into whole blood samples owing through
the device has been demonstrated employing the redox catalysis system. Moreover,
white blood cell dierentiation capabilities have been shown, validating the feasibility of




The research presented in this dissertation serves as a signicant step toward point-of-
care monitoring of clozapine treatment. However, further work is called for to advance
and rene components, as well as to fully translate the microsystem into clinical practice.
Clozapine Detection .
As discussed in Chapter 2, chitosan-catechol, platinum black, and chitosan-
CNT/graphene all oer unique advantages (and drawbacks) for clozapine detection. I
chose the latter for my demonstration of concurrent acellular/cellular monitoring system
due to its high sensitivity. To realize the full potential of these sensors and overcome
their limitations, future work should pursue a multi-sensor chemometrics approach. This
involves combining the signals from two or more orthogonal sensing modalities – i.e. ones
based on dierent mechanisms and thus providing independent information – utilizing
techniques such as partial least squares regression or articial neural networks. It is
similar in concept to how the human tongue or nose are able to dierentiate thousands to
millions of tastes and smells with only a very limited set of receptors. As part of the MiND
project, my collaborators – particularly Sheryl Chocron – and I already noted the need for
this and pursued initial work in this direction [99,100]. We demonstrated that even with
a single sensor, these chemometric techniques could enhance performance by utilizing
all available information (instead of simply peak current and potential). Integrating the
chitosan-catechol and chitosan-CNT/graphene composite lms as shown in Figure 5.2
should ultimately enable sensitive detection of clozapine as well as selectivity with respect
to norclozapine. Through further extension of the array, our understanding of a patient’s
status can be enhanced even further, something that may be especially important when
a disease is complex and incompletely understood.
My results also suggest some immediate avenues for developing new sensing
modalities for such arrays from the ones investigated. While I only employ homogeneous
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Figure 5.2: Schematic of the arrayed sensing concept to achieve synergistic clozapine
detection performance. Reproduced with permission from [99].
chitosan lms in my work, my collaborators have previously shown facile fabrication of
heterogeneous multilayer structures [85]. Since I found that diusion through chitosan
allows for dierentiation of clozapine and norclozapine, coating a chitosan-CNT/graphene
lm with a further layer of unmodied chitosan may confer such selectivity to the
redox catalysis system. Further modication with catechol may add additional signal
amplication in a combined catalysis/cycling system, although the experiments with
platinum electrodes suggest that there is a trade-o between these mechanisms.
Lastly, a single-purpose clozapine test as shown in Figure 5.3 may oer additional
benets worth pursuing over the short term. With clozapine detection in whole blood
samples established, a concept directly mirroring that of a glucose meter could be
implemented, where a drop of blood is applied directly to the sensor or sensor array.
Such an approach eliminates the need for microuidics, and thus also microfabrication
and assembly – with only an open, planar electrochemical cell, low-cost screen-printing
becomes feasible. The similarity to the glucose meter concept may also simplify regulatory
approval and thus provide a bridge solution until a fully integrated system becomes
available [1].
Systems Integration .
Toward a true point-of-care device, notable further systems integration needs
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Figure 5.3: Schematic of a single-purpose at-home clozapine monitoring concept.
involve the uid handling and actuation as well as the signal readout [52]. The latter
presents challenges, but not necessarily systems integration challenges – the precise
nature of the electronics will not aect other aspects of a device, though the device
requirements certainly have to inform the specications as observed in Subsection 4.2.4.
For impedance cytometry, this has been realized with custom-made CMOS [167] or
with o-the-shelf components [168,169]. While designed for frequency sweeps and thus
limited in data acquisition speed, the commercial AD5933 impedance analyzer is available
for less than $10 and can be sucient for cytometry in certain (slow ow, single frequency)
cases [160]. Analog Devices further oers the newer, similarly priced ADuCM350, which
oers both impedance measurement capabilities as well as potentiostat functionality
for electrochemical measurements [170]. For electrochemistry alone, the somewhat
less stringent electronics requirements and the broader applicability has further lead to
wide availability of commercial handheld potentiostats, illustrating the relative ease of
miniaturization.
A primary concern regarding uid handling is preventing a ngerstick blood sample
from coagulating or aggregating. While I have successfully avoided other reagents in
my research this particular challenge requires a chemical solution. As above, this can be
investigated independently of other components. One possibility is to adopt a persistent
surface coating that reduces platelet activation, akin to the Pluronic F-68 coating to inhibit
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surface fouling. PDMS microuidics modied with polybetaine, for instance, have been
shown to inhibit coagulation [171]; heparin has been similarly employed [172]. Another
possibility is to coat the surface of the blood sample receptacle – a necessary component
in an eventual point-of-care device – with a dry form of the requisite chemicals. The
reagents would dissolve in the sample upon contact, much like in standard blood collection
tubes.
Fluid actuation, on the other hand, does have the potential for interactions with
other aspects of the device – even in traditional benchtop syringe pumps, motor stepping
and the resulting pulsatile ow are well-established factors in ow control. Current trends
in microuidics favor capillary ow-driven devices for the point of care as they eliminate
the need for additional components [173]. For my system, they also oer the greatest
systems integration challenges due to the need for multiple well-controlled ows. Akin to
the plasma skimming design challenge in Section 4.1 in reverse, the channel dimensions
would require careful design to achieve the necessary ow ratios in all branches of the
network toward the shared outlet. While theoretically possible, in practice this approach
would likely be too sensitive to disruption. The same arguments apply to the other
available passive approach, gravity-driven ow [52]. Capillary force could still be useful
for sample loading akin to what is employed in the Chempaq XBC cartridge [69]. For
actuation, however, active approaches will likely be more promising. The literature
oers numerous examples for integration of such into microuidic lab-on-a-chip systems
[52,174,175]. The main strategies are either mechanical or electrical. A classic example
of the former are peristaltic pumps implemented in multi-layer PDMS systems through
successive valves that close and open to yield a net positive ow. Many other mechanisms
have been presented; their main shared drawback is the added fabrication complexity,
and – akin to syringe pumps – their not perfectly continuous ow. Electrical pumps
rely on electroosmotic ow and are signicantly more robust due to the lack of moving
parts, with fabrication processes also only requiring the comparatively simple addition
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of electrodes. However, complexities in the resulting ow proles – which depend on
the zeta potentials of all materials involved – need to be kept in mind. In either case,
having pumps integrated into the microsystem allows for employing them not just for
ow actuation, but also for drawing a drop of blood into the device. Integrating these
components with batteries and requisite control electronics will ultimately yield a device
suitable for point-of-care use at the pharmacy or doctor’s oce to monitor clozapine
treatment.
5.4 Conclusion
My dissertation research has yielded notable contributions to relevant elds across
the three main Chapters. The understanding of biomaterial application toward
electrochemical sensing may enable detection of other compounds lacking specic
biorecognition elements using similar approaches. The knowledge on the molecular
properties of clozapine such as diusion, electron transfer and electrophoretic transport
can open up additional avenues for its detection. Elucidating the systems interplay
between impedance cytometry, hydrodynamic focusing, and red blood cell lysis is critical
toward designing highly sensitive label-free cell- or particle counters. The studies further
serve as a showcase of how typically neglected phenomena, such as diusion, can have
outsize eects in these integrated microuidic systems, highlighting the need for in-depth
theoretical and experimental investigations of this type in designing them. Moreover,
this research claries fundamental compatibility and testing aspects towards analysis of
human blood samples using microuidic approaches.
My lab-on-a-chip platform, which successfully integrates clozapine and white blood
cell detection abilities in a microsystem while employing simple fabrication techniques
and limiting the use of chemical reagents, represents a considerable technological advance.
The nal integrated microsystem paves the way toward revolutionizing care of millions of
patients with treatment-resistant schizophrenia, including many not currently receiving
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clozapine. Monitoring capabilities for safety, ecacy, and adherence in a single, small
package make it an attractive use case for the point of care, decreasing costs and patient
burden and changing the paradigm of how we currently monitor clozapine treatment.
From its intended purpose of lowering the barriers to the use of clozapine, this system
can further be adapted to other applications that require simultaneous monitoring of
both cellular and acellular blood biomarkers, extending its impact. Ultimately, this initial
application of real-time monitoring of psychiatric drug treatment provides a systems-





6.1 Appendix A: Photomasks
All photomasks are reproduced at a 1:1 scale here, and were generally printed at 25,400 dpi
on transparency foil unless noted otherwise. Some of the extremely ne feature are
unlikely to be reproduced correctly herein when printed.
Figure 6.1: Photomask for 29 planar electrochemistry working electrodes with a surface
area of 7.5 × 7.5 mm2 or 5 × 5 mm2, depending on the orientation utilized.
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Figure 6.2: Photomask for six chips with co-planar impedance cytometry electrodes of
25 µm length and gap.
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Figure 6.3: Photomask for microuidic mold to yield six chips for hydrodynamic focusing
with 25 µm (ultimately not utilized in this work) or 50 µm wide center channels and
25 µm, 50 µm, or 75 µm wide focus channels.
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Figure 6.4: Photomask for microuidic mold to yield six chips for osmotic lysis with
120 µm wide channels (50 µm in measurement region close to outlet) with serpentine
channel lengths of 70 mm, 135 mm, or 200 mm. Hydrodynamic focusing channels of
25 µm width are included as well, but not opened up in the osmotic lysis study.
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Figure 6.5: Photomask for microuidic mold to yield plasma skimming channels as per the
design published by Yang et al. (left 3 chips) and as per the theoretical design rules from
the same paper (center 5 chips). The rightmost designs were intended as test structures.
150
Figure 6.6: Photomask for microuidic mold to yield plasma skimming channels as per the
design published by Yang et al. with small variations in cell outlet channel geometries and
number of plasma skimming channels. This mask was implemented as chrome-on-glass
with a 1.5 µm resolution.
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Figure 6.7: Photomask for six chips with co-planar impedance cytometry electrodes of
25 µm length and gap, integrated with 3-electrode electrochemical cells (2 mm diameter
working electrode).
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Appendix B: Analytical Model for Impedance Cytometry with 
Hydrodynamic Focusing
Reproduced with permission from T. E. Winkler et al., Microfluid. Nanofluidics 2016, 20, 134.
Definitions




ɛ0 = QuantityMagnitude[UnitConvert[1 ε0]];
kB = QuantityMagnitude[UnitConvert[1 k]];
NA = QuantityMagnitude[UnitConvert[1 NA]];
qe = QuantityMagnitude[UnitConvert[1 e]];
Define parameter list for array to hold cellular information, and define exemplary 
array “cell”
ø = 1; t = 2; σmem = 3; ɛmem = 4; σcyt = 5; ɛcyt = 6;
cell = 10 * 10-6, 5 * 10-9, 10-8, 11.3 ɛ0, 0.6, 60 ɛ0;
Define parameter list for array to hold channel and electrode geometry 
information, and define exemplary array “geom”
w = 1; h = 2; l = 3; g = 4;
geom = 50 * 10-6, 20 * 10-6, 25 * 10-6, 25 * 10-6;
Define parameter list for array to hold liquid medium information, and define 
exemplary arrays “sample” and “sheath”; 
“wflow” defines the width that a particular fluid occupies in the channel, and “type” 
whether it is the central sample or side sheath flow
wflow = 1; Q = 2; σmed = 3; ɛmed = 4; IS = 5; type = 6;
sample = VA, 20  3.6 * 10-12, 1.6, 78 ɛ0, 160, "sample";
sheath = geom[[w]] - VA, 20  3.6 * 10-12, 0.055 * 10-6, 78 ɛ0, 10
-4, "sheath";
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Define measurement and environmental parameters
f = 100 000;
ω = 2 π f;
Temperature = 298.15;
Analytical Hydrodynamic Focusing Model
 Relates flow ratio FR to virtual aperture width VA









Sinh2 n + 1 π VA  2 geom[[h]]
2 n + 15 Cosh2 n + 1 π geom[[w]]  2 geom[[h]]





Tanh2 n + 1 π geom[[w]]  2 geom[[h]]
2 n + 15
, {n, 0, ∞} ;
VA = x /. FindRootFR ⩵
x
geom[[w]]
γ[x], x, geom[[w]]  2;
Analytical Electrodynamic Model
Schwarz–Christoffel Mapping to account for co-planar arrangement of the 
electrodes
Adapted from Ref. [2]
TAc[geom_] := Cosh














(TBc[geom] - TCc) (TAc[geom] - TDc)
(TAc[geom] - TCc) (TBc[geom] - TDc)
;




V[geom_, med_] := κ[geom, med] geom[[g]] + 2 geom[[l]] geom[[h]];
Volume & Volume Fraction of the particle
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When considering the sample phase, use spherical segment delineated by VA; when 
considering sheath phase, use corresponding spherical caps
P[cell_, med_] := Switchmed[[type]], "sample",
1  12 π Min[VA, cell[[ø]]] 3 cell[[ø]]2 - Min[VA, cell[[ø]]]2, "sheath",
1
6
π cell[[ø]]3 - 1  12 π Min[VA, cell[[ø]]] 3 cell[[ø]]2 - Min[VA, cell[[ø]]]2
 ;




Calculation of Electrodynamic Parameters for Equivalent Circuit
Adapted from Ref. [3] and Ref. [4]
γcell[cell_] :=
cell[[ø]]
cell[[ø]] - 2 cell[[t]]
;
a1[cell_, geom_, med_] :=
γcell[cell]
3
cell[[ɛcyt]] + 2 cell[[ɛmem]] cell[[ɛmem]] + 2 med[[ɛmed]] +
2 Φ[cell, geom, med] cell[[ɛmem]] - med[[ɛmed]] + 2 cell[[ɛcyt]] - cell[[ɛmem]]
cell[[ɛmem]] - med[[ɛmed]] + Φ[cell, geom, med] 2 cell[[ɛmem]] + med[[ɛmed]];
a2[cell_, geom_, med_] := γcell[cell]
3
cell[[ɛcyt]] + 2 cell[[ɛmem]]
cell[[σmem]] + 2 med[[σmed]] + 2 Φ[cell, geom, med] cell[[σmem]] - med[[σmed]] +
γcell[cell]
3
cell[[σcyt]] + 2 cell[[σmem]]
cell[[ɛmem]] + 2 med[[ɛmed]] + 2 Φ[cell, geom, med] cell[[ɛmem]] - med[[ɛmed]] +
2 cell[[ɛcyt]] - cell[[ɛmem]] cell[[σmem]] - med[[σmed]] +
Φ[cell, geom, med] 2 cell[[σmem]] + med[[σmed]] + 2 cell[[σcyt]] - cell[[σmem]]
cell[[ɛmem]] - med[[ɛmed]] + Φ[cell, geom, med] 2 cell[[ɛmem]] + med[[ɛmed]];
a3[cell_, geom_, med_] := γcell[cell]
3
cell[[σcyt]] + 2 cell[[σmem]]
cell[[σmem]] 1 + 2 Φ[cell, geom, med] + 2 med[[σmed]] 1 - Φ[cell, geom, med] +
2 cell[[σcyt]] - cell[[σmem]]
cell[[σmem]] 1 + 2 Φ[cell, geom, med] - med[[σmed]] 1 - Φ[cell, geom, med];
b1[cell_, geom_, med_] := γcell[cell]
3
cell[[ɛcyt]] + 2 cell[[ɛmem]]
cell[[ɛmem]] + 2 med[[ɛmed]] - Φ[cell, geom, med] cell[[ɛmem]] - med[[ɛmed]] +
cell[[ɛcyt]] - cell[[ɛmem]]
2 cell[[ɛmem]] - med[[ɛmed]] - Φ[cell, geom, med] 2 cell[[ɛmem]] + med[[ɛmed]];
b2[cell_, geom_, med_] := γcell[cell]
3
cell[[ɛcyt]] + 2 cell[[ɛmem]]
cell[[σmem]] + 2 med[[σmed]] - Φ[cell, geom, med] cell[[σmem]] - med[[σmed]] +
γcell[cell]
3
cell[[σcyt]] + 2 cell[[σmem]]
cell[[ɛmem]] + 2 med[[ɛmed]] - Φ[cell, geom, med] cell[[ɛmem]] - med[[ɛmed]] +
cell[[ɛcyt]] - cell[[ɛmem]] 2 cell[[σmem]] - med[[σmed]] -
Φ[cell, geom, med] 2 cell[[σmem]] + med[[σmed]] + cell[[σcyt]] - cell[[σmem]]
2 cell[[ɛmem]] - med[[ɛmed]] - Φ[cell, geom, med] 2 cell[[ɛmem]] + med[[ɛmed]];
b3[cell_, geom_, med_] := γcell[cell]
3
cell[[σcyt]] + 2 cell[[σmem]]
cell[[σmem]] 1 - Φ[cell, geom, med] + med[[σmed]] 2 + Φ[cell, geom, med] +
cell[[σcyt]] - cell[[σmem]]
2 cell[[σmem]] 1 - Φ[cell, geom, med] - med[[σmed]] 2 + Φ[cell, geom, med];
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    
c1[cell_, geom_, med_] := med[[ɛmed]] a2[cell, geom, med] + med[[σmed]] a1[cell, geom, med] -
med[[ɛmed]] a1[cell, geom, med] b2[cell, geom, med]
b1[cell, geom, med]
;
c2[cell_, geom_, med_] := med[[ɛmed]] a3[cell, geom, med] + med[[σmed]] a2[cell, geom, med] -
med[[ɛmed]] a1[cell, geom, med] b3[cell, geom, med]
b1[cell, geom, med]
;
c3[cell_, geom_, med_] := med[[σmed]] a3[cell, geom, med];
s3[cell_, geom_, med_] :=
1
2 b1[cell, geom, med]
-b2[cell, geom, med] +
√
b2[cell, geom, med]^2 - 4 b1[cell, geom, med] b3[cell, geom, med];
s4[cell_, geom_, med_] :=
1
2 b1[cell, geom, med]
-b2[cell, geom, med] -
√
b2[cell, geom, med]^2 - 4 b1[cell, geom, med] b3[cell, geom, med];
s5[cell_, geom_, med_] :=
1
2 c1[cell, geom, med]
-c2[cell, geom, med] +
√
c2[cell, geom, med]^2 - 4 c1[cell, geom, med] c3[cell, geom, med];
s6[cell_, geom_, med_] :=
1
2 c1[cell, geom, med]
-c2[cell, geom, med] -
√
c2[cell, geom, med]^2 - 4 c1[cell, geom, med] c3[cell, geom, med];
k1[cell_, geom_, med_] :=
c1[cell, geom, med] s5[cell, geom, med] s6[cell, geom, med]
b1[cell, geom, med] s3[cell, geom, med] s4[cell, geom, med]
;
k2[cell_, geom_, med_] :=
1  b1[cell, geom, med] s3[cell, geom, med] s3[cell, geom, med] - s4[cell, geom, med]
c1[cell, geom, med] s3[cell, geom, med] - s5[cell, geom, med]
s3[cell, geom, med] - s6[cell, geom, med];
k3[cell_, geom_, med_] := 1  b1[cell, geom, med] s4[cell, geom, med]
s4[cell, geom, med] - s3[cell, geom, med] c1[cell, geom, med]
s4[cell, geom, med] - s5[cell, geom, med] s4[cell, geom, med] - s6[cell, geom, med];








Δɛ1[cell_, geom_, med_] := k2[cell, geom, med] τ1[cell, geom, med];
Δɛ2[cell_, geom_, med_] := k3[cell, geom, med] τ2[cell, geom, med];
σ0[cell_, geom_, med_] := k1[cell, geom, med];





Adapted from Ref. [4]
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Rmem[cell_, geom_, med_] :=
1
κ[geom, med]
τ1[cell, geom, med] + τ2[cell, geom, med]
Δɛ1[cell, geom, med] + Δɛ2[cell, geom, med]
-
1
k2[cell, geom, med] + k3[cell, geom, med]
-
τ1[cell, geom, med] τ2[cell, geom, med] k2[cell, geom, med] + k3[cell, geom, med] 
Δɛ1[cell, geom, med] + Δɛ2[cell, geom, med]
2 ;
Cmem[cell_, geom_, med_] := τ1[cell, geom, med] τ2[cell, geom, med]
k2[cell, geom, med] + k3[cell, geom, med] 
Δɛ1[cell, geom, med] + Δɛ2[cell, geom, med] Rmem[cell, geom, med];
Rcyt[cell_, geom_, med_] :=
1
k2[cell, geom, med] + k3[cell, geom, med] κ[geom, med]
;
Ccyt[cell_, geom_, med_] := Δɛ1[cell, geom, med] + Δɛ2[cell, geom, med] κ[geom, med];
Rmed[cell_, geom_, med_] :=
1
σ0[cell, geom, med] κ[geom, med]
;
Cmed[cell_, geom_, med_] := ɛ∞[cell, geom, med] κ[geom, med];
Ionic Double Layer Capacitor (Helmholtz Model)
λD[med_] :=
med[[ɛmed]] * kB * Temperature
2 NA * qe
2 * med[[IS]]
;




Impedance for single liquid medium phase
Adapted from Ref. [4] and Ref. [5]
Zmix[cell_, geom_, med_] :=





1 + ⅈ ω τ1[cell, geom, med]
+
Δɛ2[cell, geom, med]
1 + ⅈ ω τ2[cell, geom, med]
κ[geom, med] +
2
ⅈ ω CDL[geom, med]
;
Znull[cell_, geom_, med_] :=
1
ⅈ ω med[[ɛmed]] κ[geom, med] + med[[σmed]] κ[geom, med]
+
2
ⅈ ω CDL[geom, med]
;

















ΔZ[cell_, geom_] := Abs






Z[cell, geom] // N
ΔZ[cell, geom] // N
67 528. - 7095.48 ⅈ
71 467.6 - 7338.83 ⅈ
0.0581316
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Appendix C: MATLAB code
Sparse impedance signals from LCR meter
This code served to analyze data from the particle-based experiments in elucidating the interplay between 
hydrodynamic focusing and impedance cytometry
Data import
Read in raw timestamps t, impedance magnitudes Z, and phase values d
import = csvread(filename); 
t = import(:,1); 
z = import(:,2); 
d = import(:,3); 
Signal background - Step 1
Remove obvious peaks from Z based on a threshold (of one standard deviation) in its second derivative, then 
extrapolate smoothed points inbetween as initial approximation of background signal
ddz = abs(vertcat(0,diff(diff(z)),0)); 
temptable = table(t,z,d,ddz,'VariableNames',{'t','z','d','ddz'}); 
temptable = temptable(temptable.ddz < std(ddz),:); 
zbackground = interp1(temptable.t,temptable.z,t,'pchip'); 
dbackground = interp1(temptable.t,temptable.d,t,'pchip'); 
Signal background - Step 2
Construct 9 Hz maximally flat low-pass filter and apply to the previously approximated background
Nb   = 8;   % Numerator Order
Na   = 8;   % Denominator Order
F3dB = 9;   % 3-dB Frequency
Fs   = 180; % Sampling Frequency
h = fdesign.lowpass('nb,na,f3db', Nb, Na, F3dB, Fs); 
f = design(h, 'butter'); 
zbackground = filtfilt(f.sosMatrix,f.ScaleValues,zbackground); 
dbackground = filtfilt(f.sosMatrix,f.ScaleValues,dbackground); 
Parameter calculation
Calculate impedance signal by subtracting the background from the raw data and also express as percentage 
value; use simple local peak finding algorithm for final data processing
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zclean = z - zbackground; 
dclean = d - dbackground; 
zpercent = zclean./zbackground; 
dpercent = dclean./dbackground; 
[~,zpeak] = findpeaks(zclean); 









    ); 
Near-saturation impedance signals from LCR meter
This code served to analyze data from the blood-based experiments in elucidating the interplay between 
osmotic lysis and impedance cytometry
Data import
Read in raw timestamps t, impedance magnitudes Z, and phase values d
import = csvread(filename); 
t = import(:,1); 
z = import(:,2); 
d = import(:,3); 
Signal background
Use image erosion algorithm to determine signal floor, and apply smoothing
zbackground = imerode(z', true(1, 10))'; 
dbackground = imerode(d', true(1, 10))'; 
zbackground = smooth(zbackground,50*1/length(zbackground),'moving'); 
dbackground = smooth(dbackground,50*1/length(dbackground),'moving'); 
Parameter calculation
Calculate impedance signal by subtracting the background from the raw data and also express as percentage 
value; use simple local peak finding algorithm for final data processing
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zclean = z - zbackground; 
dclean = d - dbackground; 
zpercent = zclean./zbackground; 
dpercent = dclean./dbackground; 
[~,zpeak] = findpeaks(zclean); 









    ); 
Histogram construction - Step 1
Numerical model-derived function to transform cell radius into impedance signal, where p is the set of 
appropriate model fit parameters for the given experimental conditions
syms x
f = symfun(p(2).*(abs(x-p(1)).^p(3)), [x]); 
Histogram construction - Step 2
Translate linear range of cell radii into range of impedance signals, and perform histogram binning on this 
non-linear impedance axis to yield linear-binned histogram on cell radius axis
xh = linspace(-0.005,12.005,1202)'; 
xh = double(f(xh)); 
h = histcounts(zpercent(zpeak),xh)'; 
Sparse impedance signals from differential transimpedance/lock-in circuit
This code served to analyze impedance data from the experiments in the fully integrated microsystem
Data import




Extract applied voltage signal levels and lock-in amplifier range settings for both frequencies from filename, 
and use them to convert raw DAQ voltages to µA current values (for theoretical 1V signal)
Vin = regexp(filename,'(?<= )[.\d]+-[.\d]+(?=V )','match','once'); 
Vin = strsplit(Vin,'-'); 
lowVin = str2double(Vin{1}); 
highVin = str2double(Vin{2}); 
Vrange = regexp(filename,'(?<= )[.\d]+-[.\d]+(?=mV )','match','once'); 
Vrange = strsplit(Vrange,'-'); 
lowrange = 0.001*str2double(Vrange{1}); 




Construct 20 Hz low-pass filter
Fs = 125000; % Sampling Frequency
Fpass = 20; % Passband Frequency
Fstop = 30; % Stopband Frequency
Apass = 0.001; % Passband Ripple (dB)
Astop = 80; % Stopband Attenuation (dB)
match = 'passband'; % Band to match exactly
h  = fdesign.lowpass(Fpass, Fstop, Apass, Astop, Fs); 
Hd = design(h, 'cheby2', 'MatchExactly', match); 













Loosely based off the methods described by Caselli et al. (2016) and Evander et al. (2013)
Determine 7 timescales for wavelet analysis based on the maximum linear flow velocity (~1.9x of the average) 
for the fixed channel geometry and the experimental flowrate
scales = ((50*20*125)/(1.9*flowrate*277778))/(4e-5) * [1,1.1,1.2,1.5,1.9,2.4,3]; 
slen = length(scales); 









    disp(['Crosscorrelating Wavelet Scale ',num2str(i),' ...']); 
    v=round(scales(i)/2); 
    temp=xcorr(coefs(i,:)',gausswin(round(scales(i)),1)); 
    xcoefs(:,i)=temp(llow-v:end-v); 
end
Find peaks in the cross-correlation matrix using Matlab's simple algorithm and apply a suitable threshold 
thresh
len = round(llow/(2*max(scales))); 
pos = zeros(len,slen); 
parfor i=1:slen 
    disp(['Finding Peaks Scale ',num2str(i),' ...']); 
    w=round(scales(i)); 
    [~,temp]=findpeaks(xcoefs(:,i),'MinPeakDistance',w,'MinPeakHeight',thresh); 
    temp(length(temp)+1:len)=0; 




Employ the peak positions in the cross-correlation matrix to identify peaks in the current signal, and extract 
the relevant maxima and minima as well as the e2o norm defined by Caselli et al.
pos=unique(pos,'rows','stable'); 
len=length(pos); 
array = zeros(slen,len,6); 
for i=1:slen 
    v=round(scales(i)/2); 
for j = 1:len 
        x = pos(j,i); 
if x 
if (x+v)<llow+1 && (x-v)>0 
                eplus=low(x:x+v); 
                eminus=low(x-v:x); 
                e2o=norm((eplus+eminus)/2)/norm((eplus-eminus)/2); 
                [maglow1,indlow1]=max(low(x-v:x+v)); 
                [maglow2,indlow2]=min(low(x-v:x+v)); 
                maghigh2=max(high(x-v:x+v)); 
                maghigh3=min(high(x-v:x+v)); 
                loc=x-v+(indlow1+indlow2)/2; 






Eliminate duplicates form the multiple timescales employed in the analysis based on a window around each 
identified peak, and keep only the "best" values for each parameter stored
flatarray = zeros(len*5,6); 
for i=1:slen 






while i > 1 
    condition=(array(:,1)>array(i,1)-v); 
    line=cat(2,mean(array(condition,1))*4e-5,max(array(condition,2:5),[],1),min(a
rray(condition,6),[],1)); 
    tempoutput=cat(1,line,tempoutput); 
    array(condition,:)=[]; 
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    i=i-sum(condition); 
end
Output parameter calculation
Apply threshold of 0.5 for e2o norm to the data; for each event, output time index ztime, low-frequency signal 
xsize, and the ratio of high- to low-frequency signals yopacity
tempoutput = tempoutput(tempoutput(:,6)<0.5,:); 
output.ztime = tempoutput(:,1); 
output.xsize = tempoutput(:,2)+tempoutput(:,3); 
output.yopacity = (tempoutput(:,4)+tempoutput(:,5))./output.xsize; 
output.xsize = output.xsize./2; 
Custom functions
adapted from stackoverflow.com/questions/26981478
function y = movavg(w,x)
    w = 2*floor(w/2)+1; 
    i = floor(w/2)+1; 
    cs = cumsum(x)/w; 
    y = zeros(numel(x),1); 
    y(1:i)=cs(w); 
    y(end-(i-2):end) = cs(end) - cs(end-w); 
    y(i+1:end-(i-1))=cs(w+1:end)-cs(1:end-w); 
function y = sample(w,x)
    w = 2*floor(w/2)+1; 
    i = floor(w/2); 
    cv = conv(x, ones(1, w), 'valid')/w; 
    y = zeros(numel(x),1); 
    y(1:i) = cv(1); 
    y(end-(i-1):end) = cv(end); 
    y(i+1:end-i) = cv; 
    y = downsample(y,w); 
Published with MATLAB® R2014b
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